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III. Abstract 
The filamentous fungus Trichoderma reesei (teleomorph Hypocrea jecorina) is one of the 
most important industrial production organisms, owing to its highly efficient (hemi-
)cellulase synthesis and secretion machineries. These enzymes, which in nature allow the 
fungus to utilize energy bound in cellulosic biomass, has wide application in the pulp and 
paper, textile and biofuel industries. The genomic sequence for T. reesei was published in 
2008 and provides the basis for introducing targeted genetic alterations that could for 
example increase cellulase production yields. Like all other filamentous fungi, also T. 
reesei synthesizes a range of small bioactive metabolites which are not required for 
growth, but can broaden the ecological niche of the fungus. Since these bioactive 
metabolites are not involved in the primary metabolism, they are often referred to as 
secondary metabolites. These metabolites include some of the most potent toxins of 
natural source and can therefore have a vast implication on human health and also on 
the economy if crops are contaminated or livestock affected. Luckily, the high bioactivity 
for these metabolites also provides a range of beneficial activities and they therefore 
constitute one of the most important sources for pharmaceuticals; including drugs for 
treatment of infections, for lowering of the cholesterol level in the bloodstream and for 
minimizing undesirable immune responses. The primary objective of this study was to 
gain more knowledge about the genetic mechanisms leading to biosynthesis of two of the 
most prominent types of secondary metabolites produced by T. reesei, polyketides and 
non-ribosomal peptides. Since the molecular tools for T. reesei are not as well-developed 
as for many other species, the study was initiated with creation of new genetic tools that 
would enable pursuance of the primary objective. The developed molecular tools were 
assembled into an expression system for high-throughput construction of defined 
integrated T. reesei mutants and combined inactivation of the non-homologous end 
joining pathway that facilitates ectopic integration of exposed DNA fragments, and a 
color maker so that the mutants, in which the substrate had been integrated correct, 
could be identified by their phenotype. A new bidirectional selective marker system was 
developed based on the pyr2 gene, involved in the pyrimidine biosynthesis pathway, and 
was included in the expression system. The developed expression system was 
subsequently utilized to overexpress several transcription factor genes located in the 
proximity of polyketide synthase- or non-ribosomal synthetase genes in T. reesei. 
Overexpression of one of these transcription factor genes led to a significantly increased 
production of 78 different metabolites, some of which had previously been described and 
belong to the polyketide derived sorbicillinoids. Genetic deletions performed 
subsequently, demonstrated that two polyketide synthase genes, located near the 
overexpressed transcription factor gene, were both essential for biosynthesis of the 
sorbicillinoids. Hence, genes involved in biosynthesis of this group of polyketides were 
identified for the first time. Comparative genomics was subsequently used to identify a 
highly similar polyketide synthase gene cluster in another well-known sorbicillinoid 
producer, Penicillium chrysogenum. Twenty three T. reesei polyketide synthase- and 
non-ribosomal peptide synthetase genes were selected for heterologous expression in 
Aspergillus nidulans, using a previously developed expression system. Several of the 
resulting mutants exhibited altered phenotypes and could be divided into two groups; 
one with mutants producing a pigment and another where the mutants had changed 
colony morphology. Unfortunately, no new metabolite products could be identified with 
the applied extraction- and analysis methods. Nevertheless, the isolated mutants could 
constitute an interesting source of knowledge about the T. reesei secondary metabolism 
after optimization of the applied methods. 
   
    
 
IV. Resumé 
Den filamentøse svamp Trichoderma reesei (teleomorf Hypocrea jecorina) er en af de 
mest udbredte industrielle produktionsorganismer, hvilket skyldes en ekstremt 
veludviklet evne til at syntetisere og udskille cellulose-nedbrydende enzymer. Disse 
enzymer, der i naturen giver svampen mulighed for at udnytte den energi, der er bundet 
i plantebaseret biomasse, har industriel anvendelse ved fremstillingen af både papir og 
tekstiler og spiller desuden en betydelig rolle i fremstillingen af bioethanol. Genom 
sekvensen for T. reesei blev publiceret i 2008 og muliggør blandt andet en målrettet 
optimering af produktionsudbyttet af cellulaser fra denne svamp. Som andre filamentøse 
svampe, producerer T. reesei et arsenal af små meget bioaktive metabolitter, som ikke 
er krævet for at opretholde vækst, men er i stand til at udvide den producerende svamps 
økologiske niche. Disse bioaktive metabolitter betegnes ofte som sekundære metabolitter 
og produktion af disse påvirker også mennesker, da de blandt andet inkluderer nogle 
meget potente toksiner, som kan have både økonomiske og sundhedsmæssige 
implikationer. Den store bioaktivitet betyder ligeledes, at mange sekundære metabolitter 
bliver brugt som lægemidler til blandt andet bekæmpelse af infektioner, til at sænke 
kolesterolniveauet i blodet og til at minimere uhensigtsmæssige immunresponser. Det 
primære formål med dette studie var at få et større indblik i de genetiske mekanismer 
bag produktionen af to af de mest fremtrædende typer af sekundære metabolitter i T. 
reesei, polyketider og non-ribosomale peptider. Da de molekylære værktøjer for T. reesei 
ikke er så veludviklede som for mange andre arter, blev studiet indledt med initiativer for 
at udvide den genetiske værktøjskasse, så det primære mål kunne forfølges. De 
udviklede værktøjer blev samlet til et ekspressionssystem der faciliterer hurtig 
konstruktion af mutanter med korrekt integreret substrat. Ekspressionssystemet 
kombinerer inaktivering af mekanismen bag ektopisk integration af DNA fragmenter og 
favoriserer dermed målrettet integration og inkluderer en farvemarkør så de mutanter 
der har substratet korrekt integreret, udskiller sig fænotypisk fra baggrunden. Til 
systemet blev der ligeledes udviklet en ny effektiv dobbeltselekterbar markør baseret på 
pyr2 genet, som er involveret i syntesen af pyrimidiner. Det udviklede 
ekspressionssystem blev efterfølgende benyttet til at overudtrykke en række 
transkriptionsfaktor gener udvalgt med baggrund i deres placering nær polyketid 
syntase- eller non-ribosomale peptid syntetase gener i T. reesei´s genom. 
Overudtrykkelse af et enkelt af disse medførte en stærkt forøget produktion af hele 78 
forskellige metabolitter, hvoraf flere tidligere er beskrevet og tilhører en polyketid-
baseret gruppe af metabolitter kaldet sorbicillinoider. Efterfølgende gendeletioner 
demonstrerede, at syntesen af disse sorbicillinoider var afhængig af to polyketid syntese 
gener lokaliseret i den samme genklynge som det overudtrykte transkriptionsfaktor gen. 
Dette studie inkluderer dermed første rapporterede identifikation af gener involveret i 
syntese af sorbicillinoider. Komparativ genomisk analyse blev efterfølgende benyttet til at 
identificere en lignende klynge af gener i en anden producent af sorbicillinoider, 
Penicillium chrysogenum. Treogtyve T. reesei polyketid syntese- og non-ribosomal peptid 
syntese gener blev desuden udvalgt til heterolog ekspression i Aspergillus nidulans ved 
brug af et allerede udviklet ekspressionssystem. Flere af de resulterende mutanter 
udviste fænotypiske forandringer, der kunne inddeles i to grupper, pigmentproducerende 
og med ændret kolonimorfologi. På trods af dette kunne ingen nye metabolitter 
detekteres med de anvendte metoder og optimering af både metabolit 
oprensningsproceduren og analysemetoden er højst sandsynligt påkrævet inden dette er 
muligt. Når udført, udgør de allerede isolerede mutanter dog en yderst interessant kilde 
for yderligere indsigt ind den sekundære metabolisme for T. reesei. 
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Abbreviation Description Abbreviation Description 
 5-FdOMP 5-Fluoroorotidine monophosphate  KR b-Keto reductase domain 
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 AVF Averufin  NHEJ Non-homologous end joining 
 AVN Averantin  NMR Nuclear magnetic resonance 
 AVNN Averufanin  NOR Norsolorinic acid 
 C Condensation domain  NRP Non-ribosomal peptide 
 CAIR 5’-Phosphoribosyl 5-aminoimidazole carboxylate  NRPS Non-ribosomal peptide synthetase 
 CBH Cellobiohydrolase  OAVN Oxoaverantin 
 CDD Conserved Domain Database  OE Overexpression 
 CDS Coding sequence  OMP Orotidine monophosphate 
 CTP Cytidine triphosphate  OMST O-Methylsterigmatocystin 
 CYC Cyclization domain  Ox Oxidase 
 DAD Diode array detection  P Probe 
 DAHP 3-Deoxy-D-arabinoheptulosonate-7-phosphate   PDA Potato dextrose agar 
 DH Dehydratase domain  PEP Phosphoenolpyruvate 
 DHDMST Dihydrodemethylsterigmatocystin  Pheol Phenylalaninol 
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 DT Deletion test  PT Product template domain 
 dTMP Deoxythymidin monophosphate  R Thioester reductase domain 
 DTU Technical University of Denmark  rv Reverse 
 dUMP Deoxyuridine monophosphate  SAICAR N-succinyl-5-aminoimidazole-4-carboxamide 
ribotide  DW Downstream  
 EG Endoglucanase  SAT Starter unit acyl-carrier protein transacylase 
 EIC Extracted Ion Chromatogram  SDR Short-chain dehydroganase/reductase 
 ER Enoyl reductase  SM Secondary metabolite 
 Ery4P Erythrose 4-phosphate   ST Sterigmatocystin 
 EST Expressed sequence tag  T Thiolation domain / TtrpC terminator 
 EtOAc Ethyl acetate  TE Thioesterase domain 
 FL Flank  TF Transcription factor 
 FOBI Research School for Biotechnology  TOF Time-of-flight 
 fw Forward  TrF Transformation 
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 Gly Glycine  UHPLC Ultra-high pressure liquid chromatography 
 GMP Guanosine 5′-monophosphate  UMP Uridine monophosphate 
 GOI Gene of interest  UN Uridine nucleosidase 
 HAVN 5′-Hydroxyaverantin  UP Upstream 
 HMM Hidden Markov model  UPT Uracil phophotransferase 
 HPLC High pressure liquid chromatography  UTP Uridine triphosphate 
 HR Homologous recombination  Val Valine 
 IMP Inosine 5′-monophosphate  VAL Versiconal 
 IOI Insert of interest  VERA Versicolorin A 
 iPKS Iterative PKS  VERB Versicolorin B 
 IT Insertion test  VHA Versiconal hemiacetal acetate 
 JGI Joint Genome Institute  YPD Yeast extract peptone dextrose 
 
 
 
 
 
   
    
 
VII. Objectives and Thesis Outline 
 
The main purpose of this study was to gain more insight into the genetics behind the 
secondary metabolism of the important industrial filamentous fungus T. reesei 
(Teleomorph Hypocrea jecorina). 
While some of the secondary metabolites from this species have been described, none of 
these have previously been linked to any of the responsible genes. Recent publication of 
the full genome sequence of T. reesei (Martinez, Berka et al. 2008), freely available for 
browsing through the Joint Genome Institute (JGI) portal (http://genome.jgi-
psf.org/Trire2/Trire2.home.html), now enables bioinformatic insights into the secondary 
metabolic potential of this species. Nevertheless, biosynthesis of secondary metabolites is 
extremely complex, and linkage between metabolites and genes involved in their 
biosynthesis can typically not be achieved without application of genetic engineering at 
present. 
Elucidation of the genetics behind two important classes of secondary metabolites, 
polyketides (PKs) and non-ribosomal peptides (NRPs), was commenced for T. reesei in 
this study. These classes of secondary metabolites are widely produced by filamentous 
fungi and constitute two very important sources of bioactive molecules for the 
pharmaceutical industry and they also include several very potent toxins with 
implications on human health and economy. 
This study was initiated by development of molecular tools for T. reesei, which were 
essential for pursuance of the primary objective. Development of these was followed by 
two approaches to gain more insight into the genetics behind the PK and NRP 
biosynthesis machineries. The results obtained in duration of this study are presented in 
three manuscripts divided into two main chapters as seen below. 
 
 
Chapter I – Tool development
Chapter II – Unraveling the secondary metabolism of T. reesei
Trichodermareesei
An Efficient Expression Platform 
for Trichoderma reesei
(Teleomorph Hypocrea jecorina)
Identification of the Sorbicillinoid 
Synthase Gene Cluster in 
Trichoderma reesei (Teleomorph 
Hypocrea jecorina) by 
Overexpression of PKS- and NRPS 
Gene Cluster Specific 
Transcription Factors
Heterologous Expression of 
Trichoderma reesei (Teleomorph 
Hypocrea jecorina) Polyketide 
Synthase-, Non-Ribosomal Peptide 
Synthetase-and Hybrid Synthetase
Genes in Aspergillus nidulans
Manuscript I (section 2.2)
Manuscript II (section 3.2) Manuscript III  (section 3.3)
   
    
 
 
Manuscript I (section 2.2) presents an expression platform developed for use with T. 
reesei. The expression platform includes a new bidirectional selective marker based on 
the pyr2 gene, involved in the pyrimidine biosynthesis pathway, and a system for easy 
selection of defined integrated expression mutants. The latter was achieved by 
inactivating the non-homologous end joining (NHEJ) pathway, which normally facilitates 
random fusion of exposed DNA fragments, and use of adeB, involved in the purine 
biosynthesis pathway, as a specific integration site resulting in altered phenotypes of 
correct integrated mutants.  
This manuscript is in the final stage of preparation for submission to Fungal Genetics and 
Biology. 
 
Manuscript II (section 3.2) describes use of the developed expression platform for 
overexpression of 11 selected polyketide synthase (PKS) and non-ribosomal peptide 
synthetase (NRPS) cluster specific transcription factors. The approach successfully led to 
identification of a PKS gene cluster responsible for biosynthesis of a group of PK derived 
metabolites referred to as sorbicillinoids. It was furthermore established that two 
collaborative PKSs, encoded by genes in the cluster adjacent to the over-expressed 
transcription factor, were both essential for biosynthesis of metabolites belonging to this 
group of PKs. Comparative genomics was subsequently used to estimate the cluster size 
and to pin-point the putative sorbicillinoid gene cluster in another sorbicillinoid producer, 
Penicillium chrysogenum. 
This manuscript is in the final stage of preparation for submission to Applied and 
Environmental Microbiology. 
 
Manuscript III (section 3.3) includes a heterologous expression study of 23 T. reesei 
PKS-, NRPS- and hybrid synthetase genes in Aspergillus nidulans using an expression 
system previously developed by Bjarne Gram Hansen (Hansen, Salomonsen et al. 2011). 
Eight A. nidulans mutants with changed phenotypes were successfully isolated. 
At present this manuscript is not in preparation for publication. 
 
A phylogenetic three of all T. reesei strains included in these studies can be seen in appendix 
section 6.1. 
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1. General Background 
 
1.1. Filamentous Fungi 
 
The term filamentous fungi covers numerous taxonomically diverse species which grow 
as multi-cellular filaments, also referred to as hyphae. Like all fungi, filamentous fungi 
are heterotrophs and depend on access to organic matter for energy. Most environments 
are dependent on filamentous fungi for decomposition of different types of biopolymers 
such as (hemi-)cellulose, starch, pectin and xylan from which the fungi also obtain their 
energy. An array of hydrolytic enzymes is typically released from the hyphal tips and 
breaks the adjacent biopolymers down to simple monomers which are subsequently 
absorbed by the hyphae. The well-developed enzyme synthesis and secretion system of 
filamentous fungi has let to exploitation of these as production organisms for enzymes 
with application in diverse industries such as the detergent-, bioenergy-, textile-, paper-, 
feed-, food- and beverage industries.  
Filamentous fungi typically also synthesizes and releases a selection of small molecular 
weight bioactive secondary metabolites (SMs), which are not essential for survival of the 
producer, but provide competitive advantages in the surrounding area and also intra- and 
interspecies signaling capacity (Demain, Fang 2000). The high bioactivity of these 
metabolites includes some very potent toxins, but also provides an interesting source of 
compounds with possible advantageous activities from a human point-of-view. One of the 
best examples is penicillin, produced by Penicillium rubens among others, which was 
discovered by Alexander Fleming in 1928 (Houbraken, Frisvad et al. 2011). Since the 
discovery of penicillin a wide range of other SMs derived from filamentous fungi and with 
diverse medical applications have been discovered and are currently in use as 
antimicrobials, immunosuppressants, cholesterol lowering agents, chemotherapeutics 
and siderophores (Misiek, Hoffmeister 2007). Filamentous fungi are furthermore 
interesting for research as model organisms since they are eukaryotic and have polarized 
cells and therefore resemble human cells more than yeasts. 
Two filamentous fungi were included in these studies, Trichoderma reesei and Aspergillus 
nidulans; more detailed descriptions of these can be seen in section 1.1.1 and 1.1.2, 
respectively. 
 
1.1.1. Trichoderma reesei (Teleomorph Hypocrea jecorina) 
 
The mesophilic filamentous fungus T. reesei (teleomorph Hypocrea jecorina) is the 
primary source of industrially produced cellulases and hemicellulases with application in 
the pulp and paper, textile and biofuel industries due to their ability to saccharificate 
plant cell wall polysaccharides. 
An isolate of this green ascomycete was taken from an army tent on the Solomon Islands 
during the Second World War after it had caused severe destruction of the cotton 
canvases. The isolate was added to the US army strain collection at the QuarterMaster 
Research and Development Center where it was named T. viride QM6a (MANDELS, 
REESE 1957), but were soon after recognized as a separate species from T. viride and 
renamed T. reesei, while the isolate ID “QM6a” was retained. Interestingly, this single 
isolate is the sole ancestor of all industrially applied T. reesei production strains at 
present. For about 50 years it was believed that T. reesei reproduced exclusively 
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asexually, but in 1996 Kuhls and coworkers published molecular evidence indicating that 
it was a clonal derivative of the pantropic fungus H. jecorina (Kuhls, Lieckfeldt et al. 
1996). This was supported by Seidl and coworkers in 2009 who identified the T. reesei 
Mat1-2 mating type and successfully crossed T. reesei with a H. jecorina strain of the 
Mat1-1 mating type (Seidl, Seibel et al. 2009). Despite the linkage to the sexually 
propagating fungus H. jecorina, which normally also provides the name for the 
holomorph, the name T. reesei is still dominating in publications due to historical 
reasons. 
The original QM6a isolate has been subjected to several rounds of classical mutagenesis 
and selection steps to obtain strains that excrete more protein with limited proteolytic 
break-down. One of the most applied high cellulose-producing clones of T. reesei, called 
RUT-C30, was obtained through two UV mutagenesis steps and one chemical 
mutagenesis step. Selection for catabolite derepression, higher extracellular protein 
levels and increased cellulase activity was performed (Eveleigh, Montenecourt 1979, 
Montenecourt, Eveleigh 1977). These steps have, together with extensive process 
development, resulted in strains able to produce more than 100 g/l of cellulases and 
hemicellulases highly feasible for commercial production (Cherry, Fidantsef 2003, 
Saloheimo, Pakula 2012, Schuster, Schmoll 2010). 
The widespread application of T. reesei as a production organism is also founded by its 
good properties for large scale fermentations and the fact that it is extremely easy and 
inexpensive to cultivate. No antibiotics or mycotoxins are produced at standard 
fermentation conditions and since it is also a non-pathogen for healthy humans, 
generally regarded as safe (GRAS) status has been appointed to several T. reesei 
enzyme products by the Food and Drug Administration (FDA). The protein synthesis 
machinery of T. reesei is highly efficient, mainly reflected by the large quantities of 
cellulases that are naturally produced by this species. The main protein secreted by the 
original T. reesei isolate is cellobiohydrolase I (CBHI) which accounts for about 50% of 
the total protein production, but also cellobiohydrolase II (CBHII) and endoglucanases 
(EGI and EGII) are secreted in significant amounts (Beguin 1990). 
The T. reesei genome spans 33 MB and is divided between seven chromosomes; it has 
been fully sequenced and made accessible by JGI (http://genome.jgi-
psf.org/Trire2/Trire2.home.html) (Martinez, Berka et al. 2008). Substantial expressed 
sequence tag (EST) analysis has been carried out twice (Foreman, Brown et al. 2003, 
Diener, Dunn-Coleman et al. 2004) resulting in identifications of 5,131 and 5,429 unique 
ESTs estimated to cover more than 50% of the coding regions of the genome (Diener, 
Dunn-Coleman et al. 2004). The available sequence- and expression data for T. reesei 
have so far primarily been utilized to get an insight into the highly efficient cellulase and 
hemicellulase synthesis and secretion system of T. reesei, but has also provided 
information that can be used to elucidate other processes in the fungus. The available 
sequence data also opens up for introduction of targeted genetic modifications and 
identification of interesting genetic elements. 
T. reesei has been used for heterologous expression of several genes, most of which 
have been introduced to optimize the biomass saccharification properties of the fungus; 
including a laccase gene (lacA) from the fungal genus Trametes sp. (Zhang, Qu et al. 
2012), a laccase gene from the fungus Phlebia radiata (Saloheimo, Niku-Paavola 1991), 
a beta-glucosidase from the fungus Penicillium decumbens (Ma, Zhang et al. 2011),  and 
an endoglucanase from the bacteria Acidothermus cellulolyticus (Zou, Shi et al. 2012). 
Other gene types have also been heterologous expressed in T. reesei, spanning from a 
Saccharomyces cerevisiae dolicylphosphate mannose synthase gene (Perlinska-Lenart, 
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Bankowska et al. 2006), a shark antibody gene (Conference paper; Mohammed, S, Te'o, 
V, Nuttall, S, Nevalainen, H. 2006.) to a human derived N-acetylglucosaminyltransferase 
I gene (Maras, De Bruyn et al. 1999). The reporter genes for beta-glucuronidase (Liu, 
Wang et al. 2008) and green fluorescence protein (Zou, Shi et al. 2012) have also been 
utilized for expression studies in T. reesei. Even though expression of this wide selection 
of heterologous genes has been reported, T. reesei is still not utilized as an industrial 
production organism for other types of enzymes than cellulolytic enzymes; possibly due 
to the still relatively low expression level observed for most heterologous proteins. 
The secondary metabolism of T. reesei has not received much attention and only a 
limited number of SMs have been described for T. reesei at present. These include 
paracelsin A-D belonging to a group of NRPs referred to as peptaibols characterized by 
high α-aminoisobutyric acid content and a C-terminal 1.2-amino alcohol (Baker, Perrone 
et al. 2012). Other metabolites include the trichodermins belonging to the terpenes and 
the polyketide derived metabolite groups trichodimerols, trichodermatides and 
sorbicillinoids (Andrade, Ayer et al. 1996, Andrade, Ayer et al. 1992, Reino, Guerrero et 
al. 2008, Sun, Tian et al. 2008). 
 
1.1.2. Aspergillus nidulans 
 
Fungi in the genus Aspergillus have had an impact on human life through many years. 
Aspergillus oryzae is believed to be one of the first filamentous funguses to be 
domesticated and has been used for fermentation of Japanese and Chinese food products 
for at least 2000 years (Rokas 2009). At present A. oryzae also plays an important role 
as an industrial production organism and is together with Aspergillus niger, Aspergillus 
sojae and Aspergillus terreus responsible for production of organic acids, 
pharmaceuticals, enzymes and food products (Meyer 2008, Lubertozzi, Keasling 2009). 
Unfortunately, not all Aspergilli are beneficial from a human point of view and species like 
Aspergillus fumigatus and Aspergillus flavus can lead to aspergillosis and A. flavus also 
infects stored grain making whole crops inedible (Meyer, Wu et al. 2011). 
The widespread use of Aspergilli as production organisms is based on several factors; 
first of all the species in this genus tolerate very broad cultural conditions when it comes 
to temperature, pH, salinity, water activity and nutrient levels. They can also be used for 
both solid state- and submerged fermentations in large industrial scale. Furthermore, 
they are well-suited for degrading diverse polymers such as (hemi-)cellulose, starch, 
pectin, xylan and proteins (Meyer, Wu et al. 2011). At present eight species belonging to 
the Aspergillus genus have been sequenced serving an interesting foundation for 
comparative genomic analysis (Wortman, Gilsenan et al. 2009). 
The importance of Aspergillus nidulans as a model organism for eukaryotic cell biology 
through more than 60 years (Martinelli 1994) is based on a combination of its close 
relationship with all of the above mentioned Aspergilli and its qualities as a laboratory 
organism. One of the biggest advantages is that A. nidulans has a sexual cycle, unlike 
most other Aspergilli used by humans, and can easily be crossed in the laboratory, 
making it possible to obviate some of the laborious transformation and selection cycles. 
A. nidulans has been used as a model organism for such diverse processes as DNA 
recombination, DNA repair, cell cycle control, metabolism and secondary metabolism 
(David, Ozcelik et al. 2008, Goldman, Kafer 2004, Kahl, Means 2003, Brakhage, 
Schroeckh 2011, Bok, Noordermeer et al. 2006, Reyes-Dominguez, Bok et al. 2010). The 
genetic tools for A. nidulans are well-developed and there is a wide selection of different 
types of selective markers and both constitutive and inducible promoters at hand. 
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Previous challenges regarding low transformation- and targeting efficiency have been 
resolved in the last decade and strain lines with a deficient NHEJ system are now used 
frequently. The genome sequence was published in 2003 
(http://www.broad.mit.edu/annotation/genome/aspergillus_nidulans.1/Home.html) and 
made public in 2005 together with annotation of genes (Galagan, Calvo et al. 2005). 
The intensive research conducted for A. nidulans is also reflected by the number of SMs 
that have been described for this filamentous fungus. At most applied laboratory 
conditions only few metabolites are regularly observed including sterigmacystin, 
asperfuranone, asperthecin, emericellamide, austinol, sclerotiorin, prenyl xanthone and 
the napthopyrine precursor to the spore pigment melanin (Barnes, Dola et al. 1994, 
Chiang, Szewczyk et al. 2009, Szewczyk, Chiang et al. 2008, Chiang, Szewczyk et al. 
2008, Lo, Entwistle et al. 2012, Somoza, Lee et al. 2012, Sanchez, Entwistle et al. 2011, 
Fujii, Watanabe et al. 2001). Nevertheless, many more metabolites have been described 
for A. nidulans, to some extent enabled by approaches for activation of otherwise silent 
SM synthase pathways (methods discussed in section 3.1.7); these include 
monodictypherone, spiroanthrones, emodine derivates and a range of novel metabolites 
which have not yet been named (Bok, Chiang et al. 2009, Scherlach, Sarkar et al. 2011, 
Gerke, Bayram et al. 2012, Ahuja, Chiang et al. 2012). 
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2.1. Introduction 
 
Genetic engineering is a corner stone for research in the field of biotechnology. It is used 
for a range of applications including elucidation of gene function and for unraveling 
metabolic pathways and in the biotech industry it is a vital tool for improving the yield of 
production strains and for optimization of products. Genetic engineering is highly 
dependent on available molecular tools and development of these is required for each 
new organism taken into use.  
The first chapter of this thesis describes the development of new molecular tools for use 
in T. reesei; which were combined into a system for high throughput construction of 
defined integrated expression mutants. While development of this new toolset was not 
one of the primary objectives for this thesis, it was required before the main objective 
could be pursued - further elucidation of the secondary metabolism of T. reesei. 
Some background information essential for development of the expression system for T. 
reesei can be seen in the following sections (2.1.1 – 2.1.3). 
 
2.1.1. Gene Targeting 
 
Two competing mechanisms for repairing double stranded breaks (DSBs) in DNA exist in 
eukaryotic organisms, homologous recombination (HR) and NHEJ. While HR includes use 
of a template to guide repair of 
the DSB, NHEJ does not require a 
template and simply joins two 
exposed DNA ends to repair a DSB 
(Figure 2.1). Depending on species 
one or the other often acts as the 
primary mechanism for joining 
DSBs. In S. cerevisiae HR 
dominates, and has been widely 
exploited to conduct gene 
targeting by transformation with 
DNA substrates flanked by 
sequences homologous to the 
insertion site of interest (Miné-
Hattab, Rothstein 2013). Unlike for 
S. cerevisiae, the dominating 
mechanism in most filamentous 
fungi is NHEJ. Transformation with 
DNA substrates therefore happen 
primarily by ectopic integration, 
hampering correct gene targeting 
events which correspond to just 5-
10% depending on the fungus and 
the size of the homologous flanks 
(He, Price et al. 2007, Carvalho, 
Arentshorst et al. 2010, Wang, 
Yang et al. 2011). To increase the 
ratio between homologous- and 
Figure 2.1. The two mechanisms of DSB repair. Only HR include use of a 
template to guide repair of the DSB (Kirkman, Deitsch 2012). 
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ectopic integration events, genes encoding proteins involved in NHEJ, such as ku70, are 
often inactivated, making HR the primary mechanism of substrate integration (Carvalho, 
Arentshorst et al. 2010, Choquer, Robin et al. 2008, de Boer, Bastiaans et al. 2010, Li, 
Du et al. 2010). As seen in Figure 2.2, inactivation of NHEJ results in a lower number of 
mutants after a transformation, but the frequency of correctly integrated mutants can 
approximate 95-100% (Carvalho, Arentshorst et al. 2010, Catalano, Vergara et al. 2011) 
 
 
 
 
 
 
 
 
2.1.2. Selectable Markers 
 
The frequency of genomic integration of a substrate when transforming protoplasts
1
 is 
extremely low compared to the total number of cells. Depending on method and quality 
of the protoplasts, approximately 10-7-10-8 cells will take up the DNA and incorporate it 
into their genome. To circumvent extremely cumbersome screening studies, the 
substrates for transformation include selectable markers which ensure that the mutants 
with incorporated substrate are able to survive at conditions the original host cannot. 
Selective markers are traditionally divided into two types, dominant and auxotrophic.  
The dominant selective markers do not require previous alterations of the genome of the 
host and is therefore well-suited for use in species that are not well-studied or with little 
available sequence data. Examples of dominant markers are the hygromycin 
phosphortransferase gene (hph) originating from E. coli, which confers resistance 
towards the antibiotic hygromycin B, which is toxic to most filamentous fungi, and the 
acetamidase gene (amdS) originating from A. nidulans (Punt, Oliver et al. 1987, Tilburn, 
Scazzocchio et al. 1983) which enable mutants to utilize acetamide as nitrogen source, 
which most wild-type filamentous fungi are unable to. 
Auxotrophic selective markers require inactivation of genes involved in important 
metabolic pathways before use. These genes or their orthologous are then included in the 
substrates for transformation and re-generate the interrupted pathway if inserted. 
Examples of auxotrophic selectable markers from two different metabolic pathways are 
described in more detail below. 
 
 
 
 
                                           
1 Cells which have had the cell wall removed. Used for transformations since they allow DNA to cross the cell membrane.  
FL1 FL2Marker
Substrate
FL1 FL2GOI
Target
NHEJ
90-95%
HR
5-10%
FL1 FL2Marker
FL1 FL2GOI FL1 FL2Marker
Unwanted
Wanted
Active NHEJ Inactive NHEJ
A B
FL1 FL2GOI
Figure 2.2. Targeted gene replacement. A, transformation with a gene deletion substrate targeting the gene of interest (GOI). NHEJ 
results in integration of the substrate at a position outside the target, while HR integrates the substrate at the correct position. In rare 
events one flank can be integrated by HR while the other is integrated by NHEJ (not shown). The frequency of mutants with the 
substrate integrated by HR is approximately 5-10% when the NHEJ pathway is active. B, inactivation of the NHEJ pathway does not 
increase the number of correct integrated mutants (green), but removes the background of mutants with substrates integrated 
ectopic (red). 
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Selectable marker genes from the pyrimidine biosynthesis pathway  
Gene orthologous of the widely used S. cerevisia selective marker genes URA3, encoding 
orotidine 5-phosphate decarboxylase, and URA5, encoding orotate 
phosphoribosyltransferase, have been used as selective markers in several species 
(Goosen, Bloemheuvel et al. 1987, Ballance, Turner 1985, Edman, Kwon-Chung 1990). 
As seen in Figure 2.3 for T. reesei, deletion 
of the URA3 ortholog pyr4 or the URA5 
ortholog pyr2 will lead to pyrimidine 
deficiency and blocked RNA and DNA 
synthesis unless uridine or uracil is 
supplemented to the growth media 
permitting utilization of an alternative 
pathway. The widespread use of these genes 
as selectable markers is partly due to the 
fact that they are also counter-selectable, 
hence, there can be selected for both an 
active and inactive pathway. Negative 
selection is achieved by supplementing 5-
Fluoorotic acid (5-FOA) to the growth media. 
When this compound is metabolized by PYR2 
and PYR4, the potent suicide inhibitor of 
thymidylate synthase (TS) 5-
fluorodeoxyuridine monophosphate (5-
FdUMP) is produced and synthesis of DNA is 
halted (Santoso, Thornburg 1998, Beck, 
Dingermann et al. 2002). This enables use 
of pyr2 or pyr4 as selective markers for 
introducing consecutive genetic alterations 
when included in blaster cassettes where 
the marker gene is placed in between direct 
repeats so that it can be looped out by 
homologous recombination between these.  
 
Selectable marker genes from the purine biosynthesis pathway 
Two genes involved in biosynthesis of purines have also been utilized as selectable 
markers in several species as seen for S. cerevisiae in Figure 2.4. These genes encode 
5’-phosphoribosyl 5-aminoimidazole carboxylase (ADE2) and N-succinyl-5-
aminoimidazole-4-carboxamide ribotide synthetase (ADE1). Disruption of either ADE1 or 
ADE2 encoding these enzymes will result in accumulation of the precursor 5’-
phosphoribosylaminoimidiazole (AIR) which polymerizes into a red product, making 
disruption mutants easy to pick out from the background (Zonneveld, van der Zanden 
1995). Several important metabolic products are synthesized by the intact pathway, but 
the fatality of the ADE1 or ADE2 disruptions can be circumvented by adding adenine to 
the growth media. Re-insertion of the deleted ADE1 or ADE2 gene in connection with the 
transformation substrate will regenerate adenine prototrophy and the red polymer will 
not be accumulated. 
 
Figure 2.3. Segment of the T. reesei pyrimidine biosynthesis 
pathway and the metabolic pathway of 5-FOA leading to 
inhibition of DNA synthesis. The enzymes that are involved in 
the reactions are marked with blue text. Abbreviations: 5-
FdOMP, 5-Fluoroorotidine monophosphate; 5-FdUMP, 5-
Fluorodeoxyuridine monophosphate; 5-FOA, 5-Fluoroorotic 
acid; CTP, Cytidine triphosphate; dTMP, Deoxythymidin 
monophosphate; dUMP, Deoxyuridine monophosphate; OMP, 
Orotidine monophosphate; TS, Thymidylate synthase; UMP, 
Uridine monophosphate; UN, Uridine nucleosidase; UPT, Uracil 
phophotransferase; UTP, Uridine triphosphate. 
Normal metabolic
pathways
5-FOA
metabolism
PYR2
PYR4
Orotate 5-FOA
OMP 5-FdOMP
UMP 5-FdUMP
UTPCTP dTMPdUMP
TS
Uracil
UPT
RNA
synthesis
RNA
synthesis
DNA
synthesis
Uridine
UN
_
Alternative
pathway
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2.1.3. Molecular Cloning 
 
Molecular cloning has traditionally involved treatment of DNA fragments with specific 
restriction enzymes, forming matching overhangs, followed up with fusion of the 
fragments in a ligase dependent reaction. While this is still the most widespread method 
of molecular cloning, other more recently developed methods for molecular cloning are 
prevailing. 
 
Uracil-excision cloning 
Uracil-excision cloning exploits the activities of uracil DNA glycosylase (Lindahl, 
Ljungquist et al. 1977, Abe, Yamamoto et al. 2000) and the DNA glycosylase-lyase 
endonuclease VIII (Jiang, Hatahet et al. 1997) to form custom designed 3’ DNA 
overhangs that can be used to fuse fragments of interest (Figure 2.5). The efficiency of 
the cloning system is underlined by its ability to fuse not just two, but several DNA 
fragments in a single cloning step, enabling assembly of the wanted constructs in fewer 
cloning steps than when using classic cloning methods. Furthermore, the ligase 
treatment step can be skipped and restriction enzyme digestions made redundant by 
amplifying the vector with primers designed for uracil-excision cloning. Use of vectors 
with multiple polylinkers is therefore not required and the large degree of freedom for 
Intact pathway Disrupted pathway
PRPP PRPP
AIR AIR
CAIR CAIR
SAICAR
ADE2
Polymerization
IMP
AMP
GMP Guanine
Adenine
Extracellular
Adenine
Hypoxanthine
AAH1
HPT1
ADE1
SAICAR
Figure 2.4. Segment of the S. cerevisiae purine synthesis pathway - only the reactions important for understanding 
the nature of the selection system is included. Adenine originating from an extracellular source is marked with 
green and the red polymerized product with red. Abbreviations for selected key enzymes are marked with blue. 
Abbreviations: AAH1, Adenine deaminase; ADE1, Phosphoribosylamino-imidazole-succinocarbozamide synthetase; 
ADE2, Phosphoribosylamino-imidazole-carboxylase; AIR, 5’-Phosphoribosylaminoimidiazole; AMP, Adenosine 
monophosphate; CAIR, 5’-Phosphoribosyl 5-Aminoimidazole carboxylate; GMP, Guanosine 5′-monophosphate; 
HPT1, Hypoxanthine-guanine phosphoribosyltransferase; IMP, Inosine 5′-monophosphate; PRPP, 5-Phosphoribosyl-
1-pyrophosphate; SAICAR, N-Succinyl-5-aminoimidazole-4-carboxamide ribotide 
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designing the uracil containing primer tails deliver large plasticity for designing 
constructs.  
 
 
 
 
 
 
 
 
 
 
 
In-Fusion cloning 
In-Fusion cloning is a cloning method similar to uracil-excision cloning. In-Fusion cloning 
exploits the 3’–5’ exonuclease activity of a poxvirus DNA polymerase (Hamilton, Nuara et 
al. 2007) to form 5’ DNA overhangs that can be used to fuse fragments of interest. The 
5’ overhangs, exposed by 3’-5’ exonuclease activity, are normal distributed with a mean 
of 15 bp. The DNA fragments of interest are therefore designed so that the ends include 
15 bp complimentary sequences with the fragments they should be fused with, enabling 
formation of stable hybridized circular products. The final ligation is performed inside the 
E. coli cells after transformation as for uracil-excision cloning. 
  
 
The following manuscript describes development of new molecular tools for use with T. 
reesei and consolidation of these into a system for high throughput construction of 
defined integrated expression mutants. The system includes inactivation of the NHEJ 
pathway (section 2.1.1), integration into the purine pathway gene adeB (section 2.1.2) 
and use of the pyrimidine pathway gene pyr2 as bidirectional selective marker (section 
2.1.2). Most constructs were assembled by uracil-excision cloning (section 2.1.3). 
 
G C T G A G G T C T TA AT TA AT G C C T C A G C
C G A C T C C A G A AT TA AT TA C G G A G T C G
PacI Nt.BbvCI
Nt.BbvCI
IOI
T C T G C G A  U
A G A C G C T T
AT TA AT G C C
UA AT TA C GG
IOIC C A G A AT TA
AT TA AT G C C
U
GGTCTTAA
U
A AT TA C G G
GCTGAGGTC TTAAT
CGACT T CAGC
TAATTACGG AGTCG
C C A G A AT
TA AT G C C
Digestion (PacI/Nt.BbvCI)
Uracil-excision
enzyme treatment
Vector
PCR product preparationVector preparation
IOI
X X X X X X X X X X
X X X X X X X X X X
3 ’
3 ’
GCTGAGGTC TTAAT
CGACT T CAGC
TAATTACGG AGTCG
IOIC C A G A AT TA
AT TA AT G C C
DNA fragment
Restriction cassette
Incubation and
E. coli transformation
Mix DNA fragments
IOI
1
2
3
4 Vector with insert
Figure 2.5. Uracil-excision cloning of a PCR fragment into a vector. 1, the vector used includes a PacI/Nt.BbvCI 
restriction cassette designed to form overhangs that can be used with the uracil-excision cloning method. The insert 
of interest (IOI) is amplified using primers carrying custom designed tails including one uracil each. 2, the vector is 
prepared by digestion with PacI and Nt.BbvCI exposing 3’ overhangs. The PCR fragment is treated with uracil-excision 
enzyme mix which facilitates excision of the uracil (by uracil DNA glycosylase) and exposes the adjacent nucleotides 
(by DNA endonuclease VIII) which are complimentary to the 3’ overhangs of the vector. 3, The DNA fragments are 
mixed and the complimentary DNA overhangs hybridize to form stable circular products. The large size of the 
overhang makes a ligase reaction redundant. 4, the final ligation of the product is performed inside the E. coli cells 
after transformation.  
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Abstract 
 
The industrially applied filamentous fungus Trichoderma reesei (teleomorph Hypocrea 
jecorina) has received a lot of interest due to its highly efficient synthesis apparatus of 
cellulytic enzymes. The aim of this study was to introduce new genetic tools for T. reesei 
enabling improvement of the organism for industrial production and to pave the way to a 
possible expansion of the product portfolio. Deletion of tku70, leading to non-homologous 
end joining (NHEJ) deficiency, was combined with adeB integration in an expression 
system for high throughput construction of defined integrated expression mutants. It was 
furthermore demonstrated that the orotate phosphoribosyl transferase gene (pyr2) 
functions as a highly reliable bidirectional marker by deletion of wA, encoding the 
polyketide precursor for the spore pigment melanin, and subsequently adeB, involved in 
the adenine biosynthesis pathway, in the same ∆tku70 strain line.  
The applicability of the expression system was supported by the frequency of correctly 
targeted integration transformants obtained in the study: tku70 deletion required 
screening of sixty transformants before identification of a single correct deletion mutant 
(~3%); deletion of wA in the ∆tku70 strain yielded 37.9% (11/29) correct mutants while 
deletion of adeB in the same strain resulted in 44.4% (4/9) correct mutants. All correct 
∆adeB mutants could be identified directly on plates by phenotypic characterization. 
Expression from the expression construct inserted into the adeB loci was confirmed by 
expression of a Thermomyces lanuginosus lipase as reporter protein. 
The combination of a high throughput system for construction of defined expression 
mutants and use of the bidirectional selective marker pyr2 delivers a strong tool for the 
T. reesei toolbox.  
 
Keywords 
 
Expression, pyr2, Trichoderma reesei, defined integration 
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Introduction 
 
Trichoderma reesei (teleomorph Hypocrea jecorina) is a key workhorse for commercial 
scale production of different enzymes used by the bioethanol, pulp, paper, and textile 
processing industries. This status is a consequence of its unique capability of producing 
and secreting large amount of enzymes, its amenability to large scale fermentation as 
well as its long history of safe use in industrial enzyme production, which is also 
recognized by the generally recognized as safe (GRAS) status of several T. reesei enzyme 
products by the U.S. Food and Drug Administration (FDA). Its genome has recently been 
sequenced, setting the stage for strain development by directed genetic engineering 
(Martinez, Berka et al. 2008). Importantly, T. reesei serves as a model organism for the 
regulation of expression and biochemistry of (hemi-)cellulose degradation enzymes and 
pathways (Murray, Aro et al. 2004, Kubicek, Mikus et al. 2009). There is an increasing 
demand for these enzymes since they are employed for the saccharification of cellulosic 
plant biomass to simple sugars for biofuel production. As enzymes constitute an 
important cost in the production of bioethanol, large research efforts as well as large 
government funding have aimed to continuously improve T. reesei as an enzyme 
production host.  
Unfortunately, the highly efficient protein synthesis machineries of T. reesei, enabling 
yields of homologous proteins in excess of 100 g/l (Saloheimo, Pakula 2012), has so far 
not prevailed for synthesis of heterologous proteins and yields remain low (Liu, Wang et 
al. 2008). The potential for improvement of synthesis of heterologous proteins in this 
fungus is therefore tremendous; and if successful, T. reesei could serve as a highly 
efficient filamentous fungus for heterologous protein production. 
One bottle neck towards this goal has been the low efficiency of gene targeting in this 
fungus. However, like in a number of other fungi, the problem of random integration of 
gene targeting substrates has been dramatically reduced in T. reesei by deleting a gene 
involved in NHEJ. Hence, the frequency of successful integration by gene targeting in a 
tku70 mutant strain of a DNA marker flanked by one kb targeting sequences was 
increased from the 5-10% obtained with wild-type strains to >95% (Guangtao, Hartl et 
al. 2009). Nevertheless, a recent study has demonstrated that the efficiency of 
homologous integration in NHEJ deficient strains can be highly site specific in T. reesei 
and may vary from 33 to 100% depending on insertion site (Schuster, Bruno et al. 
2012). 
Before T. reesei can be routinely used for heterologous protein production, it is necessary 
to gain insights into e.g. the influence of promoter sequences, effects of codon optimized 
synthetic genes, or expression rates of selected orthologous genes. This type of analysis 
requires construction of large numbers of strains where the genes to be compared are 
expressed from a defined locus in isogenic strains to allow for proper comparisons. 
Moreover, such analysis may often include experiments that require multiple rounds of 
genetic engineering in the same strain. Consequently, the need for molecular tools that 
allow easy genetic modifications of T. reesei for industrial strain development are urgent. 
We have therefore developed a new expression platform in T. reesei that facilitates 
heterologous gene expression from a defined locus with an improved gene targeting 
throughput. Our expression strain includes a tku70 disruption to increase gene targeting 
efficiency, a color marker that facilitates identification of correctly targeted strains, even 
in early stages of colony development, as well as the possibility of iterative gene 
targeting using pyr2, which encodes orotate phosphoribosyl transferase, as a 
bidirectional marker. The use of pyr2 as a bidirectional marker has not previously been 
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reported for T. reesei, but we here demonstrate that it serves as a highly reliable 
alternative to pyr4. The applicability of the expression system was confirmed by 
expression of a Thermomyces lanuginosus lipase as reporter protein. 
 
Materials and Methods 
 
Strains and culture conditions 
The strains included in this study are listed in Table 1. 
A two-step selection was adopted due to the poor sporulation of transformants on the 
primary transformation plates. The transformants were first incubated five days on 
primary minimal media plates (MM1) composed of 0.1 nM Na2B4O710H2O (Merck, 
Whitehouse station, USA), 1.6 nM CuSO45H2O (Merck), 2.8 nM FeSO47H2O (Merck), 3.8 
nM MgSO42H2O (Merck), 3.4 mM Na2MoO47H2O (Merck), 27.8 nM ZnSO47H2O (Merck), 
9.6 mM Citric acid (Merck), 2 mM MgSO47H2O (Merck), 7 mM KCl (Merck), 11.2 mM 
KH2PO4 (Merck), 5 mM CaCl2 (Merck), 50 mM (NH4)2SO4 (Merck) and 2% granulated agar 
(BD/Difco, Franklin lakes, USA) supplemented with 0.5 M sucrose (Sigma, St. Louis, 
USA). After five days, the transformants were transferred to secondary minimal media 
plates (MM2) with the above composition, but supplemented with 55 mM mannitol 
(sigma) as substitute for sucrose. An overview of additional supplements for selective MM 
plates can be seen in Table S1. Potato dextrose agar (PDA) (BD/Difco) was used for all 
non-selective solid cultivations while all non-selective liquid cultivations were in YPD 
consisting of 1% Yeast extract (BD/Difco), 2% Peptone bacto (BD/Difco) supplemented 
with 2% glucose. All incubations on solid media were for five days at 28°C and all 
incubations in liquid media, other than for lipase assay, were for 48 hours at 30°C and 
200 RPM. 
 
 
Cloning and E. coli transformation 
An overview of the primers used for cloning and the resulting plasmids are listed in Table 
S2 and S3, respectively. 
PCR fragments used for the clonings were purified from agarose gel using the GFX kit 
(GE healthcare, Little Chalfont, United Kingdom). All clonings, except two, were 
performed by restriction enzyme and ligase independent uracil-excision cloning (Hansen, 
Salomonsen et al. 2011, Geu-Flores, Nour-Eldin et al. 2007). All fragments used in the 
uracil-excision clonings, except for the AsiSI/Nb.BsmI digested pMJ-023 vector, were 
acquired by PCR with primers containing a single uracil between seven and 11 bp from 
the 5’-end. The PCR reactions were performed with PfuX7 polymerase, which is a phusion 
polymerase (New England Biolabs, Ipswich, USA), mutated to enable it to read through 
Table 1. Overview of the strains used in this study. The genotypes are listed together with selected phenotypic characteristics 
Strain Genotype 
Growth in 
presence of 
5-FOA 
Prototrophy 
Reference 
Uridine Adenine 
QM6a WT - + + 
(Martinez, Berka et al. 
2008) 
MJ-T-001 tku70-::amdS+ - + + This study 
MJ-T-006 tku70-::amdS+ Δpyr2 + - + This study 
MJ-T-009 tku70-::amdS+ Δpyr2 ΔadeB::pyr2 - + - This study 
MJ-T-012 tku70-::amdS+ Δpyr2 ΔwA::pyr2 - + + This study 
MJ-T-013 tku70-::amdS+ Δpyr2 ΔwA + - + This study 
MJ-T-020 tku70-::amdS+ Δpyr2 ΔadeB-PgpdA-TtrpC-pyr2 - + - This study 
MJ-T-021 tku70-::amdS+ Δpyr2 ΔwA::Δpyr2 ΔadeB::pyr2 - + - This study 
MJ-T-033 tku70-::amdS+ Δpyr2 ΔadeB::PgpdA-lipase-TtrpC-pyr2 - + - This study 
Abbreviation: 5-FOA, 5-Fluoorotic acid 
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uracils (Norholm 2010). The uracil-excision clonings were performed as described in the 
USER™ Friendly Cloning Kit protocol (New England Biolabs). All plasmids constructed by 
uracil-excision cloning carried a vector fragment amplified from pU1111-1 (Hansen, 
Salomonsen et al. 2011). TOPO® (Invitrogen) and In-Fusion® (Clontech) cloning was 
utilized to construct pMJ-001 and pMJ-005, respectively. The approach is described in 
greater detail later. Chemically competent Fusion-Blue E. coli cells (Clontech, Mountain 
View, USA) were used to maintain all plasmid constructs assembled by TOPO® 
(Invitrogen, Carlsbad, USA), In-Fusion® (Clontech) or uracil-excision cloning. All 
transformations were performed as described in the In-Fusion® Dry-Down PCR Cloning 
Kit Protocol-at-a-Glance. 
 
T. reesei transformation 
Protoplastation and transformations of T. reesei was performed as described by Gruber 
and co-workers with minor modifications (Gruber, Visser et al. 1990). All fragments for 
transformation were released from the vector backbone by NotI digest facilitated by NotI 
sites incorporated in each end of the vector part. Approximately 10 µg linearized DNA 
was used for each transformation. Correct homologous integration was verified by 
diagnostic PCRs for all transformants; see primers in Table S4. 
 
Genomic DNA purification and Southern blot 
Biomass for genomic DNA purifications was obtained by inoculating spores from plates in 
10 ml YPD. After incubation, the mycelia were separated from the YPD by filtration 
through Miracloth (Merck) and washed with 25 ml 0.1 M MgCl2. The mycelia were 
transferred to eppendorf tubes and dried in a Jouan RC 1009 vacuum dryer over night 
(ON). The dried mycelia were crushed in the eppendorf tubes using a metal pestle and 
DNA extractions performed using solutions from the MasterPure™ Yeast DNA purification 
kit (Epicentre Biotechnologies, Madison, USA) as described in the remainder. 
Approximately 50 µg mycelia were transferred to two ml eppendorf tubes, 300 µl yeast 
cell lysis solution added and mixed by vortexing. The solution was incubated at 65°C for 
20 minutes and 150 µl MPC protein precipitation reagent added and mixed by vortexing. 
The mix was centrifuged for ten minutes at 13.400 RPM and the supernatant transferred 
to a clean eppendorf tube in which 500 µl isopropanol were added for precipitation. There 
was centrifuged at 13.400 RPM for ten minutes and the pellet washed with 500 µl 70% 
ethanol. The ethanol was removed after another ten minute centrifugation at 13.400 RPM 
the pellet dried and dissolved in 60 µl Milli-Q water; 1.5 µl 5 µg/µl RNaseA was added 
and there was incubated at 37°C for 30 minutes. 
For Southern blots 10 µg DNA was digested for each strain. The samples were loaded on 
1% agarose gels and run for two hours and 30 minutes at 160 volts.  
Transfer of the DNA from the gel to a Zeta-Probe® GT blotting membrane (Bio-Rad, 
Hercules, USA) and hybridization was performed as described in the appurtenant 
instruction manual for alkaline blotting. The probes used were amplified using the 
primers seen in Table S4, purified from gel and labelled with 32P as described in the 
following. Approximately 70 ng of the purified DNA was used for each probe and Milli-Q 
water added to a final volume of 32 µl, the mix was boiled for five minutes and put on 
ice. A buffer consisting of 1.6 µl Hexamer (Roche, Penzberg, Germany), 5 µl 10x klenow 
buffer, 0.2 µl dCTP (invitrogen), 0.2 µl dGTP (invitrogen), 0.2 µl dTTP (invitrogen) and 
7.8 µl Milli-Q water was made and added to the boiled probe. Two µl fresh 32P labelled 
dATP (PerkinElmer, Waltham, USA) was added together with 15 U klenow polymerase 
(New England Biolabs) and there was incubated at 25°C for one hour. After incubation 
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and prior to hybridization, the probe was purified over a QIAquick spin column as 
described in the protocol for QIAquick Nucleotide Removal kit (Qiagen, Venlo, 
Netherlands). The hybridized membrane was placed in a BAS cassette2 2025 (Fujifilm, 
Tokyo, Japan) and exposed for at least 18 hours and developed using a Typhoon FLA 
7000 laser scanner (GE healthcare). 
 
Construction of the strain for use with the expression system 
 
tku70 truncation 
The tku70 gene had previously been identified by Guangtao and co-workers (JGI ID: 
63200) (Guangtao, Hartl et al. 2009). The pMJ-005 construct used for truncation of 
tku70 was made in two cloning steps. First an intermediate plasmid construct, pMJ-001, 
was made by introducing a 2311 bp tku70 gene fragment amplified with primer pair 
tku70-fw/rv into the TOPO® vector pCR2.1 (invitrogen) by following the manufacturers 
TOPO® cloning protocol.  
The pMJ-001 construct was linearized by digestion with the blunt end restriction 
enzymes, StuI and SnaBI, digesting after the 1154th and the 1171th tku70 coding 
sequence (CDS) base pair, respectively. A 2762 bp amplicon of the Aspergillus nidulans 
acetamidase gene (amdS), obtained by PCR with primer pair amdS-fw/rv, was utilized as 
selective marker. The primers carried 15 bp sequences complimentary to each end of the 
linear pMJ-001 vector. The PCR product was cloned into this by In-Fusion® cloning 
(Clontech) by following the manufacturer’s protocol. The resulting construct, pMJ-005, 
contained the amdS selective marker flanked by two tku70 fragments of 1.3 and 1.0 kb 
in the pCR2.1 topo vector backbone.  
Transformation of QM6a with the tku70 truncation construct was performed as described 
previously and plated on MM1 plates with acetamide supplemented as the only 
obtainable nitrogen source. All 60 transformants appearing on the transformation plates 
were picked, isolated and genomic DNA purified. PCR screening of transformants was 
performed using primer pair tku70-DT-fw/rv and truncation of tku70 further confirmed by 
Southern blot. A correct tku70 truncated mutant, MJ-T-001, was used in the subsequent 
work. 
 
pyr2 deletion 
Identification of the T. reesei orotate phosphoribosyl transferase gene (pyr2), used as 
selective marker, was carried out using the basic local alignment search tool (BLAST) 
with the 250 amino acid (AA) sequence of the Aspergillus oryzae PyrF protein 
(/EMBL/GenBank accession number XM_001821908.2, JGI ID: 21435) in the JGI T. 
reesei filtered model proteins database (http://genome.jgi-
psf.org/pages/blast.jsf?db=Trire2). A 237 AA protein (DDBJ/EMBL/GenBank accession 
number: EGR51642.1) with a sequence similarity of 44.3 % with the A. oryzae PyrF 
came up as a single hit. 
The pyr2 deletion construct (pMJ-017) was prepared by uracil-excision cloning, as 
described previously. The vector backbone was amplified from pU1111-1 and pyr2 flanks 
of 1.5 and 1.6 kb introduced to facilitate deletion of the pyr2 CDS by homologous 
recombination. 
Protoplasts were made from MJ-T-001 and transformation with pMJ-017 set up. After 
transformation the protoplasts were grown for five hours in 5 ml YP stabilized osmotically 
with sorbitol and supplemented with 2% glucose and 10 mM uridine. After incubation, 
the protoplasts were plated on MM1 plates supplemented with 1.5 mg/ml 5-Fluorootic 
2. Chapter I – Tool Development PhD Thesis 
Manuscript I                                                                                     Mikael Skaanning Jørgensen 
 
16 
 
acid (5-FOA) and 10 mM uridine. After five days, agar plugs of the growing colonies were 
transferred to MM2 plates, also supplemented with 1.5 mg/ml 5-FOA and 10 mM uridine. 
After five days of growth on the MM2 plates agar plugs for 16 colonies were transferred 
to non-selective PDA plates for sporulation. Conidia were harvested from the PDA plates 
after four days and inoculated in YPD to obtain biomass for purification of genomic DNA. 
There were tested for uridine auxotrophy and correct deletion of pyr2 was investigated 
by PCR using primer pair pyr2-DT-fv/rv. The amplicon of the diagnostic PCR spanned the 
deletion target and yielded 3.1 kb bands for deletion transformants while presence of a 
wild-type gene would result in a 4.9 kb amplicon. Deletion of pyr2 was furthermore 
confirmed by Southern blot. A correct pyr2 deleted mutant was selected, named MJ-T-
006, and utilized in the subsequent work. 
 
pyr2 as a bidirectional marker 
 
pMJ-021 
The pMJ-021 construct was made as a tool to ensure that the pyr2 gene can be used as a 
bidirectional marker; it carries the entire pyr2 gene together with the native promoter 
and terminator flanked by two direct repeats of 375 bp. Hence, a blaster cassette that 
enables loop out of the pyr2 gene fragment by homologous recombination between the 
direct repeats. The direct repeats consisted of fragments of the Aspergillus oryzae pyrG 
promoter sequence with low homology to the T. reesei genomic sequence. 
 
wA deletion 
In Aspergillus nidulans the polyketide synthase gene wA has been shown to encode a 
protein, called YWA1, which polyketide product (naphthopyrone) act as a precursor for 
the spore pigment melanine. Deletion of this gene in A. nidulans results in completely 
white colonies due to the absence of pigment (Watanabe, Ono et al. 1998). 
Several hits came up when BLASTing the 2157 amino acid sequence of the A. nidulans 
YWA1 protein in the JGI T. reesei filtered model proteins database. The T. reesei protein 
with the highest amino acid sequence 
similarity (DDBJ/EMBL/GenBank accession 
number: EGR44538.1, JGI ID: 82208) has a 
similarity of 47% and was selected for 
deletion in this study. The wA deletion 
construct (pMJ-030) was made by uracil-
excision cloning, and carried the pyr2 
selective gene fragment and direct repeats 
between 1.6 and 1.4 kb wA flanks; the 
deletion construct was transformed into 
protoplasts of MJ-T-006 and integrated as 
demonstrated in Figure 1A.  
The transformed protoplasts were 
transferred directly to MM1 plates without 
supplements. After five days of growth on 
MM1 plates growing colonies were 
transferred to MM2 plates. Selection of 
correct wA deleted transformants was 
conducted by phenotypical characterization 
(white spores) followed up by PCR and 
Figure 1. Use of pyr2 for genetic deletion and subsequent 
loop out. A: Deletion of an unwanted gene using pyr2 as 
selectable marker. The upstream flank of the gene for 
deletion is marked with “FL1” and the downstream flank 
with “FL2”. Notice the smaller direct repeats, marked with 
an “R”, flanking pyr2. B: Loop out of pyr2 by homologous 
recombination between the direct repeats, selected for by 
subjection to 5-FOA. 
 
pyr2 Gene FL2
Gene FL1 GOI Gene FL2
Homologous recombination
Gene FL1 R R
pyr2 Gene FL2Gene FL1 R R
Gene FL1 R
Gene FL2R
Loop out
Gene FL2Gene FL1 R
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B
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Southern blot. The PCR screening included primer pair wA-DT-fw/rv which amplicon 
spans the deletion target and yielded bands of 4.6 kb for deletion transformants while 
the wild-type gene would result in a 9.1 kb amplicon. A correct wA deletion mutant was 
selected, named MJ-T-012 and utilized in the subsequent work. 
 
pyr2 loop out 
Before deletion of the adeB gene in the wA deleted strain (MJ-T-012) the pyr2 gene used 
for selection had to be looped out for re-use as selective marker as demonstrated in 
Figure 1B. Loop out of pyr2 was selected for by plating 108 spores on a MM1 plate 
supplemented with 1.5 mg/ml 5-FOA and 10 mM uridine. After five days of growth, 
colonies were picked and transferred to MM2 plates, also supplemented with 5-FOA and 
uridine. After another five days of growth the transformants were transferred to non-
selective PDA plates for sporulation. Confirmation of loop out was performed by PCR and 
Southern blot. The PCR screening was performed with the wA-DT-fw/rv primer pair as 
described for wA deletion. Correct loop out, facilitated by homologous recombination 
between the direct repeats, resulted in amplicons of 1.7 kb. A correct pyr2 looped mutant 
was selected, named MJ-T-013 and utilized in the subsequent work. 
 
adeB deletion 
The adeB gene involved in biosynthesis of purines has previously been used as a 
selective marker in Aspergillus oryzae (Jin, Maruyama et al. 2004, Jin, Maruyama et al. 
2004). The gene corresponds to the ade2 gene of Saccharomyces cerevisiae, which 
encode an enzyme converting P-ribosylamino imidazolecarboxylate (CAIR) to P-
ribosylsuccino carboxamide aminoimidiazole (SAICAIR). When ade2 is inactivated CAIR 
will not be converted to SAICAIR and the precursor P-ribosylamino imidiazole (AIR) is 
accumulated in the cell and polymerizes to form a red metabolite which is visible on 
plates (Silver, Eaton 1969). ADE2 deficient strains will furthermore be adenine 
auxotroph. 
The putative T. reesei adeB gene was identified by BLASTing the 571 AA sequence of the 
S. cerevisiae ADE2 protein in the JGI T. reesei filtered model proteins database. A 593 AA 
T. reesei protein (DDBJ/EMBL/GenBank accession number: EGR49709.1, JGI ID: 105832) 
with 45 % sequence similarity with the S. cereviasiae gene was identified. 
Deletion of adeB was performed in MJ-T-013 using the adeB deletion construct (pMJ-
031). The adeB deletion construct carried the pyr2 selective marker and direct repeats in 
between two adeB flanks of 1.6 kb each. The transformed protoplasts were spread on 
MM1 plates supplemented with 0.5 mM adenine and transformants isolated as described 
previously. The double deleted transformants were identified by their phenotypical 
characteristics (white spores, red coloration), PCR and Southern blot. The PCR screening 
included primer pair adeB-DT-fw/rv which amplicon spans the deletion target and yielded 
4.4 kb bands for deletion transformants while the wild-type gene would result in an 
amplicon of 3.0 kb. A correct adeB deletion mutant was selected and named MJ-T-021. 
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Expression of T. lanuginosus lipase from the adeB site 
 
T. lanuginosus lipase 
The DNA fragment carrying the T. lanuginosus lipase gene (accession no. AF054513) was 
kindly provided by Jan Lehmbeck, Novozymes, Bagsvaerd. 
 
Cloning of the Lipase overexpression construct 
The T. lanuginosus lipase gene was amplified using primer pair lipase-fw/rv. 
Approximately 10 µg of the pMJ-023 overexpression construct was digested with AsiSI 
and Nb.BsmI and the PCR amplified T. lanuginosus lipase gene inserted by uracil-excision 
cloning with one µl of the pMJ-023 digestion mix. The resulting construct was named 
pMJ-051. 
 
Strains included in the lipase assay 
The expression fragment of construct pMJ-051, seen in Figure 2, was transformed into 
protoplasts of MJ-T-006. Several red colonies appeared on the MM1 plate supplemented 
with 0.5 mM adenine, three of these were isolated and genomic DNA purification carried 
out. Correct insertion of the expression construct was confirmed by PCR with primer pairs 
exp-IT-UP-fw/rv, for control of correct upstream integration, and exp-IT-DW-fw/rv for 
downstream integration. One primer in each primer pair targeted the genomic sequence 
adjacent to the flank used for targeted integration and the other a sequence specific for 
the insert. Correct insertion resulted in upstream amplicons of 1.7 kb and downstream 
amplicons of 2.2 kb. The control strain was transformed with the expression construct 
without the T. lanuginosus lipase gene inserted between PgpdA and TtrpC. The same 
approach for isolation of correct T. lanuginosus lipase expression transformants was 
applied for the control strain. Two Southern blots were performed to ensure correct 
insertion of the overexpression construct and presence of the T. lanuginosus lipase gene 
in the three isolated mutants (L1-L3). 
 
 
 
 
 
 
 
 
 
 
pyr2 FLB
FLA adeB FLB
Homologous
recombination
FLA R R PgpdA lipase TtrpC
pyr2 FLBFLA R R PgpdA lipase TtrpC
T. reesei
exp-IT-UP-fw
exp-IT-UP-rv exp-IT-DW-rv
exp-IT-DW-fw
Figure 2. Replacement of adeB with the T. lanuginosus lipase overexpression fragment isolated from pMJ-051 by 
NotI digest. The substrate carries the PgpdA controlled T. lanuginosus lipase gene followed by the TtrpC 
terminator. The adeB flanks (FLA and FLB) were used for targeted integration and the pyr2 gene, flanked by direct 
repeats, as selective marker. The targets of the primers used for diagnostic PCRs are indicated in the figure. 
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Lipase assay 
The esterase activity of the T. lanuginosus lipase was detected by measuring the rate of 
hydrolyses of p-nitrophenyl valerat, releasing p-nitrophenol, using an ELISA reader. p-
nitrophenol has a peak absorbance at approximately 405 nm and measurements at this 
wavelength over time indicate the esterase activity in the samples. The amount of lipase 
units (LU) in the sample can be calculated using included standards. 
A dilution buffer solution and a stock solution were made for the lipase assays. The 
dilution buffer was an aquatic solution supplemented with 50 mM Tris/HCL (pH 7.5), 
10mM CaCl2 and 0.075% Brij-35 (Thermo Fisher Scientific, Rockford, USA) while the 
substrate stock were made by dissolving 0.13 g (117µ)p-Nitrophenyl valerate (sigma N 
4377) in 10 ml methanol.  
The substrate solution added to the microtiter plates was made by applying 100 µl of the 
substrate stock to 10 ml of the dilution buffer solution. 
The strains included in the lipase assay were inoculated in 10 ml YPD using a 10 µl 
inoculation loop and grown at 30°C for four days at 200 rpm. After growth, the 
supernatant was separated from the biomass by filtration through miracloth. From each 
collected sample, 10 µl of the supernatant was mixed with 20 µl dilution buffer where 
after 200 µl substrate solution was added. The LUs were measured as absorption at 405 
nm in 30 second intervals for 40 minutes. 
Standard samples with the following LUs were included as reference: 0.05, 0.2, 0.4, 0.6, 
0.8, 1.0, 1.5, 2.0 and 2.5. 
 
Results and Discussion 
 
Towards developing T. reesei into a solid host for heterologous protein production, we 
have developed a defined expression platform.  Our system includes strains containing a 
tku70 disruption to increase gene targeting efficiency and a new bidirectional marker, 
pyr2. Genes are inserted into a defined position in the adeB gene. Disruption of adeB 
results in development of red pigment to facilitate easy and rapid detection of correctly 
targeted transformants. 
 
Construction of a ∆tku70 ∆pyr2 strain 
First, the tku70 gene involved in NHEJ was disrupted in the original T. reesei QM6a 
isolate by transforming this strain with a gene-targeting substrate based on the amdS 
marker; see Materials and Methods for details. Sixty transformants were obtained and a 
subsequent PCR analysis (data not shown) identified only a single transformant 
containing the desired disruption of tku70. The correct integration of amdS into tku70 in 
this transformant was confirmed by Southern blotting (Figure S1) and the resulting strain 
was named MJ-T-001.  
 
pyr2 as a bidirectional marker 
Orthologous of pyr2 have been used as a bidirectional markers in several species such as 
Candida guillermondii, Scwanniomyces alluvius and Haloferax volcanii (Millerioux, Clastre 
et al. 2011, Dave, Chattoo 1997, Bitan-Banin, Ortenberg et al. 2003) based on the 
principle that 5-FOA is metabolized to 5-FdUMP, a suicide inhibitor of thymidylate 
synthase essential for DNA synthesis, in a process that depends on the orotate 
phosphoribosyl transferase activity of PYR2 (Santoso, Thornburg 1998, Beck, 
Dingermann et al. 2002). To investigate the possibility that pyr2 could also be used as a 
bidirectional marker, we deleted the entire coding sequence (CDS) of pyr2 in MJ-T-001. 
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In this case, the gene-targeting substrate did not contain a selectable marker. Instead 
we hypothesized that correctly targeted strains, unlike wild-type strains, would survive 
exposure to 5-FOA. Eleven transformants were obtained after transformation with the 
pyr2 deletion construct on 5-FOA plates, but only three of these displayed normal growth 
rates. As expected for correctly targeted strains these three transformants were all 
uridine auxotroph as they required addition of uridine to the media in order to grow (de 
Boer, Bastiaans et al. 2010, Li, Du et al. 2010, Choquer, Robin et al. 2008). Finally, 
deletion of pyr2 was confirmed in one of the three transformants by PCR (data not 
shown) and Southern blot (Figure 3) and the resulting strain was named MJ-T-006. 
 
 
 
 
 
Two gene-targeting substrates were constructed to determine whether pyr2 could also 
serve as bidirectional marker. One was designed to eliminate wA, a gene that putatively 
encodes the polyketide synthase necessary for production of green conidial pigment; and 
adeB, an ortholog of the ade2 gene in Saccharomyces cerevisiae, which encodes a 
phosphoribosylaminoimidazole carboxylase necessary for production of purines. Lack of 
this enzyme in species such as S. cerevisiae, Pichia pastoris and Aspergillus oryzae (Du, 
adeB
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Figure 3. Southern blot for confirmation of correct deletion of pyr2, wA and adeB. The restriction endonuclease NcoI was used 
for all digestions together with a 485 bp probe targeting the pyr2 promoter/FLA amplified using primer pair pyr2prom-P-fw/rv. 
The arrow on the Southern blot picture points to a faint band for MJ-T-013. Visualization of the three affected loci and the 
expected band sizes can be seen underneath the Southern blot picture. The band sizes on the Southern blot are consistent with 
the expected. Marker: BstII digested λ DNA. 
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Battles et al. 2012, Jin, Maruyama et al. 2004, Fisher 1969) results not only in adenine 
auxotrophy, but also in development of red colonies as the precursor AIR accumulates in 
the cell and polymerizes (Silver, Eaton 1969). Both gene targeting substrates were based 
on the pyr2 selectable marker, which was flanked by direct repeats to allow for 
subsequent marker excision by direct repeat recombination. 
Transformation of the wA gene-targeting substrate into MJ-T-006 produced 29 uracil 
prototroph transformants on the MM1 plates. When transferring the transformants to 
PDA plates for sporulation it was evident that eleven (~40%) of these lacked pigment 
production and were white as expected for wA deleted strains (Figure 4). PCR analysis of 
the white transformants confirmed that wA was indeed deleted in all of these strains. 
One of the white transformants was also confirmed by Southern blotting (Figure 3), 
named MJ-T-012 and used in the subsequent work. In this case, pyr2 therefore worked 
as an efficient marker for positive selection. To demonstrate that the pyr2 gene can also 
be counter-selected, approximately 108 spores from the wA deleted mutant (MJ-T-012) 
were inoculated on plates supplemented with 1.5 mg/ml 5-FOA. In this way we expected 
to select for spontaneous recombinants where the pyr2 gene had been looped out by 
recombination between the flanking direct repeats. In agreement with this, four colonies 
were isolated after five days of incubation and PCR- and sequencing analyses supported 
that the pyr2 gene was lost in all four strains as the result of recombination between the 
direct repeats. In agreement with these results, the four strains were also displaying a 
uridine auxotrophic phenotype. One of these colonies was named MJ-T-013 and used for 
further work. 
To demonstrate that our system can be used for iterative gene targeting, we transformed 
MJ-T-013 with the adeB deletion substrate. Nine uracil prototrophic transformants 
appeared on the primary transformation plates after transformation. Of these nine 
transformants, four developed an orange/red coloration after four days of growth, 
indicating successful deletion of the adeB gene. All nine colonies were tested for adenine 
auxotrophy and as expected the four red colonies were all adenine auxotrophs whereas 
the remaining five were not. Correct deletion of adeB in the four selected red 
transformants was confirmed by PCR (data not shown). One of the four transformants 
containing the wA and adeB double deletion was verified by Southern blotting (Figure 3) 
and named MJ-T-021. The iterative gene targeting proved that pyr2 can be used as an 
alternative to pyr4. Interestingly, the pyr2 CDS is 435 bp shorter than the pyr4 CDS 
enabling construction of smaller vectors.  
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As expected, gene targeting occurs with a quite high efficiency in strains with defective 
NHEJ; in our case wA was deleted with an efficiency of ~40%. In some fungi even higher 
success rates have been reported e.g. (Guangtao, Hartl et al. 2009, Nielsen, Nielsen et 
al. 2008, Choquer, Robin et al. 2008, de Boer, Bastiaans et al. 2010, Li, Du et al. 2010). 
However, our somewhat lower integration efficiency at the wA locus is consistent with the 
observation that the frequency of homologous recombination in T. reesei appears to be 
highly locus dependent (Schuster, Bruno et al. 2012). 
 
Expression of T. lanuginosus lipase from the adeB site 
The fact that adeB deletion strains rapidly developed a red color allows this site to 
function as a targeting site for new genes where correct transformants can be rapidly and 
easily identified. We decided to exploit this feature and incorporate it as a central part of 
our expression platform. Specifically we envisioned that by inserting genes for 
heterologous expression into adeB, we can select transformants that are correctly 
targeted rapidly and with an efficiency approaching 100%. Such efficiency will be a 
tremendous advantage in high throughput experiments where a high number of different 
genes need to be inserted in order to screen for e.g. a novel enzymatic activity. 
To demonstrate this concept we decided to express the T. lanuginosus lipase gene from 
the adeB locus. Accordingly, the T. lanuginosus lipase gene was positioned between the 
A. nidulans PgpdA promoter and TtrpC terminator and inserted into adeB using pyr2 as 
selection marker. After transformation, several red colonies appeared and correct 
insertion of the expression construct in these was confirmed by PCR and Southern blot 
(Figure S2). One of the mutants was selected for use in the further experiments. In a 
parallel experiment, an empty expression construct containing PgpdA::TtrpC was 
inserted into adeB. The two strains, MJ-T-033 and MJ-T-020, respectively, were analyzed 
MJ-T-006
MJ-T-009
(ΔadeB)
MJ-T-012
(ΔwA)
MJ-T-021
(ΔadeB/ΔwA)
PDA MM2 -adenine MM2 +adenine
No
Growth
No
Growth
Figure 4. Phenotypical differences between selected deletion strains obtained using pyr2 as selective marker. Three media types were 
used, the rich media PDA, and MM2 with and without 0.5 mM adenine supplemented. It is seen that MJ-T-006 is dark green (as the 
wild-type) while the other mutant strains all have variations in their colorations. The ΔadeB strain has a yellow coloration and is at the 
same time adenine auxotroph, the ΔwA strain has a white coloration and can grow in absence of adenine while the double deleted 
strain has a light brown coloration and is also adenine auxotroph. 
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for T. lanuginosus lipase production using a well-developed assay for measuring lipase 
activity, see Materials and Methods.  
Six cultures of each of the two strains were grown in YPD for four days before measuring 
the lipase activity in lipase units (LUs). The average lipase activity for MJ-T-020 was 1.19 
LU (st.dev. 0.05) pr. 10 µl supernatant and the lipase activity for MJ-T-033 was 2.00 LU 
(st.dev. 0.15) pr. 10 µl supernatant which indicate that expression of the PgpdA 
controlled T. lanuginosus lipase gene results in an amount of lipase activity 
corresponding to 0.81 LU. 
 
Concluding Remarks 
 
In summary, our developed expression system is designed for high throughput 
construction of defined integrated T. reesei mutants suitable for setup of large expression 
studies. The system furthermore allow for iterative genetic alterations in selected 
mutants, made possible by including pyr2 as a bidirectional selective marker. 
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Supplementary Tables and Figures 
 
Table S1. Additional media supplements. The supplements added to MM plates 
according to specific genotypes 
   Nitrogen source 
Genotype 5-FOA 
(1.5 mg/ml) 
Uridine 
(10mM) 
Adenine 
(0.5mM) 
Acetamide 
(10mM) 
(NH4)2SO4 
(50 mM) 
amdS+ - - - + - 
pyr2+ - - - - • 
pyr2- + • - - • 
adeB- - - • - • 
-: not added, +: added for selection, •: needed supplement 
 
 
 
 
 
 
 
 
Table S2. Oligonucleotides used for construction of plasmids  
Primer name Sequence (5’-3’) Used for construction of 
tku70-fw CTCTCATCTTGCAAGTGAAT 
pMJ-001 
tku70-rv CGTCCATTTCGATTCCGCAT 
amdS-fw AAGAGATAAAAAAGGCCTTTCTACGCCAGGACCGAGCA 
pMJ-005 
amdS-rv GGGCGTAAAGTATACGTAATGCATCTGGAAACGCAACC 
Vector-fw AGGCGTGCAUCCGCATCATC 
pMJ-017, pMJ-021, pMJ-030, pMJ-031  
Vector-rv ATCTGGGUCGTGGTCGATTGTG 
pyr2-fw AGGGCGUGGAGCTGGATGGATGGGC 
pMJ-021 
pyr2-rv ACAGCCAUGCCGACGCTGCCAAGAAG 
pyr2-FLUP-fw ACCCAGAUAGGGCTGGACGTCCACATCG 
pMJ-017 
pyr2-FLUP-rv ATAGTCUCAGGCTTGTGCCAGCCATG 
pyr2-FLDW-fw AGACTAUGCCCCGGGCTGC 
pMJ-017 
pyr2-FLDW-rv ATGCACGCCUGTCCATGTGCCCTATCTGCCTG 
Repeat-UP-fw ACCCAGAUGTACCCTAAGGATAGGCCCTAATC 
pMJ-021 
Repeat-UP-rv ACGCCCUCTAGCGCGTGCGCTGTAG 
Repeat-DW-fw ATGGCTGUGTACCCTAAGGATAGGCCCTAATC 
pMJ-021 
Repeat-DW-rv ATGCACGCCUCTAGCGCGTGCGCTGTAG 
adeB-FLUP-fw AATTAAUGCCTCAGCGCTCAAGTGAGCGACGGCTC 
pMJ-023 
adeB-FLUP-rv ACCCAGAUGCGGCCGCCAACCCATGGCGTAGGGAGG 
pyr2rep-UP-fw ATTAATUAAGACCTCAGCCGCCAGCAGTGTCACAATCGAC 
pMJ-023 
pyr2rep-DW-rv ATGCACGCCUACGCAGTGGTCACGGTCCG 
PgpdA-fw ACTGCGUCGAATGCGTGCGATAATTCCC 
pMJ-023 
TtrpC-rv ACGCGAUGGGCGCTTACACAG 
adeB-FLDW-fw ATCGCGUGATCTGACGCTGCGAGCCAG 
pMJ-023 
adeB-FLDW-rv ATGCACGCCUCGGTGGTTTGAGCGTCTGCG 
pyr2rep-fw AAGACCUCAGCCGCCAGCAGTGTCACAATCGAC 
pMJ-030, pMJ-031 
pyr2rep-rv AGCGACGGCUCGGTGATTTC 
wA-FLUP-fw ACCCAGAUGTCATTCGAGGCGACGCAAG 
pMJ-030 
wA-FLUP-rv AGGTCTUGCCCTGGACTGAAAACGGGTG 
wA-FLDW-fw ACCACTGCGTUAGGCCGCCAATGCTCTTGAC 
pMJ-030 
wA-FLDW-rv ATGCACGCCUCCGCTGGGTTGACTCGATTG 
adeB-FLUP-fw ACCCAGAUCAACCCATGGCGTAGGGAGG 
pMJ-031 
adeB-FLUP-rv AGGTCTUGCTCAAGTGAGCGACGGCTC 
adeB-FL2-fw ACCACTGCGTUGATCTGACGCTGCGAGCCAG 
pMJ-031 
adeB-FL2-rv ATGCACGCCUCGGTGGTTTGAGCGTCTGCG 
Lipase-fw AGAGCGAUATGAGGAGCTCCCTTGTGCTG 
pMJ-051 
Lipase-rv TCTGCGAUCTAAAGACATGTCCCAATTAACCCG 
Red – 5’-end tails for In-Fusion® cloning, green – nucleotides for reconstruction of restriction sites, blue – uracil-
containing 5’-end tails for uracil-excision cloning. Abbreviations: FL: Flank, UP: Upstream, DW: Downstream 
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Table S3. Plasmids constructed in connection with this study 
Plasmid ID Used for Fragments Cloning method 
pMJ-001 Tool 
pCR2.1 
tku70 
TOPO® 
pMJ-005 tku70 truncation 
pMJ-001 
amdS 
In-fusion® 
pMJ-017 pyr2 deletion 
Vector 
pyr2 FL UP 
pyr2 FL DW 
uracil-excision 
pMJ-021 
pyr2 and direct repeats 
(tool) 
Vector 
direct repeat 1 
pyr2 (gene/term/prom) 
direct repeat 2 
uracil-excision 
pMJ-023 Tool for overexpression 
Vector 
adeB target UP 
pyr2 + repeats 
PgpdA/TtrpC 
adeB target DW 
uracil-excision 
pMJ-030 wA deletion 
Vector 
wA FL UP 
pyrF+repeats 
wA FL DW 
uracil-excision 
pMJ-031 adeB deletion 
Vector 
adeB FL UP 
pyrF+repeats 
adeB FL DW 
uracil-excision 
pMJ-051 
Heterologous 
expression of  T. 
lanuginosus lipase 
pMJ-023 
lipase 
uracil-excision 
Table S4. Oligonucleotides used for diagnostic PCRs 
and Southern blot probes 
Primer name Sequence (5’-3’) 
tku70-DT-fw TGCCTAGGCTCGTCGCGTTT 
tku70-DT-rv GGGAGCGGATGGTGTTGATAA 
tku70-P-fw GCGATGGACTGTCTCTTCTC 
tku70-P-rv CGGACCACTCCTCCAAGTAA 
pyr2-DT-fw AGGGCTGGACGTCCACATCG 
pyr2-DT-rv CAGGCTTGTGCCAGCCATG 
adeB-P-UP-fw CAACCCATGGCGTAGGGAGG 
adeB-P-UP-rv GCTCAAGTGAGCGACGGCTC 
adeB-P-DW-fw GATCTGACGCTGCGAGCCAG 
adeB-P-DW-rv CGGTGGTTTGAGCGTCTGCG 
exp-IT-UP-fw GGCCAAAGATCATCCGCAGC 
exp-IT-UP-rv CAGTTGCTGAGGGAAGCCGTC 
exp-IT-DW-fw CCGTAACACCCAATACGCCG 
exp-IT-DW-rv CTTGGTTCTAGACGTGGAGGGCC 
wA-DT-fw GGGAACTAGCTGCCTTGCGTC 
wA-DT-rv TAGCTTAACCGCTCACCGTGG 
adeB-DT-fw ACAGGGTAGTCGTGGAACGGAG 
adeB-DT-rv TTCAACTGCCAGTGTTATACGCC 
lipase-P-fw ATGAGGAGCTCCCTTGTGCTG 
lipase-P-rv CTAAAGACATGTCCCAATTAACCCG 
pyr2prom-P-fw GGAGCTGGATGGATGGGCTAAG 
pyr2prom-P-rv GCTTTGTGTTGGTTCTTTCCAGGC 
Abbreviations: DT: Deletion Test, P: Probe, IT: 
Insertion Test, UP: Upstream, DW: Downstream.  
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Figure S1. Southern blot for confirmation of tku70 truncation. The restriction endonuclease 
XbaI was used for all digestions together with a 900 bp probe targeting the tku70 CDS, 
amplified using primer pair tku70-P-fw/rv. The band shift observed corresponds well with 
the expected band shift from 5.3 to 8.1 kb for truncation of tku70. Marker: BstII digested 
lambda DNA.  
 
Figure S2. Southern blots for confirmation of correct insertion of the T. lanuginosus lipase expression construct. The restriction 
endonucleases BamHI and NheI were used for all digestions. A: Southern blot using two probes, one targeting the entire 
upstream adeB flank and the other targeting the downstream adeB flank. It is seen that the band sizes are consistent with the 
expected. The 1601 bp upstream adeB flank probe was amplified with primer pair adeB-P-UP-fw/rv while the 1567 bp 
downstream adeB flank probe was amplified using primer pair adeB-P-DW-fw/rv B: Southern blot using a probe targeting the T. 
lanuginosus lipase gene. It is seen that the band sizes are consistent with the expected. The 876 bp probe was amplified using 
the primers lipase-P-fw/rv. Marker: BstII digested lambda DNA. 
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2.3. Complimentary Research Results 
 
This section includes results obtained in connection with development of molecular tools 
for T. reesei which are not included in Manuscript I. In section 2.3.1 the rationale for 
substituting pyr4 with pyr2 for development of a bidirectional marker system is described 
and in section 2.3.2 the linear growth rates of selected mutants are presented. 
 
2.3.1. Selection of pyr2 as an Alternative to pyr4 
 
The initial focus for developing a bidirectional marker system for T. reesei QM6a was on 
the orotidine-5’phosphate decarboxylase gene (pyr4) since it had previously been used 
as a homologous bidirectional marker in T. reesei (Hartl, Seiboth 2005, Gruber, Visser et 
al. 1990). A pyr4 deletion construct targeting the full CDS of the gene was designed and 
used for transformation into a NHEJ deficient QM6a strain (MJ-T-001). Subsequent PCR-, 
Southern blot screening and sequencing of 60 5-FOA resistant and uridine auxotroph 
mutants, consistent with a pyr4 deletion (section 2.1.2), surprisingly revealed that all 
carried a full wild-type copy of pyr4. This clearly indicated that the gene was not easily 
deleted and that other genetic modifications must have led to a deficient pyrimidine 
pathway. This observation could also explain why most previous studies, using pyr4 as 
selective marker for T. reesei, utilize the same γ-radiation induced orotidine-5’phosphate 
decarboxylase deficient strain (TU-6) as recipient and not a deletion strain (Guangtao, 
Hartl et al. 2009, Gruber, Visser et al. 1990). Compared to the original QM6a isolate, TU-
6 is not the optimal recipient, since mutations other than the one leading to uridine 
auxotrophy with high probability have been introduced during the γ-radiation. 
Furthermore, the entire pyr4 gene is not deleted which leaves large homologous 
sequences that could lead to growth of false positive transformants in which pyr4 had 
been introduced at the original position. 
Another study does utilize a T. reesei strain with a deletion in connection with pyr4 
(Steiger, Vitikainen et al. 2011) but the gene has only been partly deleted, leaving 
behind the first 294 bp of the CDS and the entire promoter. The nucleotide sequence that 
is still present encodes the first 98 amino acids of PYR4 which, when comparing with the 
orotidine-5’phosphate decarboxylase genes of A. nidulans, S. cerevisiae, Bacillus subtilis 
and E. coli, carries four conserved amino acids at position Asp-42, Leu-50, Lys-64 and 
Phe-96 (Figure 2.6). The Asp-42 and Lys-64 conserved amino acids are predicted to be 
active site residues forming hydrogen bonds to the 3’-OH group of the ligand’s ribosyl 
moiety and are not expected to be essential when uridine is present (Miller, Butterfoss et 
al. 2001, Hur, Bruice 2002). It is not known at present, whether this remaining part of 
the protein has an unknown dual function in which one is essential for growth, or if the 
nucleotide sequence carries hidden essential elements making it impossible to delete 
fully. 
 
 
 
 
Figure 2.6. The first 98 amino acids of the T. reesei orotidine 5‘-phosphate decarboxylase (PYR4) and the corresponding amino acid 
sequences of the A. oryzae, S. cerevisiae, B. subtilis and E. coli orotidine 5‘-phosphate decarboxylases. Notice the four conserved amino 
acids (marked with yellow). 
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Since no genetic alterations were observed in the pyr4 genes of the 5-FOA resistant and 
uridine auxotroph mutants after transformation with a pyr4 deletion construct, other 
spontaneous mutations leading to the same phenotype must have arisen. To elucidate 
this, the pyr2 gene in the pyrimidine biosynthesis pathway, previously used as a 
bidirectional selective marker in other species (Millerioux, Clastre et al. 2011, Dave, 
Chattoo 1997, Bitan-Banin, Ortenberg et al. 2003), was selected for sequencing in eight 
of the mutants. The gene encodes an orotate phosphoribosyltransferase and has 
previously been shown to have the same selectable properties as pyr4 as visualized in 
section 2.1.2. The sequencings revealed that several different types of spontaneous 
mutations had been introduced into the pyr2 genes in five of these, as seen in Figure 2.7, 
indicating that this gene is much more prone to inactivation than pyr4 in T. reesei. The 
observed mutations either result in inability to initiate correct transcription, are nonsense 
mutations or lead to a shift in the incorporated amino acid and therefore with high 
probability lead to a defective pyrimidine biosynthesis pathway. 
   
 
 
 
 
The results indicated that pyr2 could be utilized as a bidirectional selective marker in T. 
reesei as a good alternative to pyr4. The counter-selectability was proven by the 
spontaneous mutations and positive selection for presence of the gene was demonstrated 
when transforming one of the pyr2 inactivated mutants with a substrate carrying pyr2 as 
selective marker (Figure 2.8). 
 
 
 
 
 
 
 
After these results were obtained, work was initiated to implement pyr2 as a bidirectional 
marker for T. reesei as described in Manuscript I (section 2.2). 
ControlTransformation plate
Figure 2.7. The spontaneous mutations observed in the pyr2 genes of five of the 5-FOA resistant and uridine auxotroph mutants. 
The full pyr2 gene alignments can be seen in section 6.2 in the appendix. 
Figure 2.8. Use of pyr2 as selective marker. The protoplasts that have been transformed with a 
pyr2 carrying substrate were plated on the plate to the left while the plate to the right was plated 
with non-transformed protoplasts. Both plates have unfortunately been contaminated with a 
bacterium that forms small yellow colonies, but the fungal growth can luckily be distinguished from 
these. 
2. Chapter I – Tool Development PhD Thesis 
Complimentary Research Results                                                       Mikael Skaanning Jørgensen 
 
29 
 
2.3.2. Measurement of Growth Rates for Mutant Strains 
 
Introduction 
 
The growth rate experiment was set up in connection with the experimental work with 
pyr2 as selective marker. The growth rates were measured to investigate whether the 
different integration sites when using pyr2 as selectable marker, had impact on the 
growth of the mutants. The results also indicate whether deletion of adeB had an effect 
on the growth rate.  
 
Materials and Methods 
 
Strains and culture conditions 
The genotypes of all strains in the growth rate experiments can be seen in Figure 2.9 
together with a phylogenetic three. Minimal media with sucrose as carbon source (MM1, 
Manuscript I) and supplemented with 25 mM adenine was used for incubation of all 
strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MJ-T-001QM6a
tku70
truncation
∆adeB
∆wA
MJ-T-009
MJ-T-012
pyr2
loop
MJ-T-010
MJ-T-013
MJ-T-022
MJ-T-021
∆adeB
∆wA
pyr2
loop
MJ-T-006
∆pyr2
Strain Genotype 
MJ-T-001 tku70-::amdS+ 
MJ-T-009 tku70-::amdS+ Δpyr2 ΔadeB::pyr2 
MJ-T-012 tku70-::amdS+ Δpyr2 ΔwA::pyr2 
MJ-T-021 tku70-::amdS+ Δpyr2 ΔwA ΔadeB::pyr2 
MJ-T-022 tku70-::amdS+ Δpyr2 ΔadeB ΔwAB::pyr2 
Figure 2.9. Phylogenetic three and genotype of the mutants included in the growth 
experiments. The mutants included in the experiments are marked with bold in the 
phylogenetic three. 
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Fabrication and inoculation of race tubes 
25 ml serological pipettes (Sigma-Aldrich, St. Louis, USA) were used for the experiments. 
Each of the tubes were filled with 10 ml MM1 and placed on an even surface for 
solidification. Prior to inoculation holes were drilled in the bottom part of the tubes. The 
mutants were inoculated through the holes which were subsequently blocked by clear 
tape; all mutants were inoculated in triplicates. The filter in the top part of the pipettes 
enabled enough airflow to allow growth, while keeping the inside of the pipettes sterile 
(Figure 2.10). 
 
 
 
 
 
 
Measurements and calculations 
The growth distances for all replicates of the five mutants were measured once a day for 
seven consecutive days. To visualize the near linear growth throughout the measurement 
period, trend lines were drawn using the average growth distance for each of the mutant 
strains. The trend line slopes were calculated and depicted the growth rates in mm/h.  
 
Results and Discussion 
 
The growth distance measurements at the seven time points are seen in Figure 2.11. The 
figure includes trend lines from which the growth rates were calculated. 
It is seen that the growth for all of the mutants was approximately linear throughout the 
entire time span. Furthermore, it is seen that the total growth distance was similar for all 
mutant strains which is also reflected by the calculated growth rates. Slightly higher 
growth rates were observed for MJ-T-009 and MJ-T-022 (0.99 and 1.00 mm/h) compared 
to MJ-T-001, MJ-T-012 and MJ-T-021 (0.91, 0.94 and 0.91 mm/h), but this difference is 
not reflected by the location of pyr2 or any specific genetic deletion. These results 
indicate that integration of pyr2 as selective marker into the adeB- or wA genes does not 
have any influence on the linear growth of the corresponding mutant. The results also 
indicate that deletion of adeB does not affect the growth rates as long as adenine has 
been supplemented to the growth media.  
 
 
 
 
 
 
Figure 2.10. The inoculated race tubes after six days of growth. Notice that that the bottom holes are blocked by 
tape while the top holes are only blocked by a filter that allows airflow. The white arrow point towards one of the 
drilled holes through which there was inoculated. 
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 MJ-T-001 MJ-T-009 MJ-012 MJ-021 MJ-022 
Growth rates (mm/h) 0.91 (+/- 0.04) 0.99 (+/- 0.02) 0.94 (+/- 0.04) 0.91 (+/- 0.09) 1.00 (+/- 0.03) 
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Figure 2.11. The plot area shows the average growth distance for the five mutants at seven time points. Trend lines are drawn to 
visualize the linear growth. The trend line slopes indicate the growth rates for each mutant and can be seen in the appurtenant table 
together with their standard deviations.  
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3. Chapter II – Unraveling the Secondary Metabolism of T. reesei 
 
Chapter II 
 
 
 
Unraveling the Secondary  
Metabolism of T. reesei 
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3.1. Introduction 
 
Filamentous fungi produce a plethora of small highly bioactive molecules denoted as 
secondary metabolites which are not essential for the primary metabolic pathways. These 
molecules include some extremely potent toxins with both economical and health 
implications for humans, but also constitute one of the most important sources of drugs 
for the pharmaceutical industry.  Extensive research is therefore put into elucidating their 
complex biosynthesis. 
The second chapter of this thesis includes description of methods applied to elucidate the 
secondary metabolism of T. reesei and presents the results obtained in the duration of 
this study. 
Some background information about secondary metabolism and methods applied to 
elucidate this can be seen in the following sections (3.1.1 – 3.1.9). 
 
3.1.1. Secondary Metabolites 
 
The term secondary metabolites (SMs) can be endorsed to Andreas Kossel who was the 
first to distinguish these molecules from primary metabolites (Kossel 1891). These small 
and often highly bioactive metabolites, also referred to as natural products, are produced 
alongside the primary metabolites and are not essential for sustaining life and growth of 
the producing organism. The producing organism would therefore continue to grow if a 
secondary metabolic pathway was eliminated unlike if a primary metabolic pathway was 
eliminated. The secondary metabolism is tightly bound to the primary metabolism which 
provides the essential SM building blocks. Even though biosynthesis of SMs is not 
essential for the producer, these can provide benefits such as broadening the inhabitable 
environments or by giving competitive advantages against other organisms with 
overlapping resource requirements. Production of SMs is not restricted to a small group 
of closely related organisms, but has been reported for bacteria, fungi, plants and even 
animals. 
The high bioactivity observed for many SMs has arisen through many years of selection 
and provides the producing organism with different beneficial functions such as, 
defence/attack systems against other organisms, UV-protection and signalling 
capabilities. The high bioactivity of SMs is also interesting from a human point of view 
since it provides a tremendous source for new possible drug leads for the pharmaceutical 
industry (Chiang, Chang et al. 2011, Keller, Turner et al. 2005, Osbourn 2010). 
Especially fungi have been shown to be a remarkable source of SMs, as shown in a 
literature survey in which 42% out of the 23,000 included bioactive natural products 
were of fungal origin (Brakhage, Schroeckh 2011). 
 
3.1.2. Secondary Metabolite Types 
 
Based on the mode of biosynthesis, most SMs can be divided into five main groups which 
are discussed below. The metabolic origin of the building blocks for the different types of 
SMs can be seen in Figure 3.1.  
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Isoprenoids 
The isoprenoids, also known as terpenoids, are synthesized from products of the 
mevalonate pathway. Wallach propounded the so called “isoprene rule” in 1914 after his 
earlier observation (1887) (Bentley 1999) that many natural products could be dissected 
into isoprene units (C5H8); exemplified by monoterpenes (C10H16) and sesquiterpenes 
(C15H24). This rule stated that terpenes were formed 
by joining isoprene units head to tail with the 
stoichiometric formulas (C5H8)n. The nomenclature 
can be seen in Table 3.1 and the monoterpenoid 
myrcene shown as an example in Figure 3.2. Later it 
was shown that some isoprene derived compounds, 
such as the 27 carbon stereoids, do not have a 
stoichiometric formula that fits the head to tail 
principle indicating that the basic isoprenoid skeletons could be cleaved and rearranged 
(Barkovich, Liao 2001). 
Isoprenoids are found in all kingdoms and while many of the compounds are involved in 
essential metabolic processes it is also one of the most profound sources of SMs with 
more than 40.000 described compounds (http://dnp.chemnetbase.com/). The produced 
isoprenoids have several beneficial applications for the producing organisms and can act 
as for example antimicrobials, flavoring substances, hormones, insect anti-feedants or 
pigments. 
Table 3.1. Isoprenoid nomenclature 
Name Isoprenoid units Carbon atoms 
Hemiterpenoids 1 5 
Monoterpenoids 2 10 
Sesquiterpenoids 3 15 
Diterpenoids 4 20 
Sesterpenoids 5 25 
Tripenoids 6 30 
Tetrapenoids 8 40 
Polyterpenoids 9 or more 45 or more 
Carbohydrate Pyruvate Acetyl-CoA
Shikimate Aromatic amino acids
Aliphatic amino acids
TCA cycle compounds
Proteins
Non-ribosomal peptides
Shikimate derived
secondary metabolites
Steroids Isoprenoids
CO2
Malonyl-CoA
Lipids
Polyketides
Alkaloids
Figure 3.1. Connection between the primary metabolism and SMs. The different types of SMs are boxed and 
marked with bold. The figure is modified from “Secondary Metabolite biosynthesis: The First Century” 
(Bentley 1999). 
 
Figure 3.2. Myrcene consisting of two isoprene 
units 
 
Isoprene unit Isoprene unit
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Shikimate derived secondary metabolites 
The shikimate pathway is responsible for biosynthesis of aromatic amino acids in 
bacteria, plants and fungi. The pathway is initiated with the 
condensation of phosphoenolpyruvate (PEP) and erythrose 4-
phosphate (Ery4P) to 3-deoxy-D-arabinoheptulosonate-7-
phosphate (DAHP) which is converted to shikimate (Figure 3.3) 
through three metabolic steps. Seven additional metabolic steps 
are carried out before the end product of the common pathway, 
chorismate, is synthesized (Tzin, Galili et al. 2001, Herrmann 
1995). While chorismate itself is an important precursor for 
several SMs (Stalman, Koskamp et al. 2003) these can also be 
synthesized from several branches from the pathway. The 
shikimate pathway is especially important in plants and it is estimated that, under normal 
conditions, 20% of the total fixed carbon is diverted to production of secondary products 
through this route (Rohr 1995). Some of the important fungal and plant secondary 
products originating from this pathway are pigments, phytoalexins, endole acetate and 
lignin (Tzin, Galili et al. 2001, Herrmann 1995). The aromatic amino acids derived from 
the shikimate pathway can also act as precursors for two of the other groups of SMs: the 
alkaloids and non-ribosomal peptides which are discussed in the next two paragraphs. 
 
Alkaloids 
Most alkaloids are basic compounds derived from amino acids containing at least a single 
nitrogen atom in a ring structure. Alkaloids are primarily produced by plants, but are also 
synthesized by bacteria, fungi and animals (Mahmood, Ahmed et al. 2010). The alkaloids 
have great structural diversity and no uniform classification has been applied; they have 
been divided according to biological activity, chemical structure and, most accepted, after 
the origin of the metabolite as seen in Table 3.2 (Julsing, Koulman et al. 2006). The 
biological function of most alkaloids is basically unknown, but in plants most examined 
alkaloids have been shown to act as protection against 
herbivores. This is also supported by the fact that alkaloids 
often have a bitter taste. Some animals are believed to have 
adapted to the alkaloids and several of these compounds are 
now also produced by the animals themselves as 
neurotransmitters (Spiteller 2008). In 1804 morphine (Figure 
3.4) was isolated as the first alkaloid and since then more 
than 12.000 alkaloids have been described with a world 
marked exceeding $4 billion (Julsing, Koulman et al. 2006). 
 
Table 3.2. Division of alkaloids after origin 
Group Name Origin 
I Tropane-, pyrrolidine- and pyrrolizide alkaloids Ornithine 
II Benzylisoquinolone alkaloids Tyrosine 
III Indolequinoline alkaloids Tryptophane 
IV Pyridine alkaloids Nicotinic acid 
V Quinolizidine- and piperidine alkaloids Lysine 
 
 
 
 
 
 
Figure 3.3. Shikimate 
 
Figure 3.4. Morphine 
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Non-ribosomal peptides 
Non-ribosomal peptides (NRPs) are small peptides produced by bacteria and fungi. The 
peptides are assembled non-ribosomally by multimodular enzymes referred to as non-
ribosomal peptide synthetases (NRPSs). The synthases consist of modules each 
containing several catalytic domains catalyzing reactions such as substrate recognition, 
activation and condensation by peptide bond formation. The basic building blocks include 
non-proteinogenic amino acids in addition to the proteinogenic amino acids in both L and 
D configuration. NRPs achieve a high level of diversity through incorporation of a vast 
number of different amino acids, variations in peptide length and other possible 
modifications such as cyclization, oxidation, reduction or methylation. NRPSs are divided 
into three different types according to their modes of action as seen in Table 3.3. NRPs 
synthesized by type A, linear NRPSs are discussed in greater detail in section 3.1.4. 
 
Table 3.3. Division of NRPS types by mode of action 
Type Synthesis mechanism 
A (linear) Assembly line, one reaction pr. active site 
B (iterative) Iterative, all active sites are re-used 
C (nonlinear) Some domains are re-used, others are used only once in each elongation process 
 
Polyketides 
Polyketides (PKs) are a major group of SMs in both fungi and bacteria, but are also 
observed in plants. PKs are assembled from acetyl-CoA activated short-chain carboxylic 
acids, most often acetyl-CoA and malonyl-CoA, by decarboxylative Claisen condensations 
carried out by large polyketide synthase proteins (PKSs). The great structural diversity of 
PKs is primarily achieved by modifications introduced during elongation or after synthesis 
of the basic polyketide chain, and not by incorporation of different types of monomers, 
although possible. The PKSs have traditionally been divided into different types according 
to mode of action as seen in Table 3.4. Most fungal PKs are synthesized by the iterative 
type I PKS synthases, greatly resembling the mammalian fatty acid synthases. These are 
discussed in greater detail in section 3.1.5. 
 
Table 3.4. Division of PKS types by mode of action 
Type Protein(s) Synthesis mechanism Organisms 
I (modular) Single protein, multiple modules Assembly line, one reaction pr. active site Bacteria 
I (Iterative) Single protein, one module Iterative, active sites may be re-used Fungi, few bacteria 
II Multiple proteins, one active 
site for each 
Iterative, active sites may be re-used Bacteria 
III Single protein, multiple modules Iterative, active sites may be re-used Primary plants, but also 
few bacteria and fungi 
 
 
Hybrids 
The complexity of SMs is further increased by formation of hybrid products including 
parts of two or more of the above mentioned SM groups. 
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3.1.3. PKS and NRPS Gene Clusters 
 
PKs and NRPs are two of the most abundant groups of fungal SMs. Their syntheses have 
large resemblance and include selection and condensation of a predetermined number of 
monomers by large synthase proteins. While most fungal PKSs are iterative and allow re-
use of the PKS modules for elongation of the polyketide chain, fungal NRPSs are most 
often modular which means that each module adds just a single amino acid monomer 
during peptide chain synthesis. 
All genes involved in the processes for biosynthesis of specific PKs or NRPs are most 
often observed in co-regulated clusters, consistent with reports for other genes encoding 
enzymes for a specific pathway (Keller, Hohn 1997). The non-synthase genes in these 
PKS and NRPS clusters encode proteins that are involved in processes such as modifying 
the initial metabolites (tailoring enzymes), synthesis of unusual monomers, conferring 
resistance towards the produced metabolites, transportation of the metabolites and 
transcriptional regulation of the cluster. As an example a T. reesei PKS/NRPS gene 
cluster can be seen in Figure 3.5. The cluster include genes encoding enzymes with 
activities such as esterase, reductase, dehydrogenase and monooxygenase, which 
previously have been reported to contribute to modification of metabolite products. The 
preliminary annotations of the shown gene cluster have not yet been verified 
experimentally and it is therefore not certain that all shown genes are involved in the 
processes regarding the metabolite product(s); the cluster could though also include 
more genes than the ones that are shown. The widespread clustering of genes, involved 
in the same SM pathways, indicate that these could have been transferred through 
horizontal gene transfer as speculated for the fumunisin gene clusters and penicillin gene 
clusters (Khaldi, Wolfe 2011, Brakhage, Thon et al. 2009). The metabolite synthase 
clusters are also frequently surrounded by DNA repeats or fragments of transposon-like 
elements supporting this (Shaaban, Palmer et al. 2010). Genes encoding cluster specific 
transcription factors are often included in the clusters and regulate transcription of all the 
genes that are essential for complete metabolite biosynthesis. Another interesting 
observation regarding SM clusters is that these are often located near the telomeric 
regions of the chromosomes from where they can be co-regulated by global regulators of 
secondary metabolism such as LaeA (Bok, Keller 2004). Regulation of SM biosynthesis is 
discussed in more detail in section 3.1.6.  
As mentioned previously, the complexity of SMs is increased by formation of hybrid 
products including parts of two or more of the SM types. These hybrid products are most 
often produced by several independent synthases, each synthesizing a part of the SM 
molecules which are stitched together subsequently; but hybrid synthase enzymes 
assembling hybrid metabolites directly also exist (Gallagher, Fenical et al. 2010, 
Phonghanpot, Punya et al. 2012). In filamentous fungi especially hybrids of PKs and 
NRPs are widespread (Maiya, Grundmann et al. 2007, Collemare, Billard et al. 2008, 
Chang, Horn et al. 2009, Mukherjee, Buensanteai et al. 2012, Gerc, Song et al. 2012) 
and these are also observed in T. reesei as seen for the cluster in Figure 3.5 which 
include both a PKS-, a NRPS- and a hybrid synthetase gene. 
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JGI ID Gene size (bp) Predicted protein function 
59315 11,824 PKS/NRPS hybrid 
36822 2,399 Esterase/lipase/thioesterase 
59775 1,205 Reductase (Isoflavone reductase) 
105798 1,683 Transporter (Major Facilitator Superfamily) 
3262 1,826 Dehydrogenase (Aldehyd dehydrogenase) 
59377 1,455 Monooxygenase (p450) 
59690 3,309 NRPS 
105804 6,782 PKS 
 
3.1.4. Non-Ribosomal Peptides 
 
NRPs are a very diverse group of SMs provided by a biosynthesis-machinery which is not 
subjected to the same limitations regarding the amino acid monomers as ribosomal 
peptides. As previously mentioned both proteinogenic and non-proteinogenic amino acids 
can be incorporated into NRPs and unlike ribosomal peptides also amino acids with D-
configuration can be incorporated into the peptide chains (Schracke, Linne et al. 2005). 
The finished peptide chains can vary greatly in length and are often subjected to further 
alterations, such as ring formation, oxidations or reductions, catalyzed by tailoring 
enzymes expressed from other genes in the NRPS gene clusters (Zhang, Ostash et al. 
2010). 
The large NRPS enzymes, which assemble the NRPs, are in fungi most often of the type 
A, linear type consisting of repeated modules, each adding one amino acid monomer. All 
modules, involved in elongation of the peptide chain, consist of three basic catalytic 
domains essential for the elongation process, but can also carry modifying domains 
altering the growing peptide chain (Table 3.5). 
Some ribosomal peptides can undergo post-translationally modifications so that they 
resemble NRPs. One example is the polytheonamides (A/B/C) which consists of 49 
monomers and has a molecular weight of a massive (in NRP respect) 5033.75 g/mol. 
These peptides have been observed in the coral reef sponge Theonella swinhoel, but are 
believed to be produced by bacterial symbionts. The initial peptide chain has been shown 
to undergo as many as 48 post-translational modifications, including epirimizations of L-
amino acids to D-amino acids (Freeman, Gurgui et al. 2012). 
The fungal NRPs ACV (δ-(L-α-aminoadipyl)-L-cystein-D-valine), produced by Penicillium 
chrysogenum among others, and paracelsins (A-E), produced by T. reesei, are examples 
of very dissimilar true NRPs. ACV, the precursor for penicillins and cephalosporins, is a 
result of condensation of three amino acids and has a molecular weight of just 363.43 
g/mol. The paracelsins, on the contrary, consist of 20 amino acids and have a molecular 
weight approaching 2000 g/mol. While ACV undergoes further modification steps 
including cyclization, before the final products are obtained, the paracelsins are not 
modified further and remain as an intact linear peptide chain. The structure of paracelsin 
A can be seen in Figure 6.4 in appendix section 6.5.2.  
T. reesei PKS/NRPS gene cluster 23 
5 kb
JGI ID
Figure 3.5. Section of a putative PKS-, NRPS- and hybrid synthetase gene cluster in T. reesei. The predicted protein functions can be 
seen in the appurtenant table. The metabolite product(s) synthesized by the proteins encoded by the genes in this cluster has not yet 
been appointed. 
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The penicillins are probably the most well-known example of NRPs and biosynthesis of 
ACV and its subsequent conversion to penicillin G are discussed in further detail in the 
following section to give a more thorough example of a complete biosynthesis pathway of 
a NRP. 
 
 
 
Penicillin 
The penicillins were the first group of antibiotics to be exploited as chemotherapeutic 
agents. The first step was taken in 1928 by Alexander Fleming when he decided to 
investigate why a Penicillium rubens mold contamination of one of his Staphylococcus 
aureus plates was encircled by an inhibition zone (Houbraken, Frisvad et al. 2011, Ligon 
2004). A compound excreted by the mold was later subjected to thorough studies 
initiated at Oxford University in 1940 which led to utilization of this compound as an 
antibiotic. The following success and vast spread of penicillin all over the world were 
possible because of some very important characteristics of this antibiotic. Most important 
was the relative lack of toxicity toward eukaryotic cells enabling the treatment of 
humans; furthermore the compound had sufficient stability to be used as a 
chemotherapeutic agent (Koch 2000, Livermore 1996). Another important factor was the 
relative ease of isolation and modification of the compound for optimization of the 
activity (Koch 2000). In 1943 penicillin was introduced as an antimicrobial compound for 
treatment of humans when it was used to treat allied soldiers during Second World War, 
(Demain, Elander 1999, Koch 2000). Since then an array of other antibiotics carrying the 
same basic beta-lactam ring structure, but other side chains, has been introduced; some 
exhibiting broader antibiotic activity (Donowitz 1989). 
Table 3.5. Overview of the possible catalytic NRPS domains and their function. The three required domains of a module are 
marked with “R”. Some domains can act as integral parts of other domains; C/E, A/MT and A/Ox domains have for example been 
observed (Finking, Marahiel 2004, Lim, Roongsawang et al. 2007). 
Domain name Abbreviation Function Required/Optional 
Adenylation A 
Selective gatekeeper for the AA. The AA is also activated by 
the adenylation domain. 
R 
Condensation C 
Catalyzes the C-N peptide bond formation and elongation of 
the molecule 
R 
Epimerization E Catalyzes epimerization of L-amino acids to D-amino acids O 
Formylation F 
Transfer a formyl group to the N-terminus of the peptide 
chain 
O 
Heterocylization Cy 
Catalyzes cyclization of cysteine, serine and threonine 
residues. Can catalyze C-N bond formation and thereby 
replace C-domains 
O 
Methyl transferase MT 
Transfer methyl groups during NRP synthetase. Can be either 
N-methyltransferases or C-methyltransferases 
O 
Oxidation Ox Oxidition of thiazole ring structures O 
Thioester reductase R 
Release the finished NRP by reducing the terminal to aldehyde 
or alcohol 
O 
Thiolation T 
Point of attachment of the activated monomers selected for 
elongation. Has a covalently bound 4’-phosphopantetheine 
arm. Are also referred to as “PCP” 
R 
Thioesterase TE Release the finished NRP by thioesterase activity O 
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An overview of the biosynthesis of penicillin G (gold standard) by P. chrysogenum can be 
seen in Figure 3.6. Three distinct proteins are involved in the biosynthesis; ACV 
synthetase (ACVS) encoded by pcbAB, Isopenicillin N synthase encoded by pcbC and 
Isopenicillin N acyltransferase encoded by penDE (Weber, Bovenberg et al. 2012). ACVS 
is the NRPS responsible for condensation of the three amino acids of the ACV tripeptide. 
The module and domain organization of the ACVS protein can also be seen in Figure 3.6. 
The numbers indicate the five basic reactions of the enzyme which are described in the 
following. 1, the non-proteionogenic L-α-aminoadipic acid is selected by the adenylation 
domain of the first module and bound to the 
4’-phosphopantetheine arm of the thiolation 
domain. 2, L-cysteine is selected by the 
adenylation domain of the second module 
and bound to the 4’-phosphopantetheine 
arm of the thiolation domain, the 
condensation domain facilitate amide bond 
formation between the amino group of L-α-
aminoadipic acid and the carboxyl group of 
L-cysteine. 3, L-valine is selected by the 
adenylation domain of the third module and 
bound to the 4’-phosphopantetheine arm of 
the thiolation domain. Before peptide bond 
formation, catalyzed by the condensation 
domain, can take place L-valine must 
undergo epimerization to D-valine which is 
facilitated by the epimerization domain (4). 
The last step is release of the finished linear 
ACV-tripeptide catalyzed by the thioesterase 
domain (5). 
The final reactions towards biosynthesis of 
penicillin G are carried out by the two 
tailoring enzymes, isopenicillin N synthase 
and isopenicillin N acyltransferase. 
Isopenicillin N synthase converts the linear 
ACV-tripeptide to the bicyclic penam, 
consisting of a β-lactam- and thiazole ring, 
which is characteristic for all penicillins 
(Cooper 1993). Isopenicillin N 
acyltransferase catalyzes the last step of 
penicillin G biosynthesis in which the 
aminoadipic side chain is replaced by a 
phenylnoxacetyl group (Barredo, van 
Solingen et al. 1989). 
 
 
 
 
 
 
 
Figure 3.6. Synthesis of penicillin G in P. chrysogenum, from 
genes to final product. 
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Other important NRPs 
Several other NRPs than the beta-lactam antibiotics have significant pharmaceutical 
applications. These include other antibiotics such as daptomycin, vancomycin, 
teichoplanin and the capreomycins which have different modes of action and therefore 
hamper appearance of cross-resistant microorganisms. Medically relevant NRPs are not 
only antibiotics, but also include metabolites with activities such as anti-tumor 
(bleomycins and quinolaxines), immunosuppressive (cyclosporins) and anti-HIV 
(quinoxaline) (Felnagle, Jackson et al. 2008). Some NRPs also have negative implications 
for humans; some are toxins such as microcystin which can cause serious liver damages 
if ingested and other can cause negative economic implications as phytotoxins (Gilroy, 
Kauffman et al. 2000). 
 
3.1.5. Polyketides 
 
PKs constitute the most prominent group of fungal SMs. In fungi these are almost 
exclusively synthesized by the large multi-domain type I iterative PKSs (iPKSs) which are 
closely related to mammalian fatty-acid synthases. The PKSs synthesize the PKs by 
assembling short CoA activated carbon chains into long polymers by repetitive Claisen 
condensation reactions. The typical starter unit is acetyl-CoA and the typical extender 
unit malonyl-CoA, which adds two carbon atoms in each elongation step (Figure 3.7B); 
more complex carbon chains can also be incorporated. The minimal iPKS consists of three 
catalytic domains (β-ketoacyl synthase (KS), acyltransferase (AT) and acyl carrier protein 
(ACP)), but several other catalytic domains can also be included in the PKS as seen in 
Table 3.6 and Figure 3.7A. 
 
 
 
 
 
 
 
Traditionally type I iPKSs have been sub-divided into three different groups according to 
the presence or absence of the reductive domains seen in Figure 3.7A. The fully 
reducing iPKSs contain all three reductive domains responsible for reduction of the 
ketone groups that arise after each elongation step. The three domains can reduce 
ketones to hydroxyls (catalyzed by KR), hydroxyls to enoyls (catalyzed by DH) and 
enoyls to alkyls (catalyzed by ER). The rare partly reducing iPKSs contain a KR domain 
and possibly also a DH domain, but no ER, and are therefore not able to reduce the 
ketones fully to alkyls. The third group does not include any reducing domains and are 
O
SCoA
Acetyl-CoA
+
O
SCoA
O
HO
Malonyl-CoA
n
OO
OH
O
n-1
Polyketid chain
CO2
n
ATKS
DH ER KR
ACP
A
B
Figure 3.7. A, an example of the domain organization of a PKS. The dark blue domains are required for PK 
synthesis while the three remaining domains are optional and involved in reduction of the ketone groups. 
B, the basic PK synthesis with acetyl-CoA as starter unit and malonyl-CoA as extender unit. “n” depicts 
the number of extensions. 
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referred to as non-reducing iPKSs. It is important to note that even though reductive 
domains are present, reduction of the polyketide chain monomers is only optional and of 
variable degree, not necessary reflected by the reduction potential of the iPKS.  
Polyketide biosynthesis is initiated when the starter unit is loaded on the KS domain and 
the extender unit is selected by the AT domain and loaded on the 4’-phosphopatetheine 
group of the ACP domain; both as thioesters. Peptide bond formation by Claisen 
condensation is catalyzed by the KS domain between the two units. All movements 
between the catalytic domains of the iPKS are performed by the 4’-phosphopatetheine 
group that functions as a flexible carrier. If the ketone group is reduced in this cycle, the 
polyketide intermediate is presented to the corresponding reducing domains. When the 
reduction(s) are completed or if they are skipped the intermediate is transferred back to 
the KS domain and another round of elongation can take place. If the ketide chain has 
reached its predetermined length, it is released from the iPKS by catalytic activity of 
either a TE or CYC domain. 
The number of iterations iPKSs perform cannot be predicted at present, but newer 
research indicates a correlation between the size of the active site pocket of the KS 
domain and the size of the polyketide product (Yadav, Gokhale et al. 2009). Precise 
prediction of product size by in silico analysis can though be difficult to achieve since 
polyketide products which have undergone varying numbers of iterations can be 
produced by the same iPKSs (this study, described in the manuscript II, section 3.2, 
(Davison, al Fahad et al. 2012)). 
For simplicity the term iPKS is not used in the remainder of this thesis. All polyketide 
synthases will be referred to as PKSs. 
 
 
The vast diversity of PKs synthesized by fungal PKSs is not only achieved by varying 
number of iterations, selection of different starter units or extent of reduction, but is also 
provided by many possible post-polyketide synthesis steps as demonstrated in the 
example below by the aflatoxin biosynthesis. 
 
 
 
 
Table 3.6. Overview of possible catalytic domains of PKSs and their function. 
Domain name Abbreviation Function Required/Optional 
Acyl carrier protein ACP 
Point of attachment of the activated monomers selected for 
elongation. Has a covalently bound 4’-phosphopantetheine arm. 
R 
Acyltransferase AT 
Involved in loading of starter units and transfer the C3 or C4 acyl 
groups to the ACP. Act as selective gatekeeper for monomers. 
R 
β-keto reductase* KR Reduces ketones to hydroxyls O 
β-ketoacyl synthase KS 
Catalyzes the C-C peptide bond formation and elongation of the 
molecule 
R 
Claisen cyclase CYC 
Catalyzes ring formation by Claisen reaction, release PKs 
produced by non-reducing PKSs 
O 
Condensation CON Catalyzes condensation between two PKs O 
Dehydratase* DH Reduces hydroxyls to enoyls O 
Enoyl reductase* ER Reduces enoyls to alkyls O 
Methyltransferase MT 
Transfer methyl groups during PK biosynthesis. Can be either 
C-methyltransferases or O-methyltransferases. 
O 
Product template PT Control non-reducing PK folding patterns O 
Thioesterase TE Release the finished PK by thioesterase activity O 
Starter unit acyl-carrier 
transacylase carrier 
SAT Loading of starter units O 
*The basic reductive domains   
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Aflatoxins 
Some of the most well-studied polyketide derived metabolites are the potent mycotoxins 
aflatoxins which pose a potential health risk for both livestock and humans. The 
implications of aflatoxins were first observed in 1960 where more than 100,000 turkeys 
in English poultry farms died of a disease later referred to as “turkey X disease”. An 
investigation of the outbreaks pin-pointed the feed as a source of the disease and in 
1961 it was established that the toxin responsible for the deaths was produced by 
Aspergillus flavus which had contaminated the feed, hence the name “aflatoxin” (de, 
BEERTHUIS et al. 1962). Different variations of aflatoxins have since then described and 
are produced by several Aspergilli including Aspergillus parasiticus, Aspergillus nomius 
and Aspergillus ochraceus (Schroeder 1966, Kurtzman, Horn et al. 1987, Aziz, Moussa 
1997). The aflatoxin biosynthesis mechanism has been subjected to extensive studies 
due to the possible implications these toxins have on both health and economy.  
The gene cluster responsible for biosynthesis of aflatoxins includes 25 genes and spans 
70 kb as seen in Figure 3.8 for A. parasiticus and A. flavus (Yu, Chang et al. 2004). The 
highly complex biosynthesis mechanism including at least 23 enzymatic steps serves as a 
good example for the vast degree of modifications polyketide products can undergo 
before the final products are obtained. The biosynthesis mechanism diverges from the 
typical polyketide biosynthesis directly from the start where the fatty acid hexaonic acid 
is loaded as starter unit on the PKS instead of acetyl-CoA. Two fatty acid synthases (α 
and β) are responsible for synthesis of hexaonic acid and are encoded by genes present 
in the aflatoxin synthase cluster (Watanabe, Townsend 2002, Watanabe, Wilson et al. 
1996). It is seen that the majority of genes in the cluster encodes enzymes that are 
involved in tailoring the polyketide product into the finished aflatoxins; including several 
reductases, oxygenases, methyl transferases and also an esterase. A. nidulans among 
others lacks the genes encoding the proteins for the final steps of aflatoxin biosynthesis 
and therefore only produces the intermediate sterigmacytosin (Yu, Chang et al. 2004). 
 
Other important PKs 
As one of the most prominent groups of SMs, PKs have gained widespread utilization as 
pharmaceuticals. At present more than 40 such pharmaceuticals have been approved and 
are utilized as antibiotics (e.g. tetracyclins), anti-cancers (e.g. doxorubicin), anti-
parasitics (e.g. avermectin), anti-fungals (e.g. amphotericin B), cholesterol lowering 
agents (e.g. lovastatin)  and immunosuppressants (e.g. rapamycin)  (Weissman 2004). 
Due to the high bioactivity most PKs possess, this metabolite group is subjected to 
extensive research to identify new interesting drug candidates. 
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3.1.1.5 Regulation of the secondary metabolism 
 
Table 3.8. Aflatoxin biosynthesis. A, overview of the 25 genes in the 70 kb gene cluster encoding proteins involved in the 
biosynthesis of aflatoxins B1, B2, G1 and G2 in A. parasiticus and A. flavus. Both new and old gene names are included B, the 
proposed biosynthetic pathway of these aflatoxins including the gene names and corresponding enzyme activities responsible for 
each catalytic step. To the far right the genes believed to be involved in the sterigmatocystin synthesis in A. nidulans are seen. 
Abbreviations: NOR, Norsolorinic acid; AVN, Averantin; HAVN, 5′-Hydroxyaverantin; OAVN, Oxoaverantin; AVNN, Averufanin; AVF, 
Averufin; VHA, Versiconal hemiacetal acetate; VAL, Versiconal; VERB, Versicolorin B; VERA, Versicolorin A; DMST, 
Demethylsterigmatocystin; DHDMST, Dihydrodemethylsterigmatocystin; ST, Sterigmatocystin; DHST, Dihydrosterigmatocystin; 
OMST, O-Methylsterigmatocystin; DHOMST, Dihydro-O-methylsterigmatocystin (Yu, Chang et al. 2004). 
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3.1.6. Regulation of PK and NRP Biosynthesis 
 
Biosynthesis of SMs is extremely costly for the producing organism and requires 
resources that could also be utilized in the primary metabolism. Production of these 
metabolites is therefore subjected to tight regulation so that the produced SMs are 
always most favorable for the present conditions, and their biosynthesis halted if they are 
not needed. Most PKS and NRPS gene clusters include genes encoding transcription 
factors (TFs) that regulate the expression of the entire cluster; transcription of these 
cluster specific TFs are in turn regulated by an intricate system including nutrient level 
dependent global regulators, external stimuli and general needs of the producer (Calvo, 
Wilson et al. 2002).  
An example of regulation of a SM gene 
cluster as response to external stimuli is 
seen in Figure 3.9. 1, external stimuli 
activate a signal transduction inside the 
cell. The initiated signal transduction 
can lead to activation of a single 
PKS/NRPS synthase cluster, as seen in 
the figure, or several clusters depending 
on the stimuli. Global regulators such as 
AreA, CreA and PacC are also involved 
in regulation and ensures that the 
metabolite response are suitable for the 
available nitrogen and carbon sources 
and the pH in the surroundings, 
respectively (Calvo, Wilson et al. 2002). 
Some studies indicate that mitogen 
activated protein (MAP)-kinases and 
cAMP protein kinases are involved in 
signal transduction (Brodhagen, Keller 
2006, Shimizu, Keller 2001, Shimizu, 
Hicks et al. 2003). 2, the signal 
propagates inside the nucleus and 
activates transcription of the cluster 
specific TF gene. 3, the TF is 
synthesized and might be 
phosphorylated as a step in the transcriptional regulation. Phosphorylation can act as an 
extra switch for adapting the response to the stimuli (Moyano, Martinez-Garcia et al. 
1996, Igarashi, Ishida et al. 2001). 4, in this example only the dephosphorylated TF 
molecules are allowed inside the nucleus where they activate transcription of the other 
genes in the SM gene cluster (5). The TF often also increases the transcription of the TF 
gene itself creating a positive feedback system (Yu, Keller 2005). 6, the synthase protein 
is synthesized and assembles the basic metabolite frame which can be modified by 
possible tailoring enzymes. 7, some metabolite gene clusters include genes encoding 
specific metabolite transporters that export the metabolite product out of the cell. 8, A 
negative feedback loop is often observed when the metabolite product is present in the 
cytosol (Yu, Keller 2005). 
 
 
Figure 3.9. Regulation of a synthase gene cluster including a cluster 
specific transcription factor as a response to external stimuli. 
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Global regulators of secondary metabolism 
Several proteins have been shown to have an impact on the general level of SM 
biosynthesis. One of the most well-studied global regulators of the secondary metabolism 
in Aspergilli is LaeA (Bok, Keller 2004, Perrin, Fedorova et al. 2007) which has been 
shown to positively control as many as 10% of the genes in Aspergillus fumigatus; many 
located in 13 of the 22 SM clusters whereof seven are located in sub-telomeric regions 
with heavy heterochromatin (Perrin, Fedorova et al. 2007). LaeA has large sequence 
similarity with methyl transferases involved in modification of histones, indicating that 
the regulation mechanism of LaeA could be through chromatin remodeling (Hoffmeister, 
Keller 2007). Two other proteins, VeA and VelB, have been shown to assemble into a 
heterotrimeric complex together with LaeA and trigger transcription of genes involved in 
aflatoxin biosynthesis (Bayram, Krappmann et al. 2008). VeA has also been shown to 
regulate biosynthesis of other SM pathways and also sexual development in A. flavus, A. 
parasiticus and A. nidulans (Calvo, Bok et al. 2004, Kato, Brooks et al. 2003). The 
importance of chromatin remodeling in higher regulation of the secondary metabolism is 
also supported by a study showing that the production of SMs are altered in many 
different fungi when treating them with inhibitors of DNA methyltransferases or histone 
deacetylases (Williams, Henrikson et al. 2008). 
 
Interestingly, the increasing number of fully sequenced fungal genomes has revealed 
presence of much more SM gene clusters than observed metabolites, indicating that 
many of these are silent at normal laboratory conditions (Bergmann, Schumann et al. 
2007). The advancements in molecular biology provide the tools for further elucidation of 
this potential and could potentially lead to discovery of a range of new interesting drug 
candidates that could not have been discovered without genetic engineering. 
 
3.1.7. Linking SM Genes and Products 
 
The complex PK and NRP biosynthesis mechanisms which can provide a plethora of 
interesting bioactive molecules, at the same time make linkage of the involved genes and 
the final products challenging. An important step towards linkage of SMs and 
corresponding genes in filamentous fungi was taken in 2003 when the genomic sequence 
for Neurospora crassa was published as the first for a filamentous fungus (Galagan, Calvo 
et al. 2003). Shortly thereafter the genomic sequences for other filamentous fungi 
followed (Galagan, Calvo et al. 2005, Machida, Asai et al. 2005, Nierman, Pain et al. 
2005) and still continue to do so in an increasing pace. The available sequence data 
provide a basis for targeted approaches for elucidation of SM biosynthesis, which before 
was only possible through random mutagenesis coupled to large mutant screening 
setups. The sequence data also revealed that the number of SM synthase gene clusters 
clearly exceeded the number of observed SMs; the SM potential for the sequenced 
organisms was therefore far greater than observed at laboratory conditions. More insight 
into the mechanisms behind PK and NRP biosynthesis is therefore important for clarifying 
their full potential for biosynthesis of metabolites. More knowledge of the genetic basis 
for SM biosynthesis could also provide a platform enabling introduction of targeted 
alterations resulting in products with higher activities or even new activities paving the 
way for synthesis of entirely new drug candidates. 
Several methods have been applied to link SMs to the genes encoding the proteins 
responsible for their biosynthesis. 
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Deletion and overexpression 
Until now the most successful approach has been systematic deletion of synthase genes 
coupled with metabolite profiling as performed by Chiang and co-workers for identifying 
the emericellamide gene cluster (Chiang, Szewczyk et al. 2008). Unfortunately, 
identification using this method requires that the synthase gene cluster of interest is 
active at the applied conditions. To circumvent this drawback several studies have 
included manipulation of genetic silencers or activators such as the previously described 
pleiotropic regulator LaeA or other chromatin/histone modulators (Reyes-Dominguez, 
Bok et al. 2010, Reyes-Dominguez, Boedi et al. 2012, Strauss, Reyes-Dominguez 2011, 
Bok, Keller 2004). Schroeckh and co-workers even identified the natural activator of 
orsellinic acid and lecanoric acid production by co-cultivating A. nidulans with 58 different 
soil dwelling bacteria (Schroeckh, Scherlach et al. 2009). Overexpression of SM cluster 
specific TFs have been used twice by Bergmann and co-workers for identification of both 
the asperfuranone- and the aspyridone gene cluster (Bergmann, Funk et al. 2010, 
Bergmann, Schumann et al. 2007). It is important to note that transcription of genes in 
the asperfuranone gene cluster was activated by a SM cluster specific TF from another 
SM cluster and not by a TF in the same gene cluster. TF overexpression studies must 
therefore always be followed up by deletion studies to ensure that the SM with increased 
prevalence is indeed synthesized by enzymes encoded from genes in the corresponding 
cluster. 
Nielsen and co-workers combined a genome wide deletion study of A. nidulans PKS genes 
with inoculation on a range of different complex media types to pin-point an austinol 
meropenoid gene cluster and to gain more insight into the arugosin and vioaceol 
biosynthesis (Nielsen, Nielsen et al. 2011). 
 
Transcriptomics and metabolomics 
Expression of different SM cluster genes varies greatly with growth conditions - 
comparison of transcriptional data and metabolomic data obtained from different 
conditions can therefore indicate which genes that are involved in production of a specific 
SM. The extent of the SM clusters might also be estimated using this method since genes 
involved in production of specific SMs with high probability are co-regulated (Andersson, 
Andersson et al. 2009). 
 
Heterologous expression 
Another method that has been applied is heterologous expression of separate synthase 
genes or whole SM pathways. This method has been used in several studies and has led 
to identification of the gliobactin A, mensacarcin and rishirilide A gene clusters among 
others (Dudnik, Bigler et al. 2012, Yan, Probst et al. 2012, Sakai, Kinoshita et al. 2012). 
This approach requires a host with a well-described SM potential and a biochemical 
background supporting biosynthesis of the metabolite product. 
 
In silico prediction 
As the amount of collected bioinformatic and proteomic data increases, using the above 
methods, in silico prediction of metabolite biosynthesis becomes more and more reliable.  
Especially predictions of bacterial modular NRPSs products have prevailed because the 
modularity of these allows prediction of the specific amino acids monomer that will be 
added to the growing peptide chain in each elongation step (Lilien, Stevens et al. 2005, 
Stachelhaus, Mootz et al. 1999, Starcevic, Zucko et al. 2008). The predictions are based 
on alignments of a large number of adenylation (A) domains with known amino acid 
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specificity. The active sites of the adenylation domains which are involved in selection of 
the amino acid monomer are pin-pointed and can be used to predict the specificity of the 
NRPS domains that have not yet been linked to an NRP. The final NRP can though 
undergo unpredictable modifications by tailoring enzymes after synthesis of the peptide 
chain. Elucidation of these tailoring processes can be estimated by looking at the genes 
in the adjacent cluster. The amount of data collected for fungal NRPS adenylation 
domains do not yet provide reliable predictions of the selected amino acid monomers. 
Prediction of products from the fungal PKSs is hampered by their iterative mode of 
action. Even though each elongation is performed by the same set of catalytic domains, 
different monomers can be selected in each elongation cycle and the levels of reduction 
of the ketid units differ. A correlation between the sizes of active site pockets of KS 
domains and the sizes of polyketide products has been shown (Yadav, Gokhale et al. 
2009), but the number of iterations performed cannot yet be predicted based on this. 
It can be expected that in silico prediction will become more reliable as the amount of 
available data increases and bioinformatics and proteomics develop. At present it though 
far from obliterates the other methods for linking genes and SMs. 
 
3.1.8. HPLC and Detectors 
 
High pressure liquid chromatography (HPLC) is one of the most widely used 
chromatographic techniques for separation of metabolites for subsequent analysis (Figure 
3.10). The most central part of the HPLC is a column filled with tightly packed solid 
particles through which the sample of interest passes through - facilitated by movement 
of a liquid solvent. Different metabolites in the sample will have different retention times 
in the column as a function of their affinity to the column particles and the used solvent. 
Several types of HPLC exist such as normal phase, displacement and the widely used 
reverse-phase which together with the possibility for selection of different types of 
column particles and solvents allow for a high degree of optimization of the HPLC method 
according to the composition of the sample. While normal liquid chromatography relies 
on gravitational force, HPLC relies on a pump system which supplies a pressure of 
approximately 150 bar to facilitate flow through the column. The higher pressure allows 
for use of smaller particles in the columns and therefore better separation of the 
constituents of the loaded samples. Recently HPLCs utilizing an even higher pressure of 
up to 1000 bar have gained more footing; this is often referred to as ultra-high pressure 
liquid chromatography (UHPLC). For visualization of the separated metabolites one or 
more detectors are coupled to the HPLC system.  
Diode array detectors (DAD) detecting the metabolites’ response to a range of 
wavelengths from UV to visual light is often used as detectors. This detection method 
provides information of the chromophores of the analyzed metabolites and can also 
indicate the quantity of specific metabolites in a sample. 
Mass spectrometry (MS) is another detection method often utilized in connection with 
HPLC. In this method the compounds are ionized and the mass-to-charge ratio measured 
for the charged particles (ions) which subsequently can be used to determine the 
elementary composition of the metabolites of interest and also aid to elucidate their 
chemical structures. One type of MS is the high-resolution time-of-flight MS (TOFMS) 
which determines the ion’s mass-to-charge ratio by measuring the time it takes for a 
specific metabolite to travel a certain distance. Since large molecules travel slower than 
small, their masses can be estimated and a mass spectrum of metabolites according to 
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their mass-to-charge ratio drawn. A HPLC setup combining UHPLC with both DAD and 
TOFMS detectors are denominated UHPLC-DAD-TOFMS. 
 
 
3.1.9. T. reesei PK and NRP Metabolites and Genes 
 
Only a limited number of PK and NRP SMs have been described for T. reesei at present. 
One of the best known compounds is the paracelsins that belong to a group of NRPs 
called peptaibols which are often observed for species belonging to Trichoderma spp.. 
These are characterized by a high content of the non-proteinogenic amino acid α-
aminoisobutyric acid and a C-terminal 1.2-amino alcohol (Baker, Perrone et al. 2012). A 
few PK derived metabolites have also been described for T. reesei and include the 
trichodimerols, trichodermatides and sorbicillinoids (Reino, Guerrero et al. 2008, Sun, 
Tian et al. 2008, Andrade, Ayer et al. 1992, Andrade, Ayer et al. 1996). 
An extensive search for PKS-, NRPS- and hybrid synthetase genes using basic local 
alignment search tool (BLAST) searches (http://genome.jgi-
psf.org/pages/blast.jsf?db=Trire2) revealed presence of 11 PKS-, 11 NRPS- and four 
hybrid synthetase genes  in the T. reesei genome (Table 3.7), which could be appointed 
to 23 distinct gene clusters. In contrast Mukherjee and co-workers reported presence of 
11 PKS-, ten NRPS- and two hybrid synthetase genes in T. reesei (Mukherjee, Horwitz et 
al. 2012), reflecting differences in interpretation of when a gene is indeed a PKS-, NRPS- 
or a hybrid synthetase gene. Surprisingly, the number of identified synthase genes in T. 
reesei is significantly lower than observed for other sequenced filamentous fungi, even 
for closely related species. The Trichoderma virens genome has for example been 
reported to contain 18 PKS-, 28 NRPS- and four hybrid synthetase genes while the 
Trichoderma atroviride genome contain 18 PKS-, 16 NRPS- and one hybrid synthetase 
gene and the A. nidulans genome contains as much as 27 PKS-, 14 NRPS- and one 
hybrid synthetase gene (Galagan, Calvo et al. 2005, Bergmann, Schumann et al. 2007, 
Mukherjee, Horwitz et al. 2012). As discussed for other filamentous fungi in section 
3.1.7, it is apparent that the number of identified synthase genes in the T. reesei 
genome also far exceeds the number of reported PK and NRP SMs, indicating that most 
of the SM gene clusters are silent at the applied conditions. 
While some T. reesei SMs have been described and all the PKS and NRPS genes in the T. 
reesei genome have been identified, a linkage still has not been established between 
Solvent Pump Sample loading
Sample
Column DAD TOFMS
Data
Detectors
Figure 3.10. An example of a HPLC setup 
3. Chapter II – Unraveling the Secondary Metabolism of T. reesei PhD Thesis 
Introduction                                                                                     Mikael Skaanning Jørgensen 
 
51 
 
these. Based on in silico analysis it has though been speculated that the paracelsins are 
synthesized by the T. reesei gene with JGI ID number 23171 (Neuhof, Dieckmann et al. 
2007), but it has not yet been verified by experiments. Furthermore, a gene cluster with 
very high similarity to the A. fumigatus gliotoxin gene cluster has been observed in the T. 
reesei genome (includes the NRPS gene with JGI ID number 24586) (Mukherjee, Horwitz 
et al. 2012). Production of gliotoxin has though not been reported for T. reesei and the 
smaller size of the cluster in T. reesei, compared to gliotoxin producing strains, indicates 
that this could be due to a deletion. 
The limited amount of knowledge currently obtained for T. reesei SM biosynthesis, 
constituted a unique starting point for this project. Luckily, the development of molecular 
tools for T. reesei is now at a stage that allows for more insight into the complex SM 
biosynthesis of this species. 
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Table 3.7. All PKS-, NRPS- and hybrid synthetase genes in the T. reesei genome identified by BLAST in this study. The nearest protein BLAST result obtained with the NCBI BLAST 
tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) is included for all synthases. It is important to note that the BLAST results only give an indication of the protein products, due to the 
limited number of synthase proteins that have been linked to the corresponding metabolite products. Several of the proteins therefore have the same closest annotated hit due 
to few annotations in the database.  
     BLAST results 
JGI ID Type Predicted protein domains Located in (cluster) Gene Size (kb) Nearest annotated hit Accession number Max identity 
59482 PKS KS-AT-DH-ER-KR-ACP 1 7,042 Lovastatin nonaketide synthase XP_003710466.1 42% 
60118 PKS KS-AT-DH-MT-ER-KR-ACP 2 7,889 Lovastatin nonaketide synthase XP_003710466.1 37% 
65116 PKS KS-AT-DH-PT-ER-KR-ACP 3 7,608 Mycocerosic acid synthase XP_003712315.1 40% 
65172 PKS KS-AT-DH-MT-ER-KR-ACP 4 8,305 Acetolactate synthase EEH44268.1 46% 
65891 PKS KS-AT-DH-ER-KR-ACP 5 7,640 Phenolpthiocerol synthase EGY19840.1 41% 
81964 PKS SAT-KS-AT-PT-ACP 6 5,911 Conidial yellow pigment synthase XP_002848092.1 48% 
82208 PKS SAT-KS-AT-PT-ACP-TE 7 6,952 Conidial pigment synthase (Alb1) EFY88620.1 77% 
106272 PKS KS-AT-DH-MT-ER-KR-ACP 8 8,996 Phenolpthiocerol synthase XP_001934016.1 35% 
4117 NRPS A-T-R 9 3,774 Alpha aminoadipic acid reductase EGR48264.1 100%* 
24586 NRPS A-T-C-A-T-C-T 10 6,728 Gliotoxin synthase (GliP) XP_750855.1 40% 
60458 NRPS A-T-C-A-T-C-T 11 6,666 Sirodesmin synthase (SirP) AAS92545.1 34% 
60751 NRPS A-T-C 12 2,720 HC-toxin synthetase XP_001932133.1 45% 
67189 NRPS A-T-C-T-C 13 5,442 Surfactin synthetase EGY22526.1 58% 
68204 NRPS A-Ox 14 3,567 Gramicidin S synthetase XP_003004664.1 59% 
69946 NRPS A-T-C-A-T-C-T-C-A-T-C-T-C-T-C 15 14,771 Gramicidin S synthetase XP_003719607.1 44% 
71005 NRPS A-T-C-A-T-C 16 5,769 Surfactin synthetase EGY22526.1 44% 
71072 NRPS A-T-R-K 17 3,855 Male sterility protein CCF37266.1 58% 
81014 NRPS A-T-R-SDR 18 3,909 Enterobactin synthetase EGY19303.1 73% 
23171 Hybrid KS-AT-ACP-(C-A-T)×18-R 19 69,518 Syringopeptin synthetase  AAO72425.1 26% 
58285 Hybrid KS-AT-DH-MT-KR-ACP-C-A-T-R 20 12,156 Fusaproliferin synthase AFP73394.1 37% 
123786 Hybrid KS-AT-ACP-(C-A-T)×14-R 21 50,787 Syringopeptin synthetase  AAO72425.1 32% 
73618 PKS KS-AT-DH-MT-ER-KR-ACP 22 8,117 Lovastatin nonaketide synthase XP_001942484.1 36% 
73621 PKS SAT-KS-AT-PT-ACP-MT-TE 22 8,083 Citrinin synthase EJB11047.1 44% 
105804 PKS SAT-KS-AT-PT-ACP-TE 23 6,782 6-methylsalicylic acid synthase XP_001937752.1 46% 
59690 NRPS A-T-R 23 3,309 Gluconate kinase CCF32373.1 50% 
59315 Hybrid KS-AT-DH-MT-KR-ACP-C-A-T-R 23 11,824 Fusaproliferin synthase AFP73394.1 53% 
Abbreviations: A, Adenylation; ACP, Acyl carrier protein; C, Condensation; DH, Dehydratase; ER, Enoyl reductase; KR, b-Keto reductase; KS, b-Keto synthase; MT, 
Methyltransferase; Ox, Oxidase; PT, Product template; R, Thioester reductase; SAT, Starter unit acyl-carrier protein transacylase; SDR, Short-chain dehydrogenase/reductase; T, 
Thiolase; TE, Thioesterase. *The first annotated gene appearing in the BLAST results is the T. reesei gene of interest. 
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Chapter II includes two manuscripts.  
 
Manuscript II (section 3.2), describes an overexpression study of T. reesei PKS and NRPS 
cluster specific transcription factors using the expression system presented in Manuscript 
I (section 2.2). 
 
Manuscript III (section 3.3), describes a heterologous expression study of T. reesei PKS-, 
NRPS- and hybrid synthetase genes in A. nidulans. 
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Abstract 
 
Filamentous fungi constitute one of the most important sources of new drug candidates 
through their ability to produce a plethora of natural products referred to as secondary 
metabolites (SMs). Despite the ever increasing amount of available sequence data and 
extensive research, linkage between SM genes and corresponding metabolite products 
are not easily established due to the complexity of the synthase machinery. To establish 
such links, the genome of the industrially important filamentous fungus Trichoderma 
reesei were mined for transcription factor (TF) genes associated with polyketide- (PKS) 
and non-ribosomal peptide synthetase (NRPS) gene clusters. Thirty such TF genes were 
identified and 11 selected for overexpression studies using the Aspergillus nidulans 
PgpdA promoter. Interestingly, metabolite profiling showed that overexpression of the 
gene encoding one of the TFs which was named SorD, led to over-production of at least 
78 different metabolites. Biosynthesis of all the new metabolites required presence of two 
PKS synthase genes, sorA and sorB, located adjacent to sorD. Several of the over-
produced metabolites could be appointed to a class of polyketides (PKs) referred to as 
sorbicillinoids, hence for the first time linking these metabolites to specific PKSs. 
Comparative genomics were subsequently used to identify a highly similar gene cluster in 
another well-known sorbicillinoid producer, Penicillium chrysogenum. All sorbicillinoids 
identified so far have been derived from hexaketides. It is therefore surprising that the 
pentaketide trichopyrone was also found to be dependent on sorA- B, and -D, hence, 
adding to the complexity of the biochemistry of this class of compounds. The wide range 
of metabolites produced by T. reesei by overexpression of just a single TF gene provides 
an interesting source of possible new drug candidates.  
 
Keywords 
 
Sorbicillinoids, polyketides, non-ribosomal peptides, transcription factors, Trichoderma 
reesei, Penicillium chrysogenum, secondary metabolites, trichopyrone. 
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Introduction 
 
Fungi produce a multitude of SMs with high bioactivity which are not essential for 
survival of the producer, but are believed to provide competitive advantages by providing 
e.g. signalling capabilities, defense systems against other microbes and protection 
against UV-radiation (Osbourn 2010, Chiang, Chang et al. 2011, Keller, Turner et al. 
2005). A literature survey showed that 42% out of the 23,000 bioactive natural products 
investigated were of fungal origin; clearly underlining fungi as an important source for 
small molecular weight metabolites (Brakhage, Schroeckh 2011). The tremendous 
interest for these bioactive compounds is mainly driven by their importance as 
pharmaceuticals in both human and veterinarian medicine, which is supported by the fact 
that 48.6% of new drugs used for cancer treatment introduced from the 1940s to 
present, are natural products or their derivates (Newman, Cragg 2012). 
PKs and NRPs are two important classes of SMs produced by fungi and compounds from 
both classes are used, either directly or in a modified form, as important pharmaceuticals 
with activities such as antibiotic, antiviral, anti-hypercholesterolaemic, tumor inhibiting 
and immunosuppressing (Brakhage 1998, Keller, Turner et al. 2005). Importantly, the 
ever growing available fungal sequence data reveal that most of these PKS and NRPS 
genes are silent at standard laboratory conditions since the SMs identified far from 
coincides with the number of identified synthase clusters (Chiang, Oakley et al. 2010, 
Chiang, Szewczyk et al. 2008, Mukherjee, Horwitz et al. 2012). This strongly suggests 
that the fungal reservoir of SMs as a source of new drugs is far from being fully 
exploited. 
It is well-known that genes encoding different steps in a specific biosynthetic pathway for 
production of SMs are often clustered. Hence, by identifying a gene encoding a PKS or a 
NRPS, accompanying genes encoding tailoring enzymes or TFs that are important for the 
regulation of the cluster can often be identified by examination of the regions flanking 
the synthase genes (Khaldi, Wolfe 2011, Chiang, Szewczyk et al. 2009). This fact 
facilitates clarification of the individual biochemical steps from the intermediate released 
from the synthase to the final product(s) of the pathway. Presently, the most common 
strategy towards elucidating the metabolite products of orphan biosynthetic gene clusters 
is therefore to delete synthase- and tailoring enzyme genes followed by metabolite 
profiling of the resulting mutant strains (Chiang, Szewczyk et al. 2008). Moreover, 
several approaches have been developed to activate clusters that are silent at standard 
laboratory conditions. These include manipulation of genetic silencers or activators such 
as the pleiotropic regulator LaeA, other chromatin/histone modulators or cluster specific 
TFs (Chiang, Lee et al. 2009). The applicability of the latter has been demonstrated by 
Bergmann and co-workers that identified the asperfuranone- and aspyridone gene 
clusters by overexpressing cluster specific TF genes (Bergmann, Schumann et al. 2007, 
Bergmann, Funk et al. 2010). 
The filamentous fungus T. reesei is a key organism for industrial scale production of 
enzymes used for saccharification of cellulosic plant material. Its highly efficient enzyme 
synthesis and secretory machineries are capable of delivering protein yields in excess of 
100 g/l to the media (Saloheimo, Pakula 2012). Perhaps it could also act as an equally 
efficient producer of SMs. Elucidation of the metabolic potential of T. reesei is therefore 
important since interesting new drug candidates might be identified in this process. The 
T. reesei genome has recently been sequenced, providing the necessary foundation for 
an investigation of its metabolic potential through directed genetic engineering (Martinez, 
Berka et al. 2008). 
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Only a limited number of SMs has presently been described for T. reesei. These include 
paracelsin A-D belonging to a group of NRPs referred to as peptaibols, trichodermin 
belonging to the terpenes, and the PK derived metabolite groups trichodimerols, 
trichodermatides and sorbicillinoids (Reino, Guerrero et al. 2008, Sun, Tian et al. 2008, 
Andrade, Ayer et al. 1992, Andrade, Ayer et al. 1996). While production of SMs by T. 
reesei has been described to some extent, no SMs have so far been linked experimentally 
to their corresponding genes. Recently, genetic tools have been developed for T. reesei, 
allowing genetic dissections of SM pathways ((Guangtao, Hartl et al. 2009, Hartl, Seiboth 
2005, Schuster, Bruno et al. 2012) and Manuscript I). Taking advantage of these tools, 
we here report successful identification of the gene cluster responsible for biosynthesis of 
sorbicillinoids in T. reesei QM6a by screening mutants overexpressing PKS and NRPS 
gene cluster specific TF genes.  
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Materials and Methods 
 
PKS and NRPS genes and cluster specific TF genes 
 T. reesei sequence data published on the JGI genome portal (http://genome.jgi-
psf.org/Trire2/Trire2.home.html) was mined for all PKS and NRPS genes and revealed 
presence of 26 PKS-, NRPS- and hybrid synthetase genes that were divided into 23 
clusters based on their location in the T. reesei genome (Table 1). All predicted TF genes 
in a 50 kb radius of the synthase genes were searched for and revealed a total of 30 TF 
genes within this radius. Out of these TF genes 11, from eight different clusters, were 
selected for overexpression and amplified with the primers seen in Table S1 for insertion 
into overexpression constructs. 
 
Table 1. Overview of all T. reesei PKS and NRPS genes and clusters and the TF 
genes within a 50 kb radius of the synthase genes 
Cluster Synthase 
JGI ID 
Synthase 
type 
TF JGI ID Distance between TF and 
nearest synthase gene (kb) 
1 59482 PKS 121164 25.6 
2 60118 PKS - - 
3 65116 PKS - - 
4 65172 PKS 122783 
65070 
79725 
109230 
26871 
4.3 
11.0 
14.1 
15.0 
18.5 
5 65891 PKS - - 
6 81964 PKS 111742 2.5 
7 82208 PKS 112129 49.0 
8 106272 PKS 121310 
106259 
28.0 
31.7 
9 4117 NRPS 107858 18.2 
10 24586 NRPS 103122 6.6 
11 60458 NRPS 47479 
106677 
106706 
9.0 
32.4 
31.8 
12 60751 NRPS - - 
13 67189 NRPS - - 
14 68204 NRPS 111088 3.2 
15 69946 NRPS 69972 8.0 
16 71005 NRPS 112560 20.0 
17 71072 NRPS 71080 2.9 
18 81014 NRPS 123445 
110689 
10.7 
32.0 
19 23171 Hybrid 68254 18.2 
20 58285 Hybrid 72993 11.6 
21 123786 Hybrid 111408 31.4 
22 73618 
73621 
PKS 
PKS 
102497 
102499 
5.0 
9.0 
23 105804 
59690* 
59315 
PKS 
NRPS 
Hybrid 
105805 
105784 
121121 
121130 
2.7 
9.9 
18.5 
44.2 
 
Strains and plasmids 
All plasmidic constructs were assembled by restriction enzyme and ligase independent 
uracil-excision cloning that enables cloning by construction of PCR fragments with large 
custom designed overhangs and plasmids carrying specific restriction cassettes for easy 
insertion of amplicons (Hansen, Salomonsen et al. 2011, Geu-Flores, Nour-Eldin et al. 
2007). PCR fragments were purified from agarose gel using the GFX kit (GE healthcare, 
Little Chalfont, United Kingdom) and eluted in 50 µl milli-Q water prior to cloning. 
Chemically competent Fusion-Blue E. coli cells (Clontech, Mountain view, USA) were used 
to maintain all plasmid constructs. 
3. Chapter II – Unraveling the Secondary Metabolism of T. reesei PhD Thesis 
Manuscript II                                                                                   Mikael Skaanning Jørgensen 
 
59 
 
Two plasmids were used to introduce and overexpress the selected TF genes by fusing 
the amplified TF genes to the constitutive A. nidulans PgpdA promoter. The pMJ-040 
plasmid carries two different restriction cassettes for insertion of PCR fragments, 
PacI/Nt.BbvCI and AsiSI/Nb.BtsI, and allows for co-overexpression of two TF genes in 
connection with PgpdA promoters. The pMJ-023 construct (Manuscript I) only carry the 
AsiSI/Nb.BtsI cassette and hence one copy of the PgpdA promoter. The method for 
insertion of the amplified TF genes is demonstrated in Figure 1 for pMJ-040. Two pairs of 
TF genes were selected for co-overexpression in pMJ-040; these originated from cluster 
22 and from cluster 23. They were both co-overexpressed and overexpressed alone. 
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Figure 1. Insertion of TF genes into the pMJ-040 overexpression construct by uracil-excision cloning. The construct without genes 
inserted (pMJ-040) carry two restriction cassettes used for insertion, one with PacI- and Nt.BbvCI sites and one with AsiSI- and Nb.BtsI 
sites. Primers targeting the selected TF genes have a uracil incorporated which is excised when treated with uracil-excision enzyme mix 
(mixture of uracil DNA glycosylase and DNA glycosylase-lyase Endo VIII). Treatment leads to dissociation of the terminal 
oligonucleotides and reveal overhangs complimentary to the overhangs obtained by digestion of the overexpression construct. The 
length of the overhangs render use of ligase and PCR product treated with uracil-excision enzyme mix and digested vector can be 
transformed directly after incubation. The first TF gene is introduced into the PacI and Nt.BbvCI site and the resulting construct utilized 
for overexpression of this TF gene alone. The second TF gene is introduced into this construct by digestion with AsiSI and Nb.BtsI and 
uracil-excision cloning, resulting in a construct for co-overexpression of both TF genes. The constructs include flanks targeting for 
insertion into adeB (FLA and FLB). 
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Both pMJ-040 and pMJ-023 carry 1.5 kb flanks homologous to the upstream and 
downstream regions of adeB (FLA and FLB) and allow for easy selection of correct 
integrated mutants since a red pigment will accumulate in the transformants in which 
adeB has been replaced by the overexpression fragment. The constructs furthermore 
carry pyr2 as selectable marker enabling restoration of uracil prototrophy in the pyr2 
deleted MJ-T-006 strain used as recipient (Manuscript I). The pyr2 gene is flanked by 375 
bp direct repeats that can facilitate loop out of the selective marker and selected for by 
subjection to 5-Fluorootic acid (5-FOA), reverting it to uracil autotrophy. Successive 
genetic alterations can thereby be introduced using only pyr2 as selectable marker. 
The pMJ-040 plasmid was assembled by introducing two PCR fragments into a 
PacI/NT.BbvCI cassette in pMJ-023 located between the adeB flank FLA and the pyr2 
selective marker, by uracil-excision cloning. One of the fragments carried a copy of the 
PgpdA promoter and the other carried a copy of the TtrpC terminator. The primer tails of 
the PCR fragments for uracil-excision cloning were designed to position the new promoter 
and terminator copy in opposite direction of the already present copy and to introduce a 
PacI/Nt.BbvCI cassette in between these for easy integration of a TF gene. The primers 
used for amplification of PgpdA were primer pair PgpdA-PacI-fw/rv and the primers used 
for amplification of TtrpC were primer pair TtrpC-PacI-fw/rv. All primers utilized in this 
study, except the ones used to amplify the TF genes, can be seen in Table S2. A total 
number of 13 overexpression constructs were obtained, 11 carrying a single TF gene and 
two carrying two TF genes for co-overexpression. The 13 constructs were transformed 
into the MJ-T-006 recipient strain resulting in isolation of 13 TF gene overexpression 
strains. All strains included in this study can be seen in Table 2. 
 
Table 2. Strains fabricated in this study. All strains are decedents of MJ-T-006 described in manuscript I which is 
tku70-::amdS+ ∆pyr2. 
Strain 
Transformed with/ 
pyr2 looped 
Parent strain Genotype (in addition to tku70-::amdS+ ∆pyr2) 
MJ-T-016 pMJ-033 MJ-T-006 ΔadeB::PgpdA::103122 pyr2+ 
MJ-T-017 pMJ-037 MJ-T-006 ΔadeB::PgpdA::47479 pyr2+ 
MJ-T-018 pMJ-038 MJ-T-006 ΔadeB::PgpdA::68254 pyr2+ 
MJ-T-019 pMJ-039 MJ-T-006 ΔadeB::PgpdA::69972 pyr2+ 
MJ-T-020 pMJ-023 MJ-T-006 ΔadeB::PgpdA pyr2+ 
MJ-T-027 pMJ-024 MJ-T-006 ΔadeB::PgpdA::105805 pyr2+ 
MJ-T-028 pMJ-035 MJ-T-006 ΔadeB::PgpdA::111088 pyr2+ 
MJ-T-029 pMJ-036 MJ-T-006 ΔadeB::PgpdA::111742 pyr2+ 
MJ-T-030 pMJ-041 MJ-T-006 ΔadeB::PgpdA::102497 pyr2+ 
MJ-T-031 pMJ-042 MJ-T-006 ΔadeB::PgpdA::102499 pyr2+ 
MJ-T-032 pMJ-053 MJ-T-006 ΔadeB::PgpdA::102497/102499 pyr2+ 
MJ-T-035 pMJ-034 MJ-T-006 ΔadeB::PgpdA::105784 pyr2+ 
MJ-T-036 pMJ-043 MJ-T-006 ΔadeB::PgpdA::106677 pyr2+ 
MJ-T-037 pMJ-054 MJ-T-006 ΔadeB::PgpdA::105784/105805 pyr2+ 
MJ-T-039 Looped MJ-T-031 ΔadeB::PgpdA::102499 Δpyr2 
MJ-T-040 Looped MJ-T-032 ΔadeB::PgpdA::102497/102499 Δpyr2 
MJ-T-043 pMJ-069 MJ-T-039 ΔadeB::PgpdA::102499 Δpyr2 Δ73618/73621 pyr2+ 
MJ-T-044 pMJ-067 MJ-T-040 ΔadeB::PgpdA::102497/102499 Δpyr2 Δ73618 pyr2+ 
MJ-T-045 pMJ-068 MJ-T-040 ΔadeB::PgpdA::102497/102499 Δpyr2 Δ73621 pyr2+ 
 
Three constructs, obtained by uracil-excision cloning, was used for deletion/disruption of 
the two PKS genes identified in the sorbicillinoid gene cluster (JGI ID: 73618 and 73621). 
The MJ-T-031 and MJ-T-032 strains overexpressing a sorbicillinoid gene cluster specific 
TF gene (JGI ID: 102499) were used for deletion or disruption of the PKS genes. The 
deletion/disruption constructs utilized pyr2 as selective marker and loop out of the pyr2 
gene present in connection with the introduced overexpression fragment was performed 
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prior to deletion/disruption. Loop out was confirmed by PCR using primer pair pyr2-rep1-
fw/rv. The loop out strains of MJ-T-031 and MJ-T-032 was named MJ-T-039 and MJ-T-
040, respectively. The primers used to amplify 1.5 kb PKS gene flanks, for disruption by 
homologous integration, can be seen in Table S2. The vector fragment for the deletion 
constructs was amplified from pMJ-023 using the primer pair vector-fw/rv and the pyr2 
fragment, flanked by 375 bp direct repeats, were amplified from pMJ-023 using primer 
pair pyr2-rep1-fw/rv. When assembled, the pyr2 fragment and direct repeats, was 
flanked by sequences homologous to the PKS gene flanks. The close proximity of the two 
PKS genes, facing in opposite directions in the cluster, made full deletion of a single PKS 
gene expedient since it could affect expression of the remaining PKS gene. The flanks for 
homologous integration were therefore designed so that approximately 2300 bp of the 
promoter sequence would still be present for the remaining PKS gene, while the majority 
of the other gene was deleted. A construct for simultaneous deletion of both genes 
included the two outermost flanks used for disruption of the two PKS genes. Construct 
pMJ-067 was obtained for disruption of 73618 in MJ-T-040, resulting in MJ-T-044; pMJ-
068 for disruption of 73621 in MJ-T-040 resulting in MJ-T-045 and pMJ-069 for deleting 
both 73618 and 73621 in MJ-T-039, resulting in MJ-T-043. A phylogenetic three of these 
strains can be seen in Figure S1. 
 
Culture conditions 
Two basic compositions of selective media were used for T. reesei, one for primary 
selective plates, with sucrose as carbon source and osmotic stabilizer (MM1), and one for 
secondary selective plates with mannitol as carbon source (MM2) as described in 
Manuscript I. For loop out of the pyr2 selective marker, restoring the uracil auxotrophy, 
MM2 plates were supplemented with 1.5 mg/ml 5-FOA and 10 mM uridine. Potato 
dextrose agar (PDA) (Oxoid, Hampshire, United Kingdom) was used for all non-selective 
solid cultivations. All incubations on solid media were for five days at 28°C. Liquid 
cultivations were in YPD media consisting of 1% Yeast extract (BD Difco, Franklin Lakes, 
USA), 2% Peptone bacto (BD Difco, Franklin Lakes, USA) and supplemented with 2% 
glucose. All liquid cultivations were with 10 ml YPD at 30°C and 200 rpm agitation; there 
was incubated for 24 hours to obtain biomass for purification of genomic DNA and for 96 
hours to obtain supernatant for UHPLC-DAD-TOFMS analysis. 
 
T. reesei transformation and loop out.  
Protoplastings and transformations of T. reesei were performed as described by Gruber 
et al. with minor modifications (Gruber, Visser et al. 1990). All plasmid constructs were 
linearized by NotI to release the fragment for insertion from the vector backbone 
exposing the flanks targeting for homologous integration prior to transformation. 
Digestions were set up with approximately 30 µg DNA in 200 µl restriction enzyme 
reactions, there was precipitated with isopropanol, washed with 70% ethanol and eluted 
in 30 µl Milli-Q whereof 10 µl was used for each transformation. Correct homologous 
integration was verified by diagnostic PCRs with the primers seen in Table S2. 
Loop out of the pyr2 selective gene by homologous recombination between the direct 
repeats flanking the gene was achieved by plating 108 spores on selective plates 
supplemented with 5-FOA. There was incubated for five days on MM1 where after 
colonies were transferred to MM2 plates for another five days of incubation. After this, 
the fastest growing loop out mutants were transferred to non-selective plates. 
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Genomic DNA purification and Southern blot analysis 
DNA extractions were performed using solutions from the MasterPure™ Yeast DNA 
purification kit (Epicentre Biotechnologies, Madison, USA) using a modified approach 
(Manuscript I). All DNA purifications utilized for Southern blot were digested for at least 
18 hours using the restriction endonuclease BsrGI. A 510 bp p32 labelled probe targeting 
a portion of the pyr2 coding sequence (CDS) was amplified using the primers: pyr2prob-
fw (5’-TCCCAGCTGCCTGCCTACAA-3’) and pyr2prob-rv (5’-GAGCTTCTCCATGCGGTCCA-
3’) and used for the Southern blot as described in Manuscript I. 
 
Metabolite extraction from supernatant 
The metabolite extractions were performed using strata-X polymeric reversed phase 
columns (part number: 00M-S033-B0-CB, Phenomenex, Torrance, USA).  
The columns were primed with two ml methanol followed up by one ml 2% formic acid 
(98% analytical grade, Sigma-Aldrich, St. Louis, USA). The sample was added to the 
column by transferring 500 µl of the growth media supernatant, mixing with 20 µl 
undiluted 98% formic acid and adding another 500 µl of the supernatant. The sample 
was run through the column by gravity flow and another 2 x 500 µl of the supernatant 
added as described above so that a total of two ml of the samples were run through each 
of the columns. The metabolites were eluted by adding 2 x 300 µl methanol before 
UHPLC-DAD-TOFMS. 
 
UHPLC-DAD-TOFMS 
Extracts (0.1-2µl) were analyzed by UHPLC-DAD-TOF method on a Dionex Ultimate 3000 
UHPLC system equipped with a 100 x 2.0 mm, 2.6 µm, Kinetex C-18 column, held at a 
temperature of 40°C and using a linear gradient system composed of A: 20 mM formic 
acid in water, and B: 20 mM formic acid in acetonitrile. The flow vas 0.4 ml/min: starting 
with 10% B which was increased to 100% B in 0-10 min, and held there for three min. 
Time-of-flight detection (TOF) were made using a MaXis 3G QTOF (Bruker Daltonics, 
Bremen, Germany), operated at a resolving power of 40.000 FWHM and a typical mass 
accuracy <1.5 ppm.  The MS was equipped with an electrospray ionization source and 
samples were analysed by both negative and positive polarity, in both cases scanning 
m/z 100–1000. For calibration, a mass spectrum of Sodium formate (5 mM) was 
recorded at the beginning of each chromatogram using the divert valve (0.3-0.4 min). 
MS-TOFMS experiments were conducted as targeted MS/MS using four potentials, either 
15, 25, 35 and 55 eV or 18, 30, 45 and 65 eV; an isolation width of m/z 4 was used to 
obtain a true isotope pattern of the fragment ions. MS/MS were set up for fifteen m/z 
values: 193, 249, 251, 265, 377, 441, 481, 497, 499, 513, 560, 692, 708, 710 and 808. 
 
UHPLC-DAD-TOFMS data analysis 
All UHPLC-DAD-TOFMS data were calibrated using Compas TargetAnalysis 1.2 (Bruker 
Daltonics, Bremen, Germany) and the most prevalent metabolites automatically 
compared to a database of known metabolites produced by T. reesei and closely related 
species. The calibrated data was loaded in to Compas DataAnalysis 4.0 (Bruker Daltonics, 
Bremen, Germany) for more thorough data analysis, visualization of chromatograms and 
comparison of the signal intensities obtained through extracted ion chromatograms 
(EICs). The best predicted stoichiometric formula of the metabolites of interest were 
estimated by the in-build function “SmartFormula manually” using data from at least 
three different independent samples. 
To compare the metabolites with high abundance in the TF gene overexpression strains 
with sorbicillinoids, the database visualizer ACD/Chemfolder 12.02 (Advanced Chemistry 
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Development, Inc., Toronto, Canada) was used to mine the antibase 2010 database for 
all previously identified sorbicillinoid metabolites (Nielsen, Mansson et al. 2011). 
 
Sorbicillinoid gene clusters 
The predicted amino acid sequences of proteins from genes in vicinity of the TF gene 
102499 were BLASTed using the NCBI BLAST search tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). A highly similar gene cluster was identified in 
the well-known sorbicillinoid producer Penicillium chrysogenum and the BLAST data used 
to predict the extent of the two PKS clusters. The amino acid sequences of the predicted 
proteins were obtained from the Joint Genome Institute (JGI) Genome Portal for both T. 
reesei (http://genome.jgi-psf.org/Trire2/Trire2.home.html) and P. chrysogenum 
(http://genome.jgi.doe.gov/Pench1/Pench1.home.html). The amino acid sequences were 
loaded into AlignX (a component of Vector NTI Advance 11.0, Invitrogen, Carlsbad, USA) 
for sequence alignment and to investigate the consensus and identity percentage for the 
similar proteins. 
 
PKS domain identification 
Identification of the domains of the two PKS genes 73618 and 73621 was done by using 
the NCBI Conserved Domain Database (CDD) 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) and by aligning the amino acid 
sequences of the two proteins with other well-characterized PKSs.   
 
Results  
 
To initiate linkage of gene clusters in T. reesei to their corresponding metabolites, we 
decided to use the strategy developed by Bergman et al. (Bergmann, Schumann et al. 
2007, Bergmann, Funk et al. 2010), who demonstrated that it is possible to activate 
silent gene clusters containing a TF gene by controlled expression of these genes. 
Accordingly, we examined the genome of T. reesei for TF genes potentially located in PKS 
or NRPS gene clusters. This analysis uncovered 30 different TF located near the 23 PKS 
and/or NRPS gene clusters. Eleven of these TF genes possibly located in eight different 
gene clusters were selected for the further work. Next, these TF genes were individually 
inserted into an ectopic locus using an expression platform that we had previously 
developed (Manuscript I). Three of the PKS and/or NRPS clusters contained two or more 
TF genes. In such cases it is possible that activation of the cluster depends on the 
presence of more than one of the TFs. We therefore made two additional mutants where 
TF gene pairs, originating from the same clusters, were simultaneously inserted into our 
ectopic expression site for constitutive expression facilitated by the A. nidulans PgpdA 
promoter. In summary 13 strains were constructed which potentially could produce new 
metabolites. 
 
Overexpression of one of the TF genes affects the metabolite profile 
Metabolites were extracted from fermentation broth of the 13 strains and sampled for 
UHPLC-DAD-TOFMS analysis. Only two of the overexpression strains (MJ-T-031 and MJ-
T-032) had significant change in the metabolite profile as compared to a reference strain 
(Figure 2). Both strains overexpressed the same gene (JGI ID: 102499), which is 
predicted to encode a Zn(II)2Cys6-type TF, and which is located in cluster 23. In MJ-T-
031 it was overexpressed alone and in MJ-T-032 it was overexpressed together with the 
other TF gene in the cluster, JGI ID: 102497. Specifically, the UHPLC chromatograms 
from these two strains contained >30 new metabolite peaks. Since no new metabolites 
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were detected with the strain overexpressing 102497 alone, we conclude that the novel 
metabolites were solely dependent on the TF encoded by 102499. Among the new peaks, 
some contained several metabolites, and further analysis, using the Compass 
DataAnalysis 4.0 software, revealed that metabolites with at least 54 different predicted 
stoichiometric formulas were over-synthesized (Table 3). Furthermore, several retention 
times were observed for 18 of the different masses, hence, indicating that these include 
compounds with different configuration. In total, we detected 78 different metabolites. 
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Figure 2. Chromatograms for a control strain and strains overexpressing the 102497 and 102499 TF genes. MJ-T-020 is the control 
strain with the empty expression construct inserted; MJ-T-030 overexpress TF gene 102497, MJ-T-031 overexpress TF gene 102499 
and MJ-T-032 overexpress both TF genes 102497 and 102499. It is seen that overexpression of 102497 alone do not result in any 
change of the metabolite profile while the metabolite profiles of the two strains overexpressing 102499 reveal many new peaks. The 
numbers depicts new peaks emerging when 102499 is overexpressed. The main metabolite for each peak can be seen in Table 3. 
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Table 3. Overview of the metabolites with higher prevalence in the 102499 overexpression strains. The “peak number” depicts the corresponding metabolite peak seen in Figure 2. The signal intensities for the 
EICs are included for MJ-T-020, MJ-T-031 and MJ-T-039. 
Monoisotopic 
Mass (Da) 
Retention 
Time (min) 
Predicted 
Stoichiometric 
formula 
Possible  metabolite(s) 
Known 
sorbicillinoid 
Possible 
dimer/trimer 
Subunit(s) 
Peak 
number 
MS/MS Signal 
MJ-T-020 
(10^X) 
Signal 
MJ-T-031 
(10^X) 
Signal 
MJ-T-039 
(10^X) 
C5H7
 
missing 
Subunit III 
fragment 
192.07863 5.008 C11H12O3 Trichopyrone No I 1 Yes No 4 6 ND 
206.09428 5.600 C12H14O3 - - - 2 - - ND 5 ND 
208.10993 5.496 C12H16O3 - - - - - - ND 5 ND 
219.12592 2.371 C13H17NO2 - - - - - - ND 5 ND 
220.10993 7.161 C13H16O3 Sohirnone A Yes - - - - ND 4 ND 
232.10993 3.756 C14H16O3 Sorbicillin Yes II - - - ND 5 ND 
248.10485 4.845, 5.067 C14H16O4 Sorbicillinol Yes III 3 Yes Yes ND 5 ND 
   Sohirnone B Yes        
250.12049 4.845 C14H18O4 Vertinolide Yes IV 4 Yes No 3 5 ND 
   Sohirnone C Yes        
264.09976 4.393 C14H16O5 Sorbimycin 
Oxosorbicillinol 
Epoxysorbicillinol 
Yes V 5 Yes No ND 6 ND 
Yes        
Yes        
266.11541 3.867, 4.148, 5.045 C14H18O5 5-hydroxyvertinolide Yes VI - - - ND 5 ND 
289.16778 4.571, 4.696 C17H23NO3 - - - - - - ND 5 ND 
292.13106 5.993 C16H20O5 - - - - - - ND 5 ND 
303.18343 5.134 C18H25NO3 - - - - - - ND 5 ND 
311.12698 4.422, 5.378 C17H17N3O3 - - VII 6 - - 4 6 ND 
313.14263 4.185 C17H19N3O3 - - - - - - 5 5 ND 
318.11032 5.119, 5.230 C17H18O6 - - - - - - ND 5 ND 
323.15213 4.585 C20H21NO3 - - - - - - ND 5 ND 
337.16778 5.141 C21H23NO3 - - - - - - ND 5 ND 
358.17801 5.778, 5.904, 6.304 C21H26O5 - - - 7 - - ND 5 ND 
370.15285 3.756 C20H22N2O5 - - - 8 - - ND 6 ND 
375.17940 3.496 C19H25N3O5 - - - - - - ND 5 ND 
376.15218* 4.689, 6.059 C20H24O7 Trichodermanone A/B Yes - - Yes Yes ND 5 ND 
379.16308 4.600 C19H25NO7 - - - 9 - - ND 5 ND 
388.16342 3.800 C20H24N2O6 - - - 10 - - ND 6 ND 
394.14162 5.889, 5.978 C23H22O6 - - - - - - ND 5 ND 
412.15218 6.282, 6.600 C23H24O7 - - - 11 - - ND 6 ND 
428.14710 5.489 C23H24O8 - - - 12 - - ND 5 ND 
440.18348 8.445 C25H28O7 - - I+III 13 No Yes ND 5 ND 
443.16923 4.237, 4.415 C22H25N3O7 - - VIII 14 - - ND 5 ND 
447.17940 5.489 C25H25N3O5 - - - - - - ND 6 ND 
ND: Not detectable, * [M-CH4O+H]
+ adduct, ** [M-H2O+H]
+ adduct. 
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 Table 3. Continued. 
Monoisotopic 
Mass (Da) 
Retention 
Time (min) 
Predicted 
stoichiometric 
formula 
Possible metabolite(s) 
Known 
sorbicillinoid 
Possible 
dimer/trimer 
subunits 
Peak 
number 
MS/MS Signal 
MJ-T-020 
(10^X) 
Signal 
MJ-T-031 
(10^X) 
Signal 
MJ-T-039 
(10^X) 
C5H7 
missing 
Subunit III 
fragment 
449.19505 5.163, 5.341 C25H27N3O5 - - - - - - ND 5 ND 
450.17907 5.171, 5.437 C25H26N2O6 - - - 15 - - ND 6 ND 
452.19472 4.104 C25H28N2O6 - - - 16 - - ND 5 ND 
456.17840 6.771 C25H28O8 - - I+V 17 - - ND 4 ND 
459.20053 4.608 C23H29N3O7 - - - - - - ND 5 ND 
478.19913** 6.904 C28H30O7 496.20970 - - 18 - - ND 6 ND 
480.21478 7.252 C28H32O7 Sorbiquinol Yes II+III 19 Yes No 4 5 ND 
482.19405 6.408, 7.459 C27H30O8 Demethyltrichodimerol Yes - 20 - - ND 5 ND 
   Demethylbisorbibutenolide Yes     ND 5 ND 
489.21109 4.363 C24H31N3O8 - - - - - - ND 5 ND 
496.17331 8.807 C27H28O9 Bisorbibetanone Yes - 21 Yes Yes ND 5 ND 
496.20970 
6.385, 6.608, 
6.793, 6.904, 
7.904 
C28H32O8 
Bisorbicillino 
Trichodimerol 
Trichotetronine 
Bisorbicillinolide 
Bislongiquinolide 
Yes 
Yes 
Yes 
Yes 
Yes 
III+III 22 Yes Yes ND 6 ND 
       
       
       
       
498.22534 7.119, 7.852 C28H34O8 
Bisvertinol 
Bisvertinoquinol 
Dihydrotrichodimerol 
Dihydrotrichotetronine 
Dihydrobislongiquinolide 
Yes 
Yes 
Yes 
Yes 
Yes 
III+IV 23 No Yes 4 5 ND 
       
       
504.21076 4.163, 4.608 C25H32N2O9 - - - 24 - - ND 5 ND 
512.20461 8.030 C28H32O9 Bisvertinolone Yes III+V 25 No Yes ND 6 ND 
514.22026 7.726 C28H34O9 Dihydrobisvertinolone Yes III+VI - - - ND 4 ND 
559.23183 5.963, 6.667 C31H33N3O7 - - III+VII 26 Yes Yes ND 6 ND 
593.23730 4.882 C31H35N3O9 - - - - - - ND 5 ND 
656.26212 8.296, 9.430 C38H40O10 - - - 27 - - ND 5 ND 
691.27408 6.511 C36H41N3O11 - - III+VIII 28 No Yes ND 5 ND 
707.26899 4.045 C36H41N3O12 - - V+VIII 29 No Yes ND 6 ND 
709.28464 3.852, 4.022 C36H43N3O12 - - VI+VIII 30 No Yes ND 5 ND 
760.30946 9.007 C42H48O13 - - III+III+V - - - ND 4 ND 
776.43465 5.393 C42H64O13 - - - - - - ND 5 ND 
807.33668 7.326 C45H49N3O11 - - III+III+VII - No Yes ND 5 ND 
ND: Not detectable, * [M-CH4O+H]
+ adduct, ** [M-H2O+H]
+ adduct. 
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Identification of the metabolite group synthesized by the overexpression strains 
Comparison of the predicted stoichiometric formulas for metabolites more prevalent in 
the overexpression strains with a database of possible T. reesei metabolites revealed that 
several of these with high probability belonged to the PK derived sorbicillinoids (Harned, 
Volp 2011). Out of the 54 predicted stoichiometric formulas observed, 15 were consistent 
with previously described sorbicillinoids (Table 3). Furthermore, the sorbicillinoid origin of 
four of the metabolites was supported by comparing their UV λmax with previously 
reports (Table S3). MS/MS conducted for 16 of the 54 metabolite masses observed, 
showed that at least nine of these experienced a mass loss corresponding to C5H7 
consistent with the outermost part of a sorbyl side chain moiety, which is characteristic 
for sorbicillinoids (Figure 3, Table 3). 
The sorbicillinoids are polyketide derived metabolites, often with great structural 
complexity due to the high reactivity of the hexaketides synthesized by the polyketide 
synthase. Common for most sorbicillinoids is the presence of a sorbicillin skeleton, 
consisting of a cyclohexanone ring structure and the previously mentioned sorbyl side-
chain, which both contribute to the high reactivity of the monomers (Figure 4). Members 
of this metabolite group are therefore most often observed as more stable dimeric 
compounds such as trichodimerol, bisorbicillinol, oxosorbiquinol and bisvertinolone; 
collectively referred to as bisorbicillinoids or as monomers subjected to further oxidation 
such as oxosorbicillinol and epoxysorbicillinol. These, together with the vertinolides, with 
a tetronic acid ring structure, comprise the most often observed monomeric sorbicillin 
derivates (Figure 4). Interestingly, over-production of the pentaketide trichopyrone was 
also observed in the 102499 overexpressing strains. 
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Figure 3. MS/MS result examples for the metabolites with monoisotopic masses of 264.09976 Da and 498.22534 Da. The rhombi point 
out the metabolites for which MS/MS was conducted, the circle a fragment corresponding to the cyclohexanone fragment when C5H7 
from the sorbyl side-chain moiety is lost from epoxysorbicillinol, and the triangles fragments corresponding to separated subunits of 
bisvertinol. 
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Possible sorbicillinoid dimers and trimers 
The high reactivity of the sorbicillinoids was supported by the observation that 13 of the 
metabolite masses from this study seemed to be dimeric or trimeric compounds 
comprised of smaller over-synthesized metabolites (Table 3). A metabolite with a 
monoisotopic mass of 248.10485 Da seemed especially reactive since the results showed 
that it could be a constituent of dimeric or trimeric metabolites with ten different 
stoichiometric formulas. MS/MS results for seven of the ten indicated that this 
speculation was correct, since metabolite fragments corresponding to this subunit was 
observed in these (Table 3). An example can be seen in Figure 3 for bisvertinol, in which 
both proposed subunits can be pointed out in the MS/MS chromatogram. Out of the 
possible di/trimers observed, divided into 13 predicted stoichiometric formulas, only five 
were consistent with previously described bisorbicillinoids. 
 
Two PKSs are necessary for production of sorbicillinoids 
The SM gene cluster containing the 102499 TF gene contains two PKS genes (JGI ID: 
73618 and 73621); neither of these synthases have so far not been linked to any 
metabolite(s). We therefore disrupted both PKS genes individually in MJ-T-032 and 
deleted both simultaneously in MJ-T-031 to assess their importance for biosynthesis of 
sorbicillinoids induced by overexpression of the 102499 TF gene. The Southern blot made 
to confirm deletion of 73618 and 73621 can be seen in Figure S2. EICs for the three PKS 
disruption or deletion strains (MJ-T-043, MJ-T-044 and MJ-T-045) demonstrated that all 
large peaks observed for MJ-T-031 and MJ-T-032 were absent and their metabolite 
profiles closely resembled the profile obtained with the control strain (Table 3). 
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Figure 4. Known sorbicillinoids and trichopyrone. The four monomers 1-4 has the classic sorbicillinoid cyclohexanone ring structure 
and a sorbyl side-chain, while 5 carry the sorbyl side-chain, but has a tetronic acid ring structure. All these monomers are polyketide 
derived hexaketides. Notice the cyclohexanone ring structures and sorbyl side-chain in the two bisorbicillinoids 6 and 7. The 
pentaketide trichopyrone 8 are also over-synthesized in the TF gene overexpression strains. 
 
 
3. Chapter II – Unraveling the Secondary Metabolism of T. reesei    PhD Thesis 
Manuscript II                                                                                   Mikael Skaanning Jørgensen        Mikael Skaanning Jørgensen 
 
69 
 
Accordingly, both PKSs in this cluster appear to contribute to the formation of all 78 
metabolites and we therefore named 73618 for sorA and 73621 for sorB. 
 
The sorbicillinoid genes and cluster 
Elucidation of the PKS domains revealed that SorA is a reducing PKS. Hence, in addition 
to the three basic PKS domains;  ketosynthase (KS), acyl transferase (AT) and the acyl 
carrier protein (ACP) it also contains a keton reductase (KR) domain, a dehydrogenase 
(DH) domain and an enoyl reductase (ER) domain with the potential to fully reduce 
ketones to alkyls in three concurrent reduction steps. Furthermore, SorA also carries a 
methyl transferase domain (MT). The sequential order of domains in SorA is: KS-AT-DH-
MT-ER-KR-ACP. SorB lacks reducing domains and can be categorized as a non-reducing 
PKS. In addition to the three basic PKS domains, this PKS contain four domains: a starter 
unit acyl-carrier protein transacylase domain (SAT), a product template domain (PT), a 
MT domain and a thioesterase (TE) domain. The sequential order of domains in SorB is: 
SAT-KS-AT-PT-ACP-MT-TE. To investigate whether other fungi contained a PKSs pair 
similar to the one identified above, we subjected the predicted amino acid sequence of 
SorA and SorB to a BLAST search using the NCBI BLAST tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). This analysis revealed a highly similar cluster in 
P. chrysogenum, a known sorbicillinoid producer (Bringmann, Lang et al. 2005). 
Comparison of the two clusters indicated that they consist of two PKS genes, two TF 
genes, one monooxygenase gene, one major facilitator superfamily transporter gene and 
possibly also a short-chain dehydrogenase/reductase gene (Figure 5). 
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Transcription factor
Monooxygenase
MFS transporter
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SDR
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Scaffold 1
sorG
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Scaffold 1
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   Protein 
Gene JGI ID Species Function 
Size 
(AA) 
Consensus Identity 
sorA 73618 T. reesei Polyketide synthase 2567 
75.9% 64.7% 
 2039 P. chrysogenum (Reducing) 2581 
sorB 73621 T. reesei Polyketide synthase 2633 
73.7% 62.9% 
 21983 P. chrysogenum (Non-reducing) 2671 
sorC 102497 T. reesei TF 665 
55.6% 45.2% 
 32109 P. chrysogenum (Zn(II)2Cys6-type) 684 
sorD 102499 T. reesei TF 686 
46.3% 37.1% 
 66895 P. chrysogenum (Zn(II)2Cys6-type) 620 
sorE 73623 T. reesei Monooxygenase 457 
67.9% 55.3% 
 69790 P. chrysogenum (Aromatic-ring hydroxylase-like) 445 
sorF 43701 T. reesei Transporter 535 
73.7% 62.9% 
 32108 P. chrysogenum (Major facilitator superfamily) 522 
sorG 102492 T. reesei Short-Chain dehydrogenase/reductase 350 
50.4% 31.3% 
 85555 P. chrysogenum  330 
Figure 5. Chromosomal regions of the two sorbicillinoid gene clusters in T. reesei and P. chrysogenum. The arrows indicate direction of 
transcription and the colors function of the corresponding protein products. The proposed gene names are included in the arrows and 
their JGI IDs can be seen in the appurtenant table. The predicted protein function can be seen in the table together with comparisons 
of the highly similar proteins of the two putative sorbicillinoid synthase clusters. Overexpression of the TF gene sorD activated over-
synthesis of the sorbicillinoids. 
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Discussion 
 
Bioinformatic mining of the T. reesei genome revealed presence of 23 putative PKS and 
NRPS clusters, which is far from reflected in the much lower number of metabolites 
synthesized by T. reesei at standard laboratory conditions. A search for TFs inside a 50 
bp radius of the synthase genes revealed presence of 30 possible cluster specific TF 
genes with numbers ranging from zero to five in vicinity of each cluster. In this study, 11 
of the identified TF genes were selected for overexpression to induce over-production of 
the corresponding metabolite products; enabling linkage between SM clusters and their 
metabolite products. This approach for the first time successfully facilitated identification 
of a gene cluster responsible for biosynthesis of the PK derived sorbicillinoids; it is 
furthermore the first experimentally confirmed linkage between a SM group and the 
corresponding gene cluster in T. reesei. 
Despite the positive outcome of the TF gene overexpression approach, the drawbacks 
were underlined by the fact that overexpression of only one out of the 11 TF genes led to 
change in the metabolite profile. This approach can therefore not be applied to elucidate 
the full metabolic potential, but provides a good starting point for investigation of a new 
organism’s metabolic potential; especially if a high throughput overexpression system, as 
the one utilized in this study, is at hand.  
The surprisingly low success rate observed when overexpressing cluster specific TFs can 
have several explanations. A crucial factor could be that the TF genes have not been 
annotated correctly. Furthermore it is also important to note that a TF gene situated 
adjacent to PKS or NRPS genes not necessarily constitutes a part of the corresponding 
SM gene cluster. The selected TF could also act as a single element in a highly complex 
regulatory system that is not fully understood; for instance it has previously been shown 
that the state of phosphorylation of some TFs is involved in regulation of transcription 
(Igarashi, Ishida et al. 2001, Moyano, Martinez-Garcia et al. 1996). The presence of 
several TF genes in the same metabolite clusters, as observed for six of the 23 PKS and 
NRPS gene clusters in T. reesei, could in fact indicate a very intricate system possibly 
including regulatory complexes. Overexpression studies of these would therefore require 
co-overexpression of several TF genes for induction of metabolite production, as made 
possible for two TF genes in T. reesei by pMJ-040. Unfortunately, co-overexpression of 
the two TF gene pairs selected in this study did not result in biosynthesis of any new 
metabolite products. 
Overexpression of the sorD TF gene triggered over-production of as much as 78 
metabolites with 54 different stoichiometric formulas. Many of the metabolites could be 
classified as sorbicillinoids, but the majority have not been described previously. The 
plethora of over-synthesized metabolites does not necessarily reflect that all of these are 
produced natively by T. reesei at inducing conditions in nature, but they could be an 
artefact of the extremely elevated biosynthesis of the highly reactive monomeric 
sorbicillinoid building blocks which, due to the elevated levels, react to form unusual 
products. This was supported by the inability to identify these new compounds in the 
control strain when using EICs. Occurrence of unusual metabolites was also indicated by 
identification of 25 different metabolite masses predicted to include nitrogen atoms, 
which is a trait that has only been observed for three sorbicillinoids previously 
(Bringmann, Lang et al. 2005, Cabrera, Butler et al. 2006). Replacement of oxygen 
atoms with nitrogen atoms in the ring structures of fusarubin and bostrycoidins has been 
observed when growth media with high nitrogen content such as YPD has been utilized 
(Rasmus Frandsen, personal communication), but cannot explain all the nitrogen atoms 
incorporated into the sorbicillinoids in this study. Instead it is more likely that the 
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sorbicillinoid building blocks have reacted with non-ribosomal peptides to form these new 
products; a hypothesis which 15N labelling studies could be used to affirm.  
The sorbicillinoid metabolites have been linked to a few genera including Trichoderma 
(teleomorph Hypocrea), Verticillium, Acremonium, Paecilomyces and Penicillium (Abe, 
Yamamoto et al. 2000, Maskey, Grun-Wollny et al. 2005, Trifonov, Bieri et al. 1982, 
Trifonov, Bieri et al. 1983, Cabrera, Butler et al. 2006, KONTANI, SAKAGAMI et al. 1994) 
which agrees with the finding of a gene cluster in the known sorbicillinoid producer P. 
chrysogenum, with significant similarity to the T. reesei gene cluster from which the TF 
gene sorD originates from. Thus, the P. chrysogenum sorbicillinoid gene cluster has 
probably also been identified in this study through comparative genomics. 
Extensive homology searches revealed that the two clusters most likely consist of six 
highly similar genes and possibly a seventh gene that is placed outside the cluster in P. 
chrysogenum. The two PKS genes in the sorbicillinoid cluster were named sorA and sorB. 
The predicted domain organization of the two PKSs resemble the one reported for the 
asperfuranone synthases (Chiang, Szewczyk et al. 2009) and strongly indicates that both 
SorA and SorB are required for biosynthesis of the polyketide products. First of all SorA is 
lacking a TE domain, which is most often used to release the finished ketide chain from 
the synthase. Secondly, SorB carries a SAT domain which enables loading of unfinished 
ketide chains synthesized from other polyketide synthases and importantly, SorB carries 
a TE domain for release of the final polyketide product. The proposed biosynthesis of 
sorbicillin and sorbicillinol based on the knowledge of the polyketide domains and genes 
in the clusters can be seen in Figure 8. A review by Harned and Volp gives an excellent 
overview of the proposed biosynthetic pathways from sorbicillin and sorbicillinol to many 
of the presently known sorbicillinoids (Harned, Volp 2011). 
Remarkably, a previously conducted phylogenomic analysis of PKS genes in T. reesei, 
Trichoderma atroviride and Trichoderma virens revealed that the two PKS genes in the T. 
reesei sorbicillinoid synthase cluster did not have any homologous in either of the two 
other species despite being placed in the same taxonomic family (Baker, Perrone et al. 
2012). 
Disruption of sorA and sorB in the 102499 overexpression strains supported that both 
PKSs were required for biosynthesis of sorbicillinoids since inactivation of either of the 
genes resulted in complete absence of all over-synthesized metabolites. Accumulation of 
intermediates was also not observed. The PKS gene disruptions precluded that the vast 
number of new metabolites synthesized, when overexpressing sorD, was due to any 
cross regulation of other metabolite clusters, as observed by Bergmann and co-workers 
when overexpressing a NRPS cluster associated TF gene (Bergmann, Funk et al. 2010). 
Interestingly, biosynthesis of the pentaketide trichopyrone was also halted by disruption 
of the PKS genes indicating that this metabolite is synthesized by the same polyketide 
synthases as the hexaketide sorbicillin. Biosynthesis of polyketides with different 
numbers of ketide units from the same PKS(s) is extremely rare, but has been observed 
previously (Davison, al Fahad et al. 2012). 
Several bioactivities with possible pharmaceutical applications such as anticancer, anti-
inflammatory and anti-oxidative activity have previously been appointed to the 
sorbicillinoids (Balde, Andolfi et al. 2010, Lee, Lee et al. 2005, Washida, Abe et al. 2007). 
The numerous new sorbicillinoids synthesized in T. reesei, when sorD is overexpressed, 
thus provides a possible treasure chest for new interesting drug candidates. Importantly, 
elucidation of the genes involved in biosynthesis of sorbicillinoids could also permit for 
industrial scale production of metabolites from this polyketide family decreasing need for 
chemical synthesis steps. 
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Figure 6. Predicted biosynthesis of sorbicillin and sorbicillinol by SorA, SorB, SorE and SorG. The ketide units added by the reducing PKS 
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synthase as an aldehyde by the aminoadipate semialdehyde dehydrogenase-type TE domain (TIGR01746), a domain typically known 
for NRPSs. Ring formation is most likely catalyzed by the PT domain. 
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Supplementary Tables and Figures 
 
Table S1. TF genes selected for overexpression in T. reesei and primers used for their 
amplification. All primers carry a uracil adjacent to an AsiSI/Nb.BtsI (blue) or a PacI/Nt.BbvCI 
(red) cassette targeting sequence. 
Cluster 
TF genes 
(JGI ID)  
Primer name Sequence (5’-3’) 
6 111742 111742-fw 
111742-rv 
AGAGCGAUATGGCGTCCTCTTACGGCAC 
TCTGCGAUTTAGAATACTAAACTCTTCGCCGCC 
10 103122 103122-fw 
103122-rv 
AGAGCGAUATGACCAGCCACGAAGGAGG 
TCTGCGAUCTAATTCTCTCCGCCCTCCCTC 
11 47479 
 
106677 
47479-fw 
47479-rv 
106677-fw 
106677-rv 
AGAGCGAUATGGGTGTGACTGGCCCAAC 
TCTGCGAUTTAGACACCATTTAAGAAATGCATCC 
GGCATTAAUATGCCCAGCATCAGGCAAATC 
GGTCTTAAUGTGCACAATGCCGATGAATTCC 
14 111088 111088-fw 
111088-rv 
AGAGCGAUATGACCGCCAACGGAGAAGTC 
TCTGCGAUTCACGTCTCAGCAACAGTAGCCG 
15 69972 69972-fw 
69972-rv 
AGAGCGAUATGCAGCTCGACAATAGCGACG 
TCTGCGAUTCATTGCATAAAATTATTGTTAAAGAGC 
19 68254 68254-fw 
68254-rv 
AGAGCGAUATGGAAAGGATGACCTCTTCTCC 
TCTGCGAUTCAAACAGAACCGCCCTGCC 
22 102497 
 
102499 
102497-fw 
102497-rv 
102499-fw 
102499-rv 
AGAGCGAUATGTCCGCCCGTCAAGACGAG 
TCTGCGAUGACTGGACGGAACGTGCCG 
GGCATTAAUATGGGGAGCAGCGCCACG 
GGTCTTAAUGCGAGGTGCAAGTATACCCGAG 
23 105805 
 
105784 
105805-fw 
105805-rv 
105784-fw 
105784-rv 
AGAGCGAUATGCTGCTGTTCGGTGGCC 
TCTGCGAUTCACCGATCAAGACTCCGATGG 
GGCATTAAUGGCCCAATCACATGAGTAGCCC 
GGTCTTAAUCCGGCCTGGTGTTGATGAGAG 
 
Table S2. Primers used for construction of pMJ-040, pMJ-069, pMJ-070 and pMJ-071 and for diagnostic 
PCRs. Primer tails designed for fusion by uracil-excision cloning are marked with blue. 
Primer name Used for Sequence (5’-3’) 
Vector construction  
Vector-fw 
pMJ-067, 068, 069 
AGGCGTGCAUCCGCATCATC 
Vector-rv ATCTGGGUCGTGGTCGATTGTG 
pyr2-rep1-fw 
pMJ-067, 068, 069 
AAGACCUCAGCCGCCAGCAGTGTCACAATCGAC 
pyr2-rep2-rv AACGCAGTGGUCACGGTCCG 
PgpdA-PacI-fw 
pMJ-040 
GGTCTTAAUGACCCAGATCGAATGCGTGC 
PgpdA-PacI-rv AATGCCUCAGCGCGGTAGTGATGTCTGCTCAAGC 
TtrpC-PacI-fw 
pMJ-040 
GGCATTAAUACGCGATGGGCGCTTACACAG 
TtrpC-PacI-rv AGGCATUAATTAAGACCTCAGCATCGCGTGCATTCGGATCC 
73618-FLUP-fw 
pMJ-067, 069 
ACCCAGAUGACTCTTTCCAGAGCTTGCTAATAAAG 
73618-FLUP-rv AGGTCTUGGATTTTCAGAATACGGAAGAGGATG 
73618-FLDW-fw 
pMJ-067 
ACCACTGCGTUTTGTTGATGGAGGCACGGCG 
73618-FLDW-rv ATGCACGCCUGGGAAGTCTCGGCCCCGATAG 
73621-FLUP-fw 
pMJ-068 
ACCCAGAUCGGCCTCAAGTACACGCACTC 
73621-FLUP-rv AGGTCTUCCTGATACGCTGCCTGCAGC 
73621-FLDW-fw 
pMJ-068, 069 
ACCACTGCGTUCAGGCGTGGAAGGATAGCGG 
73621-FLDW-rv ATGCACGCCUCTTGCGATCGAATGCCATCG 
Diagnostic PCR  
IT-adeBFL1-fw OE insert test1,3 GGCCAAAGATCATCCGCAGC 
IT-pyrF-rv OE insert test1 CAGTTGCTGAGGGAAGCCGTC 
IT-TtrpC-fw OE insert test2,3,4 CCGTAACACCCAATACGCCG 
IT-adeBFL2-rv OE insert test2, 4 CTTGGTTCTAGACGTGGAGGGCC 
73618-∆CTRL-fw Deletion test5, 7 CCTCCTCACCGCATCCTCCTG 
73618-∆CTRL-rv Deletion test5 ACCGGCTTCGTTTTCCCAGG 
73621-∆CTRL-fw Deletion test6 AACCTCGTTCGCCAGCTTGC 
73621-∆CTRL-rv Deletion test6,7 TGGGCGTATTGCGCTCTTGG 
1Used for test of correct upstream insertion of pMJ-023 based overexpression constructs, 2used for test of 
correct downstream insertion of pMJ-023 based overexpression constructs, 3used for test of correct 
upstream insertion of pMJ-040 based overexpression constructs, 4used for test of correct downstream 
insertion of pMJ-040 based overexpression construct, 5used for test of correct 73618 deletion, 6used for 
test of correct 73621 deletion and 7used for test of correct deletion of both 73618 and 73621 
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Table S3. UV absorption maxima for four selected metabolites and previously reported 
UV absorption maxima for the proposed compounds 
 UV(MeOH) λmax nm (logε) 
Metabolite This study References 
Epoxysorbicillinol 293 2881 
Bisvertinol 236, 273, 294, 378 240, 274, 299, 3631 
Trichopyrone 249, 354 249.5, 3462 
Demethylbisorbibutenolide 285, 370 362, 2822 
1(Abdel-Lateff 2004), 2(Washida, Abe et al. 2007) 
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Figure S1. Phylogeny of the strains used for examination of the sorbicillinoid gene cluster. 
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Figure S2. Southern blot including strains used for examination of the sorbicillinoid gene cluster.  The restriction endonuclease BsrGI 
was used for all digestions together with a 510 bp probe targeting the selectable marker pyr2. The expected hybridization bands sizes 
can be seen in the schematic drawings of the targeted loci. The boxes marked with “FLA” and “FLB” depict the adeB flanks that are 
used for homologous integration into the adeB locus and “FL1” to “FL4” the flanks that are used for disruption and/or deletion of the 
polyketide genes by homologous integration. Marker: BstII digested λDNA. Abbreviation: T, TtrpC terminator. 
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3.3. Manuscript III 
Heterologous Expression of Trichoderma reesei (Teleomorph Hypocrea jecorina) 
Polyketide Synthase-, Non-Ribosomal Peptide synthetase- and Hybrid 
synthetase Genes in Aspergillus nidulans. 
 
Introduction 
 
Most microorganisms including fungi produce a multitude of highly bioactive natural 
products defined as secondary metabolites (SMs). These compounds are not essential for 
survival of the producer under normal conditions, but are believed to give competitive 
advantages in the immediate environment by providing signalling capabilities, protection 
against UV-radiation, defence systems, and even attack systems (Chiang, Chang et al. 
2011, Keller, Turner et al. 2005, Osbourn 2010). A literature survey showed that 42% of 
the 23,000 small bioactive metabolites investigated had fungal origin, emphasizing the 
vast metabolic potential of fungi (Brakhage, Schroeckh 2011). The high bioactivity of 
these molecules constitutes an interesting source of drug candidates, supported by the 
fact that 34% of all small-molecules approved as drugs today are natural products or 
derived from natural products. Mimics of natural products or synthetic compounds with a 
natural product derived pharmacophore constitute another 30% (Newman, Cragg 2012). 
Two of the most important classes of fungal secondary metabolites are polyketides (PKs) 
and non-ribosomal peptides (NRPs) which have given rise to a multitude of 
pharmaceuticals with activities such as antibiotic, antiviral, anti-hypercholesterolaemic, 
tumor inhibiting and immunosuppressing (Brakhage 1998, Keller, Turner et al. 2005). 
Not different from other genes encoding proteins involved in specific biosynthetic 
pathways, also PKS- NRPS- and their appurtenant genes are clustered (Khaldi, Wolfe 
2011, Chiang, Szewczyk et al. 2009). Interestingly, the ever growing available fungal 
sequence data reveal that most of these gene clusters are untranscribed at laboratory 
conditions since the number of identified SMs for a species far from coincides with the 
number of observed synthase gene clusters (Chiang, Oakley et al. 2010, Mukherjee, 
Horwitz et al. 2012). This is also coincident with data from the industrial applied 
filamentous fungus T. reesei in which 23 PKS- and NRPS gene clusters have been 
identified (nine PKS-, ten NRPS-, three hybrid- and one PKS/NRPS/hybrid) (section 
3.1.9). For comparison, only few SMs have been described for T. reesei. The three PK 
derived SM groups: trichodimerols, trichodermatides and sorbicillinoids are presently the 
only PK groups that have been identified for T. reesei (Andrade, Ayer et al. 1996, 
Andrade, Ayer et al. 1992, Reino, Guerrero et al. 2008, Sun, Tian et al. 2008). Other SMs 
that have been reported for T. reesei are the NRP derived paracelsin A-D belonging to the 
peptaibols, characterized by high α-aminoisobutyric acid content and a C-terminal 1.2-
amino alcohol (Baker, Perrone et al. 2012) and trichodermin which is a terpene. 
While some T. reesei SMs have been described, the true SM potential has not been 
clarified and only the sorbicillinoids have so far been linked experimentally to the 
corresponding synthase gene cluster in T. reesei (Manuscript II). To clarify the metabolite 
products of orphan biosynthetic gene clusters and to establish a link between these, 
three main approaches have been pursued: (I) prediction of the natural activator of the 
clustered genes, (II) prediction of the metabolite product by available bioinformatic data 
and (III) prediction of metabolite products by using molecular and epigenetics based 
methods.  
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The outcome of the first approach where the natural activator is identified is almost 
impossible to predict due to the complexity of the regulatory system. It has though been 
applied successfully by Schroeckh and co-workers who identified the gene cluster 
responsible for biosynthesis of orsellinic acid and lecanoric acid through an extensive 
screening study in which 58 soil dwelling bacteria were co-cultured with Aspergillus 
nidulans (Schroeckh, Scherlach et al. 2009). The second approach becomes more and 
more reliable as available data increases and bioinformatics and proteomics develops, 
but it still far from obliterates the other two methods. The third approach has so far been 
the most successful and has primarily involved deletion of synthase genes coupled with 
metabolite profiling (Chiang, Szewczyk et al. 2008). For this method to be applicable, it 
is though required that the synthase cluster of interest is active at the applied conditions. 
To circumvent this, deletion studies have often included manipulation of pleiotropic 
silencers or activators such as the regulator LaeA or other chromatin/histone modulators. 
Transcriptional activation of SM clusters have also been achieved successfully by 
overexpressing cluster specific TF genes  (Bok, Keller 2004, Perrin, Fedorova et al. 2007, 
Bok, Hoffmeister et al. 2006, Bergmann, Funk et al. 2010, Bergmann, Schumann et al. 
2007). 
Heterologous expression of synthase genes or whole pathways have been applied with 
success in several studies to investigate corresponding metabolite products (Sakai, 
Kinoshita et al. 2012, Hansen, Salomonsen et al. 2011, Cox, Glod et al. 2004, Halo, 
Marshall et al. 2008). One of the main advantages of heterologous expression is that 
well-known expression hosts with well-known metabolic potentials and well-developed 
molecular tools can be utilized; this enables easy pin-point of new metabolites and 
obviates development of molecular tools for every new organism included in the 
research. The drawbacks of the other methods such as lack of transcription of many 
synthase genes at the applied conditions, the inability for pleiotropic regulators to 
activate transcription of all synthase genes and the observation that not all synthase 
clusters contain TF genes, makes heterologous expression an efficient supplement for 
elucidating the metabolic potential and for establishing links between genes and their 
corresponding metabolite products. 
Here we report our observations when expressing 23 T. reesei PKS-, NRPS- and hybrid 
synthetase genes in the model organism Aspergillus nidulans using a previously 
developed expression system (Hansen, Salomonsen et al. 2011). Eight of the obtained 
mutants, corresponding to 35%, had a changed phenotype on agar plates; four of these 
expressed genes encoding synthases with PKS domains and produced metabolite 
pigments and four expressed genes encoding NRPSs and had changed colony 
morphologies. However, detection of new products with UHPLC-DAD-TOFMS was not 
successful. 
 
Materials and Methods 
 
Strains and culture conditions  
The A. nidulans strain IBT28738 (argB2 veA1 pyrG89 nkuA-trS::AFpyrG) (Nielsen, 
Nielsen et al. 2008) was used for all transformations with PKS-, NRPS- and hybrid 
synthetase gene expression constructs. As reference for metabolic profiling the IBT28738 
strain transformed with the expression construct without any inserted synthase gene was 
included. The strains transformed with synthase genes were renamed according to the 
JGI ID of the synthase gene expressed; hence, the A. nidulans strain expressing the T. 
reesei PKS gene with the JGI ID 82208 were renamed MJ-A-82208. Minimal media (MM) 
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was composed of 1% glucose, 10 mM NaNO3, salt solution (Cove 1966) and 2% agar. 
MM was supplemented with 10 mM uridine, 10 mM uracil and 4 mM L-arginine when 
necessary. Incubations were for five days at 37°C if not for metabolic profiling for which 
incubations were for seven days at 30°C. 
 
Annotation of coding sequences of PKS- NRPS- and hybrid synthetase genes in T. reesei 
To estimate the correct size of the coding sequences (CDSs) of the selected PKS-, NRPS- 
and hybrid synthetase genes, the prediction made by JGI were supplemented with 
FGeneSH analysis using the online tool developed by SoftBerry 
(http://linux1.softberry.com/berry.phtml). FGeneSH is a hidden Markov model (HMM) 
based gene structure prediction tool and has been described as the most successful gene 
finding program in connection with the rice sequencing projects (Yu, Hu et al. 2002). To 
estimate the size of T. reesei synthase CDSs by FGeneSH, Fusarium graminearum and 
Neurospora crassa were selected as template organisms due to their close relations with 
T. reesei. The results of the CDS analysis can be seen in Table S1 together with the CDSs 
that were selected for the studies. 
 
PCR and cloning 
All PCRs were performed with the PfuX7 polymerase (Norholm 2010) with 35 cycles in 50 
µl reactions. Uracil-excision cloning was utilized for all cloning steps as previously 
described (Manuscript I). The primers used for amplification of the synthase genes 
smaller than 15 kb can be seen in Table S2 and all of the T. reesei PKS-, NRPS- and 
hybrid synthetase genes expressed in A. nidulans can be seen in Table 1. Before insertion 
of the amplified synthase genes into the previously constructed pU1111-1 expression 
vector (Hansen, Salomonsen et al. 2011), ten µg of the vector was digested with 20 U of 
both AsiSI and Nb.BsmI for six hours in a 100 µl reaction. One µl of the heat inactivated 
restriction mix was transferred to ten µl of GFX (GE healthcare, Little Chalfont, United 
Kingdom) purified PCR product of the gene of interest, one µl TE buffer (100 mM Tris-
HCl, 1 mM EDTA; pH 8.0) was added together with one U of uracil-excision enzyme mix 
(New England Biolabs, Ipswich, USA). Incubation was carried out for 20 min at 37°C, 
followed by 20 min at room temperature. Next, three µl of the reaction mix was used to 
transform chemically competent Fusion-Blue E. coli cells (Clontech, Mountain view, USA). 
Four constructs were assembled for expression of the 69.5 kb T. reesei PKS/NRPS hybrid 
gene with JGI ID 23171 in A. nidulans. The primers utilized to assemble these constructs 
can be seen in Table S3 and an overview of the approach can be seen in Figure 1. 
All constructs were designed to target a well-characterized insertion site (IS1) located 
between AN6638 and AN6639 in the A. nidulans genome (Hansen, Salomonsen et al. 
2011). 
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Table 1. Overview of the PKS-, NRPS- and hybrid synthetase genes expressed heterologous in A. nidulans. The nearest protein BLAST result obtained with the NCBI 
BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) is included for all synthases. It is important to note that the BLAST results only give a rough indication of the protein 
products due to the limited number of synthase proteins that have yet been linked to corresponding metabolite products. 
     BLAST results 
JGI ID Type Predicted protein domains Located in (cluster) Gene Size (bp) Closest annotated hit Accession number Max identity 
59482 PKS KS-AT-DH-ER-KR-ACP 1 7,042 Lovastatin nonaketide synthase XP_003710466.1 42% 
60118 PKS KS-AT-DH-MT-ER-KR-ACP 2 7,889 Lovastatin nonaketide synthase XP_003710466.1 37% 
65116 PKS KS-AT-DH-PT-ER-KR-ACP 3 7,608 Mycocerosic acid synthase XP_003712315.1 40% 
65172 PKS KS-AT-DH-MT-ER-KR-ACP 4 8,305 Acetolactate synthase EEH44268.1 46% 
65891 PKS KS-AT-DH-ER-KR-ACP 5 7,640 Phenolpthiocerol synthase EGY19840.1 41% 
81964 PKS SAT-KS-AT-PT-ACP 6 5,911 Conidial yellow pigment synthase XP_002848092.1 48% 
82208 PKS SAT-KS-AT-PT-ACP-TE 7 6,952 Conidial pigment synthase (Alb1) EFY88620.1 77% 
106272 PKS KS-AT-DH-MT-ER-KR-ACP 8 8,996 Phenolpthiocerol synthase XP_001934016.1 35% 
24586 NRPS A-T-C-A-T-C-T 10 6,728 Gliotoxin synthase (GliP) XP_750855.1 40% 
60458 NRPS A-T-C-A-T-C-T 11 6,666 Sirodesmin synthase (SirP) AAS92545.1 34% 
60751 NRPS A-T-C 12 2,720 HC-toxin synthetase XP_001932133.1 45% 
67189 NRPS A-T-C-T-C 13 5,442 Surfactin synthetase EGY22526.1 58% 
68204 NRPS A-Ox 14 3,567 Gramicidin S synthetase XP_003004664.1 59% 
69946 NRPS A-T-C-A-T-C-T-C-A-T-C-T-C-T-C 15 14,771 Gramicidin S synthetase XP_003719607.1 44% 
71005 NRPS A-T-C-A-T-C 16 5,769 Surfactin synthetase EGY22526.1 44% 
71072 NRPS A-T-R-K 17 3,855 Male sterility protein CCF37266.1 58% 
81014 NRPS A-T-R-SDR 18 3,909 Enterobactin synthetase EGY19303.1 73% 
23171* Hybrid KS-AT-ACP-(C-A-T)×18-R 19 69,518 Syringopeptin synthetase AAO72425.1 26% 
58285 Hybrid KS-AT-DH-MT-KR-ACP-C-A-T-R 20 12,156 Fusaproliferin synthase AFP73394.1 37% 
73618 PKS KS-AT-DH-MT-ER-KR-ACP 22 8,117 Lovastatin nonaketide synthase XP_001942484.1 36% 
73621 PKS SAT-KS-AT-PT-ACP-MT-TE 22 8,083 Citrinin synthase EJB11047.1 44% 
105804 PKS SAT-KS-AT-PT-ACP-TE 23 6,782 6-methylsalicylic acid synthase XP_001937752.1 46% 
59315 Hybrid KS-AT-DH-MT-KR-ACP-C-A-T-R 23 11,824 Fusaproliferin synthase AFP73394.1 53% 
Abbreviations: A, Adenylation; ACP, Acyl carrier protein; C, Condensation; DH, Dehydratase; ER, Enoyl reductase; KR, b-Keto reductase; KS, b-Keto synthase; MT, 
Methyltransferase; Ox, Oxidase; PT, Product template; R, Thioester reductase; SAT, Starter unit acyl-carrier protein transacylase; SDR, Short-chain 
dehydrogenase/reductase; T, Thiolase; TE, Thioesterase.*Entire gene probably not integrated successfully.  
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23171 CDS (69.5 kb)
T. reesei
18 kb
18 kb
20 kb
20 kb
Amplification
Fragments for use in uracil-excision fusions were obtained by PCR with primers
containing a single uracil designed for uracil-excision cloning. The plasmid pU1111,
carrying the PgpdA promoter, TtrpC terminator, argB selective marker and
sequences for homologous integration into a well characterized A. nidulans insertion
sequence (IS1), were used as vector template.
USER fusion
Gene fragments
NNN························NNNACCCAGAT
TCCGCACGTANNN························NNN
NNN························NNNAGGGGTGTT
TGGGTCTANNN························NNN
NNN························NNNAGGCGTGCAT
TCCCCACAANNN························NNN
NNN························NNNACCGCAT
TCCGCACGTANNN························NNN
NNN························NNNAAGCCGT
TGGCGTANNN························NNN
NNN························NNNAGGCGTGCAT
TTCGGCANNN························NNN
NNN························NNNACCCAGAT
TCCGCACGTANNN························NNN
NNN························NNNATCACCTTCT
TGGGTCTANNN························NNN
NNN························NNNAGGCGTGCAT
TAGAGGAAGANNN························NNN
NNN························NNNACCCAGAT
TCGCGGGTANNN························NNN
NNN························NNNAGTGCCCCT
TGGGTCTANNN························NNN
NNN························NNNAGCGCCCAT
TCACGGGGANNN························NNN
pMJ-011
pMJ-012
pMJ-013
pMJ-014
Vector fragments 23171 CDS fragments
Transformation
The four constructs obtained were NotI digested to obtain linear fragments for
transformation. The digestion mixes were pooled and precipitated to gain a high DNA
concentration before transformation. There are homologous overlaps of approximately
1.6 kb between each fragment and with the IS1 sequence of the A. nidulans genome.
pU1111
12043 bp
Amp(R)
argB PgpdA
TtrpC
IS1 target (UP)IS1 target (DOWN)
NotI (1298)NotI (10515)
Uracil-excision enzyme reaction removes the uracils incorporated in the PCR
products and generates overhangs which allow fusion of several fragments.
IS1 FL1
IS1 FL2
PgpdA 23171 fragment 1
23171 fragment 2
23171 fragment 3
23171 fragment 4
TtrpC argB
IS1A. nidulans
IS1 FL2TtrpC argBIS1 FL1 PgpdA
A. nidulans
23171 CDS (69.5 kb)
Amplified vector fragments
IS1-Ins-DW-fw
IS1-Ins-DW-rv
IS1-Ins-UP-fw
IS1-Ins-UP-rv
Fr1-Ins-fw Fr2-Ins-fw Fr3-Ins-fw Fr4-Ins-fw
Fr1-Ins-rv Fr2-Ins-rv Fr3-Ins-rv Fr4-Ins-rv
Figure 1. Approach for introducing the 69.5 kb PKS/NRPS hybrid gene with JGI ID 23171 into A. nidulans IS1. Four 
constructs were fabricated, each one carrying a fragment of the gene with overlapping regions of approximately 1.6 kb. 
The pMJ-011 construct carrying the first part of the gene also carried the IS1 FL1 targeting sequence and the PgpdA 
promoter and the pMJ-014 construct carrying the last part of the gene also carried the TtrpC terminator, the argB 
selective gene and the IS1 FL2 targeting sequence. If correctly integrated, a full 23171 gene expression construct would 
be integrated into IS1 as seen in the bottom of the figure. Primers used for diagnostic PCRs are included in the drawing. 
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Protoplasting and transformation 
Protoplasting and integration of the expression fragments were performed as described 
previously (Johnstone, Hughes et al. 1985, Nielsen, Albertsen et al. 2006). Before 
transformation, ten µg of the plasmids carrying synthase genes of less than 15 kb were 
digested with NotI to separate the fragments for insertion from the vector backbones. If 
a NotI site was present in the synthase gene sequence, another restriction enzyme with a 
single digestion site in the vector backbone was chosen for linearization of the construct 
before transformation. 
The four plasmids that were constructed for heterologous expression of the 23171 gene 
were digested with NotI prior to transformation to release the fragments for insertion 
from the vector backbones. The digestions were set up as four separate 100 µl reactions 
each with 25 µg DNA and 20 U NotI and digested ON at 37°C where after another 20 U 
of NotI were added before another four hours of digestion. Twenty µl from each digestion 
were pooled, ethanol precipitated and eluted in 25 µl Milli-Q water. Before the DNA 
fragments were used for transformation they were subjected to heat treatment in a 
thermal cycler as described in the following; the first temperature step was at 98°C for 
five minutes where after the temperature was dropped to 95°C for five minutes, from 
this step the temperature dropped 5°C each five minutes until a temperature of 25°C 
was reached. Ten µl of the heat treated DNA fragment mix was used for transformation. 
Integration of the expression 
constructs into IS1 can be seen in 
Figure 1 for the synthase gene with 
JGI ID 23171 and Figure 2 for the 
remaining synthase genes. All 
targeting events were verified by 
two diagnostic PCRs using genomic 
DNA purifications as template. 
Correct upstream insertion was 
verified using the primers IS1-Ins-UP-fw, targeting a genomic sequence just upstream of 
IS1 FL1, and IS1-Ins-UP-rv targeting PgpdA. Correct downstream insertion was verified 
using primer pair IS1-Ins-DW-fw, targeting argB and IS1-Ins-DW-rv, targeting a 
genomic sequence just downstream of IS1 FL2. Four additional diagnostic PCRs, each 
targeting one of the four 23171 gene fragments, were set up for verification of correct 
insertion of the entire gene as seen in Figure 1. The sequence of all primers used for 
diagnostic PCRs can be seen in Table S4. 
 
Metabolite extraction and UHPLC-DAD-TOFMS 
Strains selected for metabolic profiling were inoculated in three-point stabs on MM plates 
and grown for seven days at 30°C. Six plugs with a diameter of 6 mm were picked for 
each strain from different parts of the growing colonies. The plugs were transferred to 4 
ml vials and one ml extraction solvent (one part Methanol, two parts Dichloromethane, 
three parts Ethyl acetate and 0.5% formic acid) added. The vials were ultrasonicated for 
45 minutes where after the extraction solvent was decanted to new vials. The solvent 
was evaporated using N2 flow at 33°C and the dried metabolites resuspended in 200 µl 
methanol and released from the glass-surface by 45 minutes of ultrasonication. The 
solution was filtered through filters with a pore size of 0.22 µm prior to UHPLC-DAD-
TOFMS. 
Figure 2. Introduction of expression constructs into the A. nidulans IS1. 
Primers used for diagnostic PCRs are included in the drawing  
 
Homologous
recombination
argB IS1 FL2IS1 FL1 PgpdA GOI TtrpC
IS1 FL1 IS1 FL2
argB IS1 FL2IS1 FL1 PgpdA GOI TtrpC
A. nidulans
A. nidulans
IS1-Ins-UP-fw IS1-Ins-DW-fw
IS1-Ins-UP-rv IS1-Ins-DW-rv
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The UHPLC-DAD-TOFMS was carried out on a Dionex Ultimate 3000 UHPLC and data 
analysis performed with Compas Target Analysis 1.2 and Compas DataAnalysis 4.0 
(Bruker Daltonics, Bremen, Germany), as previously described (Manuscript II). 
 
Results 
 
Twenty three A. nidulans mutants expressing T. reesei PKS-, NRPS- or hybrid synthetase 
genes were isolated and analyzed. 
 
Isolation of correct transformants 
All diagnostic PCRs targeting the upstream and downstream points of integration into IS1 
were positive, indicating that A. nidulans mutants with correct integrated expression 
constructs could be isolated for all introduced synthase genes of less than 15 kb. The 
diagnostic PCRs targeting both IS1 integration points of the 23171 gene expression 
fragments were also positive, but surprisingly only one of the additional diagnostic PCRs 
that were set up to ensure presence all four 23171 gene fragments was positive (Table 
2).  
Altered phenotypes could be observed directly on the transformation plates after 
transformation with eight of the T. reesei synthase/synthetase gene expression 
substrates. The new phenotypes could be divided into two basic types; one with mutants 
producing a pigment and one with mutants that had changed colony morphology. 
Examples of both can be seen in Figure 3 and an overview of the mutants with changed 
phenotypes can be seen in Table 3. Interestingly, the mutant transformed with the 
23171 gene expression constructs had a changed phenotype even though the diagnostic 
PCRs indicated that the entire gene was not integrated. 
 
Table 2. Diagnostic PCRs for verification of correct insertion of 23171 
PCR # 1 2 3 4 5 6 
Primers IS1-Ins-UP-fw/rv Fr1-Ins-fw/rv Fr2-Ins-fw/rv Fr3-Ins-fw/rv Fr4-Ins-fw/rv IS1-Ins-DW-fw/rv 
PCR result + - - - + + 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pigment Limited growth / rough surface
Figure 3. Selection plates with transformants expressing synthase genes that result in changed phenotype. The 
blue arrows point out colonies in which the introduced expression construct is active and affect the phenotype. 
The green arrows point to colonies in which the expression construct has not been introduced correctly and which 
phenotype resemble the one of the control.  
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Mutants producing a pigment 
Transformation with four of the expression constructs resulted in pigment producing 
mutants (Figure 4). Common 
for all four synthase genes that 
led to pigment production was 
presence of PKS domains. Two 
of the genes encode highly 
reducing PKSs while one 
encodes a non-reducing PKS. 
The last pigment producer 
expressed a gene encoding a 
PKS/NRPS hybrid with a highly 
reducing PKS moiety. The 
observed pigmentation differed 
from bright orange for MJ-A-
65891 to light reddish for MJ-A-
106272 to bright yellow for both MJ-A-59315 and MJ-A-82208. The pigments seemed to 
be restricted to the mycelia and were not released into the growth media.  
UHPLC-DAD-TOFMS metabolite chromatograms for all pigment producing mutants can be 
seen in Figure 5. It is seen that the chromatograms for all the strains were highly similar 
and that no new apparent peaks were present for any of the mutants.  Thorough 
examination of potentially interesting metabolites by Extracted Ion Chromatograms 
(EICs) supported that no new metabolites could be detected in any of the metabolite 
samples for the pigment producing mutants. 
 
 
Table 3. Phenotypical traits for selected A. nidulans strains expressing T. reesei PKS-, 
NRPS- or hybrid synthetase genes. Only mutants with a change in the phenotype are 
included. The different phenotypes can be seen in Figure 4 and 6. 
Strain ID Synthase type Gene size (bp) Phenotype 
MJ-A-65891 PKS 7,640 Pigment 
MJ-A-82208 PKS 6,952 Pigment 
MJ-A-106272 PKS 8,996 Pigment 
MJ-A-67189 NRPS 5,442 Limited growth / rough surface 
MJ-A-68204 NRPS 3,567 Limited growth / rough surface 
MJ-A-81014 NRPS 3,909 Limited growth / rough surface 
MJ-A-23171 Hybrid 69,518 Rough surface 
MJ-A-59315 Hybrid 11,824 Pigment 
Figure 4. Reverse of the plates with A. nidulans strains expressing T. reesei 
synthase genes that lead to pigment production. Expression of both 59315 and 
82208 results in production of a bright yellow pigment and only the plate for MJ-
A-59315 are therefore shown as an example. 
MJ-A-59315 / 82208 Control
MJ-A-65891 MJ-A-106272
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Mutants with changed morphology 
Transformation with four of the expression constructs resulted in changed colony 
morphology when grown on plates (Figure 6). Two new colony morphologies were 
observed, both with a 
rough brownish surface. 
While the growth rates 
were negatively 
affected for both 
morphologies when 
compared to the control 
strain, this was much 
more pronounced for 
three of the mutants. 
Common for all four 
synthase genes leading 
to changed morphology was the presence of NRPS domains.  
UHPLC-DAD-TOFMS metabolite chromatograms for mutants with changed colony 
morphology can be seen in Figure 7. It is evident that the metabolite profiles for all four 
mutants expressing a synthase gene which affects the colony morphology differ from the 
profiles for the two controls. The number of metabolites produced by MJ-A-23171, MJ-A-
Control
MJ-A-106272
MJ-A-59315
MJ-A-65891
MJ-A-82208
Figure 6. Phenotypes of the A. nidulans strains expressing T. reesei synthetase genes affecting 
the colony morphology. Two new phenotypes were observed, one for MJ-A-23171 with a 
rougher surface with a relatively high growth rate, and one for MJ-A-67189, MJ-A-68204 and 
MJ-A-81014 with severe negatively affected growth rate. 
 
Limited growth / rough surface ControlRough surface
Figure 5. UHPLC-DAD-TOFMS metabolite profiles for mutants expressing synthase genes resulting in production of pigments. Some 
variations are seen between the different chromatograms, but none of the metabolite extractions for the pigment producing 
mutants seem to have any new metabolite peaks not observed for the control. 
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68204 and MJ-A-81014 seems to be lower than observed for the two controls while MJ-A-
67189 on the contrary seems to produce a higher number of metabolites. The profound 
changes in the metabolite profiles hamper identification of metabolite products 
originating from the expressed synthase genes and none of the observed metabolites 
could be appointed to the T. reesei synthases that were expressed heterologous. An 
interesting observation is that the three mutants with the limited growth and rough 
surface morphology all produce the same two metabolites not observed for the control 
(Figure 7).  
 
 
The two metabolites observed for the mutants with limited growth and rough surface 
have a mass of m/z 741.5512 [M+H]+ and m/z 757.5464 [M+H]+. EICs for these masses 
show that these two metabolites are not synthesized by the control strain (Figure 8). The 
mass difference of 15.9952 Da indicates that just one oxygen atom separates the two 
metabolites and that they therefore highly likely are synthesized by the same synthase. 
All stoichiometric formulas predicted by the “SmartFormula manually” function in Compas 
DataAnalysis include nitrogen atoms and indicate that they are both NRPs consisting of 
seven amino acids. 
Control 2
Control 1
MJ-A-81014
MJ-A-67189
MJ-A-68204
MJ-A-23171
Figure 7. UHPLC-DAD-TOFMS metabolite profiles for mutants expressing synthetase genes resulting in changed colony 
morphology. It is seen that all of the metabolite profiles are heavily affected; some metabolites seem to be produced in higher 
amounts and some in lower amounts while some are completely absent. Two chromatograms are included for the control strain 
to visualize the low variation normally observed between two independent metabolite extractions. The red box encircles two 
metabolites which are synthesized in large amounts in three of the mutants overexpressing a NRPS.  
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Mutants with no new phenotype 
UHPLC-DAD-TOFMS metabolite chromatograms for the 15 remaining mutants expressing 
T. reesei synthase genes without phenotypical changes did not reveal biosynthesis of any 
new metabolites. 
 
Discussion 
 
The results show that all expression constructs, except the ones for the 23171 gene, 
were successfully inserted into IS1. Phenotypical changes were observed for eight of the 
23 obtained mutants confirming that these T. reesei PKS-, NRPS- or hybrid synthetase 
genes were indeed expressed in A. nidulans. The mutants with changed phenotype could 
be divided into two basic groups, one expressing genes encoding PKS domains, resulting 
in pigmentation, and one expressing genes encoding NRPS domains, resulting in changed 
colony morphology. 
Surprisingly, the UHPLC-DAD-TOFMS metabolite chromatograms for the four mutants 
producing a pigment did not reveal presence of any new metabolite peaks despite the 
obvious presence of chromophores in these. The inability to pin-point any new 
metabolites in the chromatograms are therefore probably due to absence of these 
metabolites in the extractions and not caused by limitations of the detection method. The 
extraction method utilized was developed to release as broad a range of metabolites as 
possible from A. nidulans; unfortunately the great structural diversity of metabolites 
makes it impossible to extract all using just one method. The failure of the applied 
method to extract the metabolites of interest was supported by the observation that the 
new pigments seemed to be retained in the biomass when extracting. These metabolites 
might be tightly embedded in the mycelium in the heterologous host due to absence of 
the corresponding transporters and are therefore not extracted using the standard 
approach. Further investigation revealed that genes encoding transporters are indeed 
present in all four T. reesei gene clusters from which the heterologous expressed PKS 
genes originated from. The observation that all four pigment producing mutants carried 
synthase genes with PKS domains agrees with previous reports showing that pigments 
1
2
MJ-A-81014
MJ-A-67189
MJ-A-68204
Control
Figure 8. EICs for the masses between m/z 742.5543 [M+H]+ (peak 2) and m/z 758.5397 [M+H]+ (peak 1) for strains with limited 
growth and rough surface. It is seen that the two metabolites are produced only by the strains with changed colony morphology. 
Notice that the scale of signal-intensity for the control strain is different than for the others. 
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are often derived from PKs (Fujii, Watanabe et al. 2001, Mapari, Thrane et al. 2010, Gao, 
Qin et al. 2010).  
While the metabolite chromatograms for the mutants producing pigments resembled the 
one for the control strain, large changes were observed in the chromatograms for the 
strains with altered colony morphology. The changes included both appearance of several 
new metabolite peaks, but also disappearance of numerous peaks. Production of SMs 
have previously been shown to be dependent of the growth phase in fungi (Calvo, Wilson 
et al. 2002) and the highly affected colony morphology and limited growth observed for 
the four mutants not surprisingly also affected their metabolite profiles heavily. The large 
alterations in the metabolite profiles hampered identification of new metabolite peaks 
appearing due to expression of the T. reesei synthase genes. As also observed for the 
pigment producing synthases, genes encoding transporters are present in three of the T. 
reesei clusters for the morphology changing synthetases, only the cluster with the 
synthetase gene 68204 did not include a transporter gene in T. reesei. Presence of the 
NRP metabolites possibly synthesized by the heterologous synthetases was therefore not 
certain in the extractions. 
The severely affected phenotypes when expressing the synthetase genes with NRPS 
domains are consistent with numerous previous reports of the antifungal activity of NRPs 
(Manavalan, Murugapiran et al. 2010, Wiest, Grzegorski et al. 2002, Silva-Stenico, Silva 
et al. 2011, Tincu, Taylor 2004). Expression of these synthetase genes in a heterologous 
host could therefore affect the fitness of the producer since it is a possible natural target 
of the foreign NRP metabolites. Heterologous expression of just the synthetase genes 
also entails that possible resistance genes, that might be present in the original host, are 
not expressed in the heterologous producer. 
Two new NRP metabolites were produced in the three mutants with limited growth and 
rough surface. Both of these are most likely products of a single A. nidulans NRPS and 
could be a part of a stress response induced by the presence of foreign NRPs which affect 
the overall fitness of the mutants. These two NRPs could possibly act as antifungals and 
be synthesized by A. nidulans as a part of a defense system. The metabolites have not 
previously been reported for A. nidulans and as seen in Figure 8, the control strain does 
not synthesize these. Co-cultivation of T. reesei and A. nidulans coupled with metabolite 
profiling could enlighten if these metabolites are indeed produced to gain competitive 
advantages, as observed previously when co-cultivating A. nidulans and soil dwelling 
bacteria (Schroeckh, Scherlach et al. 2009).  
The new phenotype with rough surfaced colonies observed for MJ-A-23171 was surprising 
since diagnostic PCRs showed that only some of the first part and the last part of the 
gene were present in the mutant. The results of the diagnostic PCRs indicate that 
homologous recombination could have happened between fragment one and four of the 
23171 gene; possibly facilitated by the large sequence homology between these due to 
the repeated nature of NRPS domain encoding genes. The changed phenotype indicates 
that a new product could be synthesized by the mutant, which would be possible if the 
two gene fragments had combined so that the domain sequences fit each other. If this is 
indeed the case a new smaller NRP, than produced originally by T. reesei, will be 
synthesized by the smaller synthetase. The altered phenotype could also be caused by 
insertion of the large DNA fragments, but integration of the other expression construct 
with genes of up to 14.8 kb into IS1 did not confer the same phenotypical change. 
Sequencing of the inserted fragment could enlighten whether the two outermost 23171 
gene fragments had fused and expression studies could indicate whether the inserted 
gene fragment is indeed expressed. 
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The unaltered phenotype for the 15 remaining mutants transformed with PKS-, NRPS- or 
hybrid synthetase gene expression constructs, does not necessarily reflect that the 
inserted genes are not expressed in the heterologous host. If the synthase products are 
not pigments or do not affect the colony morphology, their presence will not be visible 
directly on the plates. Nevertheless, several factors could result in failed biosynthesis of 
the metabolite product. Correct annotations of the synthase genes are extremely 
important and even though automatic in silico predictions of genes are usually very 
efficient, it sometimes fails to provide correct results. Other factors that can influence 
metabolite biosynthesis are presence of elements such as thioesterases or thioester 
reductases which are often involved in release of the metabolite product from the 
synthase. If this is not a part of the synthase itself, but dependent on other enzymes, the 
product might not be released from the synthase in the heterologous host and 
biosynthesis will be halted. Another possible limitation in heterologous hosts could be 
availability of unusual subunits required for biosynthesis of specific products. One 
example is the previously mentioned group of NRPs synthesized by T. reesei referred to 
as peptaibols which contain a high proportion of the non-proteinogenic α-aminoisobutyric 
acids. This group of NRPs has not been appointed to any Aspergilli which may therefore 
not synthesize the α-aminoisobutyric acid subunit. 
The results of this study underline both the advantages and drawbacks when using 
heterologous expression to link genes and metabolites. Phenotypical changes were 
observed for a high proportion (35%) of the isolated mutants supporting that the method 
can be applied for PKS-, NRPS- and hybrid synthetase genes of even distantly related 
filamentous fungi. Unfortunately, no conclusions can yet be drawn from the results since 
the products of the heterologous synthases could not be identified. Nevertheless, a range 
of mutants expressing PKS-, NRPS- and hybrid synthetase genes has been obtained and 
optimization of the extraction method and possibly also the analytical methods could in 
the near future provide interesting insights into the T. reesei PK and NRP biosynthesis. 
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Supplementary Tables 
 
 
Table S1. The location of estimated PKS-, NRPS-, and hybrid synthetase gene CDSs in the T. reesei genome. 
The location predicted by JGI and by SoftBerry FGeneSH using Fusarium graminearum and Neurospora 
crassa as template organisms are included. The CDSs that were chosen are black while the predictions that 
were not used are faded. 
     SoftBerry FGeneSH 
  JGI  Fusarium graminearum Neurospora crassa 
Gene ID Scaffold Start End  Start End Start End 
59482 6 489709 496750  489709 496750 489709 496750 
60118 7 961671 969559  961671 969559 961671 969559 
65116 15 578930 571323  578930 571323 578930 571323 
65172 15 76106 84410  76097 84410 76097 84410 
65891 17 631535 639174  631484 639174 631484 639174 
81964 29 42489 36579  44305 36579 44305 36579 
82208 33 15745 8794  15766 8878 15766 8878 
106272 7 215526 224521  215526 224521 215526 224521 
24586 1 2715208 2721935  2715190 2721980 2715190 2721980 
60458 7 1346092 1352757  1346092 1352757 1346092 1352757 
60751 8 526840 524121  526840 523434 526840 523434 
67189 20 536612 542053  536612 542053 536612 542053 
68204 24 269353 272919  269317 272919 269551 272919 
69946 31 54649 39879  51286 39879 54649 39879 
71005 46 32532 26764  33077 26764 33892 23176 
71072 50 14095 10241  14095 10241 14095 10241 
81014 22 51332 47424  51332 47424 51332 47424 
23171 24 123560 193077  123560 193077 123560 193077 
58285 5 37773 25618  37773 25644 37773 25618 
73618 1 490277 482161  490277 482236 490277 482236 
73621 1 491045 499127  491045 499083 491045 499083 
105804 6 69489 62708  69489 62708 68710 62708 
59315 6 46569 34746  46569 34746 46569 34746 
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Table S2. Primers used for amplification of T. reesei PKS-, NRPS- and hybrid synthetase 
gene CDSs for heterologous expression in A. nidulans. Primer tails used for integration 
into the overexpression constructs by uracil-excision cloning are marked with blue.  
Primer Name 
Synthase gene 
(JGI ID) 
Sequence (5’-3’) 
60118-fw 
60118 
AGAGCGAUATGGCTTCGACGAACGGGATTG 
60118-rv TCTGCGAUTTACTTCTTCTCCTCCGCAACCC 
65172-fw 
65172 
AGAGCGAUATGGCTACAATGGAGCCGCTC 
65172-rv TCTGCGAUCTAACTGCTGGCCGCAATTTGAAC 
73621-fw 
73621 
AGAGCGAUATGGCGGCCTCAAGTACACGC 
73621-rv TCTGCGAUTCATCGCAAAAAGCCGCTATCC 
81964-fw 
81964 
AGAGCGAUATGGCTTCAACCACCAAACCC 
81964-rv TCTGCGAUCTATTTGCTCAGCCACTCCGTCAAC 
82208-fw 
82208 
AGAGCGAUATGCTGGATTCAACGTCTGCCATG 
82208-rv TCTGCGAUTTACTTTGAGAAAGCACTCTTGATAAACTC 
105805-fw 
105805 
AGAGCGAUATGCTATCAGCCATGGCCAATGTATC 
105805-rv TCTGCGAUCTACGTGTCGATGTCCCGCATAC 
106272-fw 
106272 
AGAGCGAUATGTCTCAGCCCGCGACTGTAG 
106272-rv TCTGCGAUTTACGCCTTGCCAACCGTGC 
58285-fw 
58285 
AGAGCGAUATGGATCAACAAAGACAGCAGGATG 
58285-rv TCTGCGAUTTAATCGCTTCCCATATAAGGGAAAATC 
59315-fw 
59315 
AGAGCGAUATGGCGCACAATCCTGCGG 
59315-rv TCTGCGAUCTAAAGTAGGCTCGGTAAAATCGCC 
59482-fw 
59482 
AGAGCGAUATGTCGTCCTCGAAGCAGGACATG 
59482-rv TCTGCGAUTCACTCCTTCGTCCAGACTCCCTC 
60458-fw 
60458 
AGAGCGAUATGGCTCAAACCAGGAGAGGCC 
60458-rv TCTGCGAUTCATGAGAACATCCAAGCAATGTCTC 
65116-fw 
65116 
AGAGCGAUATGTTCACTCTTGAACCCGCTCTAG 
65116-rv TCTGCGAUTCAACCAGACCAGCTGGCAATAAG 
65891-fw 
65891 
AGAGCGAUATGTGTGAACAACCACCAGGAGACG 
65891-rv TCTGCGAUTCACTGCGACTTGTCTCCCCC 
73618-fw 
73618 
AGAGCGAUATGGGAAGTCTCGGCCCCG 
73618-rv TCTGCGAUTCATGAAGACTTTGCAAATTTGGC 
81014-fw 
81014 
AGAGCGAUATGAGCATCATCGATACGACAAAGG 
81014-rv TCTGCGAUTCAAATAGGCTCATCCCGCG 
103032-fw 
103032 
AGAGCGAUATGTGCGAATCCATTCATCCAAG 
103032-rv TCTGCGAUTTAATAGTTCCACTGGTCGCACC 
24586-fw 
24586 
AGAGCGAUATGACATCCCTACCAACCAATCTCTG 
24586-rv TCTGCGAUCTATACTATGATATGCTTCACCAGTTCGG 
55306-fw 
55306 
AGAGCGAUATGAGCTCTCTACAGACCCCGTCAG 
55306-rv TCTGCGAUTCAATGAGTCGCTGCTCGCTTC 
60751-fw 
60751 
AGAGCGAUATGGACAACCCCATAACGCCAG 
60751-rv TCTGCGAUTCACAACGAAGCAACTACACCAAAAG 
67189-fw 
67189 
AGAGCGAUATGGCTATTGACGGGGATGGATATG 
67189-rv TCTGCGAUTCAGCCCTCGAGCTGGTCCTC 
68204-fw 
68204 
AGAGCGAUATGGAAATGTCAAGTCCAAGCTGG 
68204-rv TCTGCGAUTTAGCTGTCCCAGATGGCACCG 
69946-fw 
69946 
AGAGCGAUATGGAGAAACTCGATGACCTATCCG 
69946-rv TCTGCGAUTCATGTCTTTTTCCCATTCCCAATC 
71005-fw 
71005 
AGAGCGAUATGAACGGAACGCCAAAACTTCC 
71005-rv TCTGCGAUCTAATACACCTCAAGCAGAGTCTGCTCC 
71072-fw 
71072 
AGAGCGAUATGCCTGCGACGATATACATTCC 
71072-rv TCTGCGAUTTAGAGCCATCCAACAGCGTCATC 
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Table S3. Primers used for amplification of fragments for construction of plasmids for introducing the 
PKS/NRPS hybrid gene 23171 into the A. nidulans genome. 5’ primer tails for use with uracil-excision 
cloning are marked with blue. 
Primer name Construct Sequence (5’-3’) Amplicon size (bp) 
Frag1-PT1-fw 
pMJ-011 
ACCGCAUATGGCGCCGAACACTACGTACG 
8,568 
Frag1-PT1-rv ACGGCTUGGGTCGTTTGGCT 
Frag1-PT2-fw 
pMJ-011 
AAGCCGUCTTGTGCCCATCG 
9,456 
Frag1-PT2-rv ATGCACGCCUCGAAAACGAACGCAGCGAATTG 
Frag4-PT1-fw 
pMJ-014 
ACCCAGAUCACTCGTCACATCTGGCAAGC 
9,037 
Frag4-PT1-rv AGGGGCACUACCGAGGCGTTC 
Frag4-PT2-fw 
pMJ-014 
AGTGCCCCUGCCTTCATGAGC 
8,988 
Frag4-PT2-rv ATGGGCGCUTCAGCCATGGCGCTGGAAAG 
Vector-fw 
pMJ-011 
AGGCGTGCAUCCGCATCATC 
7,309 
PgpdA-rv ATGCGGUGCGGTAGTGATGTCTGCTCAAGC 
Vector-fw 
pMJ-012/013 
AGGCGTGCAUCCGCATCATC 
3,058 
Vector-rv ATCTGGGUCGTGGTCGATTGTG 
TtrpC-fw 
pMJ-014 
AGCGCCCAUCGCGTGCATTCGGATCCAC 
7,780 
Vector-rv ATCTGGGUCGTGGTCGATTGTG 
Frag2-PT1-fw 
pMJ-012 
ACCCAGAUATTGGTGGTGACTCAATCGCTGC 
10,124 
Frag2-PT1-rv AACACCCCUTGGCAGCTGATAGAC 
Frag2-PT2-fw 
pMJ-012 
AGGGGTGTUGACGTTGCTCGC 
9,898 
Frag2-PT2-rv ATGCACGCCUCCGCGTTCGTAGGATATCACG 
Frag3-PT1-fw 
pMJ-013 
ACCCAGAUTGAGAAGCAAGCCGCTGCC 
9,932 
Frag3-PT1-rv AGAAGGTGAUGGGCAAGCTTGTTAG 
Frag3-PT2-fw 
pMJ-013 
ATCACCTTCUCAACGCCGGC 
10,061 
Frag3-PT2-rv ATGCACGCCUGACAGTTGCACATCGAGCTGAG 
Table S4. Primers used for diagnostic PCRs. 
Primer name Sequence (5’-3’) Target Amplicon size (bp) 
IS1-Ins-UP-fw GGTCTACTCCCCTGCGTCTA IS1 upstream 
2,318 
IS1-Ins-UP-rv TTCCAAGCGGAGCAGGCTCG  
Fr1-Ins-fw TTTTTCGTGTCTGTTATTGCTG 23171 fragment 1 
4,901 
Fr1-Ins-rv AGAGCAACCTTTGACAATCG  
Fr2-Ins-fw CTCTGTTGGCGAGATATATGGC 23171 fragment 2 
5,066 
Fr2-Ins-rv TGATGGCGTAGTTGATGAAGCG  
Fr3-Ins-fw GTCCAGCATCTTGCGCACTC 23171 fragment 3 
5,011 
Fr3-Ins-rv ATCGAAGACGTATGCGGCGA  
Fr4-Ins-fw GTCTGGCCTCATGGACATGC 23171 fragment 4 
5,040 
Fr4-Ins-rv CGTCCCAGGTATTCGAGCTT  
IS1-Ins-DW-fw CGCCTTGGAGGGTTTCGTTG IS1 downstream 
2,595 
IS1-Ins-DW-rv GTTCAGGGTGACGGTGAGAG  
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3.4. Description of Appendices for Chapter II 
 
UV absorption spectra for the sorbicillinoids 
UV absorption spectra were made for all of the sorbicillinoid metabolites that were 
observed in larger quantities when the sorbicillinoid cluster specific transcription factor 
(JGI ID 102499) was overexpressed (Manuscript II). The entire collection of spectra can 
be seen in appendix section 6.3. 
 
Structures of known sorbicillinoids 
The molecular weights of some of the sorbicillinoid metabolites that were observed in 
larger quantities when the sorbicillinoid cluster specific transcription factor (JGI ID 
102499) was overexpressed are consistent with previously described sorbicillinoids. 
Structural drawings of these can be seen in section 6.4. 
 
Alignment and phylogeny of PKS AT domains 
The acyltransferase (AT) domains of PKSs are responsible for selection of the correct 
short-chain carboxylic acids monomers for incorporation into the PK chain. Alignments of 
these, seen in appendix section 6.5.1, might indicate the relation of the PKSs and 
whether they utilize the same monomers.  
 
Alignments and phylogeny of 23171 A domains 
Based on the predicted number of domains in the NRPS encoded by the gene with JGI ID 
23171, this is highly likely involved in biosynthesis of paracelsins. The amino acid 
sequences of some paracelsins have been described and alignments of the NRPS A 
domains, responsible for selection of the amino acid for incorporation, could therefore 
indicate whether this NRPS do in fact assemble the paracelsins. Alignment of the A 
domains and the phylogeny of these are compared to the known amino acid sequences of 
paracelsins in appendix section 6.5.2.  
 
Alignments and phylogeny of all T. reesei NRPS A domains 
As described above the A domains are gatekeepers for amino acid specificity of NRPSs. 
Alignments of these therefore indicate which amino acids they incorporate and could also 
indicate the relations between the included NRPSs. All identified T. reesei NRPS A 
domains are aligned and a phylogenetic three drawn in appendix section 6.5.3. 
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4. Summation and Perspectives 
 
The main objective of this study was to aid to unravel the secondary metabolism of the 
biotechnological important filamentous fungus T. reesei. Despite being a widespread 
production organism, surprisingly little of its secondary metabolism had previously been 
described. This study was initiated with development of new molecular tools for T. reesei 
which was subsequently used to pursue the primary objective by genetic engineering. 
 
Manuscript I (An efficient expression platform for Trichoderma reesei (teleomorph 
Hypocrea jecorina) (section 2.2)) described development of a system enabling high 
throughput construction of defined integrated T. reesei expression mutants.   
It was shown that NHEJ deficiency (section 2.1.1) in combination with targeted 
integration into adeB (section 2.1.2) constituted a highly efficient system for achieving a 
frequency of correctly integrated mutants approaching 100%. The expression system 
included pyr2 as selective marker (section 2.1.2), which provided an extremely reliable 
bidirectional selective system. The applicability of the entire expression system was 
supported by expressing a Thermomyces lanuginosus lipase as reporter protein. 
An interesting side note is that one of the two genetic deletions performed to 
substantiate that pyr2 could be used as a bidirectional marker was the PKS gene with JGI 
ID 82208. The amino acid sequence of the predicted protein of this gene bears great 
similarity to the A. nidulans PKS YWA1, encoded by wA, that synthesizes the PK 
precursor for the spore pigment melanine (Watanabe, Ono et al. 1998). As for the wA 
gene in A. nidulans, deletion of the PKS gene with JGI ID 82208 in T. reesei resulted in 
formation of white spores. 
 
To pursue the primary goal – elucidation of the secondary metabolism of T. reesei - two 
concurrent approaches were followed. 
 
Manuscript II (Identification of the sorbicillinoid gene cluster in Trichoderma reesei 
(teleomorph Hypocrea jecorina) by overexpression of PKS and NRPS cluster specific 
transcription factors (section 3.2)) described overexpression of 11 putative PKS-, NRPS- 
and hybrid synthetase gene cluster specific TFs and identification of the PKS cluster 
responsible for biosynthesis of the PK derived sorbicillinoids. 
As speculated, the expression system described in Manuscript I proved to be a valuable 
tool in the quest for elucidating the secondary metabolic potential of T. reesei. Out of the 
30 TF genes that were identified within a 50 kb radius of the PKS-, NRPS- or hybrid 
synthetase genes in the T. reesei genome, 11 were overexpressed using the expression 
system. Two mutants, both overexpressing the same TF gene (JGI ID 102499), were 
shown to over-produce as many as 78 independent metabolites; of which several could 
be appointed to the previously described group of PKs, sorbicillinoids. A subsequent 
deletion study showed that all of the over-produced metabolites were products of two 
collaborative PKSs encoded by genes adjacent to the overexpressed TF gene. Hence, the 
genes involved in biosynthesis of sorbicillinoids were pin-pointed for the first time. 
Comparative genomics furthermore led to identification of a highly similar gene cluster in 
the well-known sorbicillinoid producer P. chrysogenum, indicating that the sorbicillinoid 
gene cluster was identified in two separate species in connection with this study. 
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Manuscript III (Heterologous expression of Trichoderma reesei (teleomorph Hypocrea 
jecorina) polyketide synthase-, non-ribosomal peptide synthetase and hybrid synthetase 
genes in Aspergillus nidulans (section 3.3)) described heterologous expression of 23 of 
the 26 PKS-, NRPS- or hybrid synthetase genes identified in the T. reesei genome in A. 
nidulans using a previously developed expression system (Hansen, Salomonsen et al. 
2011).  
Interestingly, eight of the isolated mutants had changed phenotypes, indicating that the 
inserted genes were indeed overexpressed in the A. nidulans background. Subsequent 
metabolite analysis unfortunately failed in pin-pointing presence of any new metabolites 
synthesized by the proteins encoded by the inserted T. reesei PKS-, NRPS- or hybrid 
synthetase genes. The results indicate that the limitation of the applied method was 
connected to the extraction and/or analysis method and not expression of the T. reesei 
PKS-, NRPS- or hybrid synthetase genes. 
Four of the obtained A. nidulans heterologous expression mutants were more pigmented 
in the reverse than the control strain; one of these overexpressed the PKS gene with JGI 
ID 82208, which led to formation of white spores when deleted in T. reesei (Manuscript 
I). The pigment production when the gene is overexpressed in A. nidulans further 
supports that this gene could encode the PKS involved in formation of the PK precursor of 
the spore pigment melanine, as speculated. 
The remaining four mutants with altered phenotypes, all showed changed colony 
morphology. Three of these overexpressed NRPSs that had severe negative effect on the 
growth rates of the mutants which all produced two NRPs which had not previously been 
observed for A. nidulans. Biosynthesis of these two NRPs in three different mutants 
indicated that they were not products of the inserted T. reesei NRPSs, but could be a part 
of an A. nidulans defense response towards other fungi; initiated when subjected to 
foreign NRPs. 
The remaining mutant with changed colony morphology had been transformed with four 
overlapping fragments of the 69.5 kb putative paracelsin synthase gene with JGI ID 
23171. The changed phenotype for this mutant was surprising since diagnostic PCRs 
showed that only fragment one and four of the gene was present in the mutant, 
indicating that homologous recombination could have happened between these; possibly 
facilitated by the repeated sequences of the NRPS gene. Whether the changed phenotype 
was caused by production of a new smaller NRP or by insertion of the large gene 
fragments was not established in the duration of the study. 
 
This study provides an interesting initial insight into the genetics of the secondary 
metabolism of T. reesei. For the first time a linkage was established between a T. reesei 
PKS cluster and the corresponding metabolites; it also serves as the first reported 
identification of a sorbicillinoid synthase gene cluster in any organism. Interestingly, 
some sorbicillinoids have previously been reported to exhibit beneficial activities such as 
anticancer, anti-inflammatory and anti-oxidative (Balde, Andolfi et al. 2010, Lee, Lee et 
al. 2005, Washida, Abe et al. 2007) and the plethora of sorbicillinoids produced by the 
transcription factor overexpressing strains could therefore constitute an interesting 
source for new drug leads. 
The results of the A. nidulans heterologous expression study enlighten the need for 
optimization of the applied extraction and/or analysis method before providing a feasible 
source of insights into the secondary metabolism of T. reesei. The different phenotypes 
observed for several mutants indicate that the system could provide highly interesting 
information after implementation of optimizations. 
4. Summation and Perspectives PhD Thesis 
                                                                                           Mikael Skaanning Jørgensen 
 
96 
 
The developed system for defined integration of T. reesei expression mutants constitutes 
a unique tool for further elucidation of the T. reesei secondary metabolism. Also 
important, the system is not limited to unravel the secondary metabolism, but can be 
utilized for expression of all genes of interest. The utilized A. nidulans PgpdA promoter 
does not serve as a strong promoter in T. reesei, but this can easily be replaced by 
another promoter of interest by uracil-excision cloning (section 2.1.3). Furthermore, the 
highly efficient bidirectional selection system, based on pyr2, could gain wide usage for 
all genetic engineering performed in T. reesei. 
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6.1. Phylogeny of T. reesei Strains Included in the Study 
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Figure 6.1. Phylogeny of all T. reesei strains included in this study. Notice that some are included in both chapter I and II. The five digit numbers are JGI gene IDs. Abbreviations: 
OE, Overexpression; TF, Transcription factor; TrF, Transformation. 
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6.2. pyr2 Alignment 
 
The following pyr2 sequences were obtained from mutants included in the pyr4 deletion 
experiments described in section 2.3.1. Several transformations were set up with pyr4 
deletions constructs and several uridine auxotroph mutants were isolated. Further 
elucidation revealed that the pyr4 gene had not been deleted in any of these, instead 
mutations were observed in the pyr2 genes in five out of eight of the mutants that were 
selected for sequencing. The sequence alignments for these can be seen below together 
with the full wild-type pyr2 CDS. 
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6.3. UV Absorption Spectra for the Sorbicillinoids 
 
UV absorption spectra were made for all 78 metabolites that were synthesized in higher 
amounts when the sorbicillinoid cluster specific transcription factor (JGI ID 102499) was 
overexpressed. These spectra are seen in the following pages. The monoisotopic masses 
are included in the top right of every spectra together with the retention time of the 
compound for which the UV absorption are measured. All samples have an extra 
absorption peak at approximately 220 nm which is an artifact caused by use of formic 
acid in the extraction procedure (Figure 6.2). These large peaks could potentially mask 
absorption peaks for the metabolites of interest. 
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Figure 6.2. An example of a UV absorption curve with heavy absorption at approximately 220 nm facilitated by presence of 
formic acid in the sample.   
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6.4. Sorbicillinoid Structures 
 
The structure of known sorbicillinoids with monoisotopic masses corresponding to some 
of the metabolites observed in higher quantities when the sorbicillinoid cluster associated 
transcription factor (JGI ID: 102499) was overexpressed can be seen in the following 
pages. The shown metabolites might not be present in the samples obtained in this 
study. Each of the metabolites is located under their corresponding monoisotopic mass. If 
the metabolite is a possible dimer, the monoisotopic masses of the possible monomers 
are also included under the main monoisotopic mass. 
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6.5. PKS and NRPS Alignments 
 
6.5.1. Alignment and Phylogeny of PKS AT Domains 
 
The acyltransferase (AT) domains of PKSs are the gatekeepers of specificity for the short-
chain carboxylic acids that will be incorporated into the growing PK chain. Drawing of 
their phylogenetic relations can indicate whether they utilize the same monomers (Figure 
6.3). The full alignment of the PKS AT domains can be seen in the following pages. 
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Figure 6.3. Phylogeny of the AT domains of all PKSs identified in the T. reesei genome. 
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6.5.2. Alignment and Phylogeny of 23171 A Domains 
 
The adenylation (A) domains of NRPSs are the gatekeepers for selection of the correct 
amino acids for incorporation into the growing peptide chain. Based on the predicted 
number of domains in the NRPS encoded by the gene with JGI ID 23171 it is highly likely 
involved in biosynthesis of the paracelsins. The amino acid sequence of some paracelsins 
has been described (Figure 6.4), drawing of the phylogenetic relations of the A domains 
could therefore indicate whether this NRPS in fact assemble the paracelsins (Figure 6.5). 
The following pages show the full alignment of the A domains of the NRPS encoded by 
23171. 
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Figure 6.5. Phylogeny of the A domains of the NRPS encoded by the gene with JGI ID: 23171. It is seen that some A domains 
with the same AA specificity is clustered, supporting that the NRPS protein encoded by the gene with JGI ID 23171 indeed 
synthesize the paracelsins. 
 
Figure 6.4. Structure of Paracelsin A. The amino acid sequence is indicated by three letter 
abbreviations. The letters in brackets depicts the different paracelsins and what amino acids they 
have incorporated at the corresponding positions; only the amino acids that differ from paracelsin A 
are included. Abbreviations: Aib, 2-Aminoisobutyric acid; Ala, Alanine; Gln, Glutamine; Gly, Glycine; 
Leu, Leucine; Pheol, Phenylalanine; Pro, Proline; Val, Valine. 
6. Appendices PhD Thesis 
Alignment and Phylogeny of 23171 A Domains                                    Mikael Skaanning Jørgensen 
 
143 
 
 
 
 
6. Appendices PhD Thesis 
Alignment and Phylogeny of 23171 A Domains                                    Mikael Skaanning Jørgensen 
 
144 
 
 
 
6. Appendices PhD Thesis 
Alignment and Phylogeny of 23171 A Domains                                    Mikael Skaanning Jørgensen 
 
145 
 
 
 
6. Appendices PhD Thesis 
Alignment and Phylogeny of 23171 A Domains                                    Mikael Skaanning Jørgensen 
 
146 
 
 
 
 
 
6. Appendices PhD Thesis 
Alignment and Phylogeny of 23171 A Domains                                    Mikael Skaanning Jørgensen 
 
147 
 
 
 
 
6. Appendices PhD Thesis 
Alignment and Phylogeny of 23171 A Domains                                    Mikael Skaanning Jørgensen 
 
148 
 
 
 
6. Appendices PhD Thesis 
Alignment and Phylogeny of NRPS A Domains                                    Mikael Skaanning Jørgensen 
 
149 
 
6.5.3. Alignment and Phylogeny of NRPS A Domains 
 
The adenylation (A) domains of NRPSs are responsible for selection of the correct amino 
acids for incorporation into the growing peptide chain. Alignments of these can therefore 
indicate which domains that are specific for the same amino acids and could also indicate 
the relations between the included NRPSs. A phylogenetic three of all identified T. reesei 
NRPS A domains are seen in Figure 6.6 and the full alignment of these can be seen in the 
following pages. 
 
 
 
 
 
123786 A domain 01 (0.1919)
23171 A domain 01 (0.1652)
23171 A domain 17 (0.2160)
23171 A domain 12 (0.2056)
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23171 A domain 07 (0.1875)
23171 A domain 18 (0.1865)
23171 A domain 19 (0.1880)
123786 A domain 14 (0.2186)
23171 A domain 20 (0.2325)
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123786 A domain 09 (0.1632)
123786 A domain 13 (0.1446)
23171 A domain 14 (0.1406)
23171 A domain 02 (0.2302)
24586 A domain 01 (0.3470)
60458 A domain 01 (0.3421)
58285 A domain (0.3278)
59315 A domain (0.3065)
68204 A domain (0.3572)
24586 A domain 02 (0.3484)
60458 A domain 02 (0.3387)
4117 A domain (0.3988)
55306 A domain (0.4019)
59690 A domain (0.4226)
71072 A domain (0.3865)
71005 A domain 02 (0.4855)
81014 A domain (0.3772)
69946 A domain 01 (0.3389)
69946 A domain 02 (0.3427)
69946 A domain 03 (0.3267)
60751 A domain (0.3308)
67189 A domain (0.2396)
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23171 A domain 09 (0.2361)
123786 A domain 03 (0.2335)
23171 A domain 15 (0.1785)
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23171 A domain 04 (0.1655)
23171 A domain 11 (0.1646)
23171 A domain 06 (0.2324)
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123786 A domain 04 (0.2075)
123786 A domain 08 (0.1783)
23171 A domain 10 (0.1641)
123786 A domain 12 (0.1583)
23171 A domain 16 (0.1343)
23171 A domain 05 (0.1519)
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Figure 6.6. Phylogeny of the A domains of all NRPSs identified in the T. reesei genome. 
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